10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________________ to ___________________

Commission file number: 001-36204

ENERGY FUELS INC.

(Exact name of registrant as specified in its charter)

Ontario,	Canada	98-1067994
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

225 Union Blvd., Suite 600
Lakewood,	Colorado	80228
(Address of principal executive offices)		(Zip Code)

(303) 974-2140

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Shares, no par value	UUUU	NYSE American
	EFR	Toronto Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act): Yes ☐     No ☒

As of May 2, 2023, the registrant had 158,029,412 common shares, without par value, outstanding.

ENERGY FUELS INC.

FORM 10-Q

For the Quarter Ended March 31, 2023

INDEX

	Page
PART I – FINANCIAL INFORMATION
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	9
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	27
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	41
ITEM 4. CONTROLS AND PROCEDURES	42
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS	43
ITEM 1A. RISK FACTORS	43
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	43
ITEM 3. DEFAULTS UPON SENIOR SECURITIES	43
ITEM 4. MINE SAFETY DISCLOSURE	43
ITEM 5. OTHER INFORMATION	43
ITEM 6. EXHIBITS	43
SIGNATURES

3

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report and the exhibits attached hereto (the “Quarterly Report”) contain “forward-looking statements” and “forward-looking information” within the meaning of applicable United States (“U.S.”) and Canadian securities laws (collectively, “forward-looking statements”), which may include, but are not limited to, statements with respect to Energy Fuels Inc.’s (the “Company” or “Energy Fuels”): anticipated results and progress of our operations in future periods, planned exploration, if warranted, development of our properties, plans related to our business, including our rare earth element (“REE”) initiatives, including our recent acquisition of the South Bahia property in Brazil (the “Bahia Project”) and our planned development of capabilities for the commercial separation of REEs at our White Mesa Mill (the “White Mesa Mill” or the “Mill”) in Utah, any plans we may have with respect to the recovery of radioisotopes for use in the production of medical isotope therapeutics, any plans we may have to evaluate the ramp-up of production at any of our uranium and/or uranium/vanadium properties, and the expected costs of production of any properties that may be ramped up. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, schedules, assumptions, future events, or performance (often, but not always, using words or phrases such as “expects” or “does not expect,” “is expected,” “is likely,” “budgets,” “scheduled,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” “continues,” “plans,” “estimates,” or “believes,” and similar expressions or variations of such words and phrases or statements stating that certain actions, events or results “may,” “could,” “would,” “might,” or “will” be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements.

Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. We believe that the expectations reflected in these forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct, and such forward-looking statements included in, or incorporated by reference into, this Quarterly Report should not be unduly relied upon. This information speaks only as of the date of this Quarterly Report.

Readers are cautioned that it would be unreasonable to rely on any such forward-looking statements as creating any legal rights, and that the forward-looking statements are not guarantees and may involve known and unknown risks and uncertainties, and that actual results are likely to differ (and may differ materially) and objectives and strategies may differ or change from those expressed or implied in the forward-looking statements as a result of various factors. Such risks and uncertainties include, but are not limited to, global economic risks, such as the occurrence of a pandemic, political unrest or wars; risks associated with the restart of any of our uranium and uranium/vanadium mines; risks associated with our ramp-up to commercial production of an REE carbonate (“RE Carbonate”), our steps to enhance and modify our existing facilities at the Mill to allow for the commercial separation of REEs, and risks associated with the exploration and development of our recently acquired South Bahia Project in Brazil; risks associated with the potential recovery of radioisotopes for use in the production of medical isotope therapeutics; and risks generally encountered in the exploration, development, operation, closure and reclamation of mineral properties and processing and recovery facilities. Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation the following risks:

•global economic risks, including the occurrence of unforeseen or catastrophic events, such as political unrest, wars or the emergence of a pandemic or other widespread health emergency, which could create economic and financial disruptions and require us to reduce or cease operations at some or all of our facilities for an indeterminate period of time, and which could have a material impact on our business, operations, personnel and financial condition;

•risks associated with Mineral Reserve and Mineral Resource estimates, including the risk of errors in assumptions or methodologies and changes to estimate disclosure rules and regulations;

•risks associated with estimating mineral extraction and recovery, forecasting future price levels necessary to support mineral extraction and recovery, and our ability to increase mineral extraction and recovery in response to any increases in commodity prices or other market conditions;

•uncertainties and liabilities inherent to conventional mineral extraction and recovery and/or in situ recovery (“ISR”);

•risks associated with our ramp-up to commercial production of RE Carbonate our planned implementation and operation of REE separation facilities, and potentially other REE and REE-related value-added processes and facilities, at the Mill or elsewhere including the risk: that we may not be able to produce RE Carbonate or separated REE oxides that meet commercial specifications at commercial levels or at all, or at acceptable cost levels; of not being able to secure adequate supplies of uranium and REE-bearing ores in the future at satisfactory costs to us; of not being able to increase our sources of uranium and REE-bearing ores to meet future planned production goals; of not being able to sell the RE Carbonate and/or separated REE oxides we produce at acceptable prices to us; of not being able to successfully construct and operate potential other downstream REE activities, including metal-making and alloying, in the future, which are currently being

4

evaluated; of legal and regulatory challenges and delays; and the risk of technological or market changes that could impact the REE industry or our competitive position;

•risks associated with the newly established uranium reserve program for the U.S. (the “U.S. Uranium Reserve Program”), being subject to appropriation by the U.S. Congress, and the expansion of the U.S. Uranium Reserve Program;

•risks associated with current federal, state and local administrations and changes thereto, including a lack of support of mining, uranium mining, nuclear energy or other aspects of our business, such as the new U.S. Uranium Reserve Program;

•geological, technical and processing problems, including unanticipated metallurgical difficulties, less than expected recoveries, ground control problems, process upsets, and equipment malfunctions;

•risks associated with the depletion of existing Mineral Resources through mining or extraction, without replacement with comparable Mineral Resources;

•risks associated with identifying and obtaining adequate quantities of other uranium-bearing materials not derived from conventional material and sourced by third parties (“Alternate Feed Materials”) and other feed sources required for the operation of our Mill;

•risks associated with labor costs, labor disturbances, and unavailability of skilled labor;

•risks associated with the availability and/or fluctuations in the costs of raw materials and consumables used in our production processes;

•risks and costs associated with environmental compliance and permitting, including those created by changes in environmental legislation and regulation, and delays in obtaining permits and licenses that could impact expected mineral extraction and recovery levels and costs;

•actions taken by regulatory authorities with respect to mineral extraction and recovery activities;

•risks associated with our dependence on third parties in the provision of transportation and other critical services;

•risks associated with our ability to obtain, extend or renew land tenure, including mineral leases and surface use agreements, on favorable terms or at all;

•risks associated with our ability to negotiate access rights on certain properties on favorable terms or at all;

•risks associated with potential information security incidents, including cybersecurity breaches;

•risks that we may compromise or lose our proprietary technology or intellectual property in certain circumstances, which could result in a loss in our competitive position and/or the value of our intangible assets;

•risks associated with our ongoing ability to successfully develop, attract and retain qualified management, Board members and other key personnel critical to the success of our business, given that the number of individuals with significant experience in the uranium, vanadium, REE and radioisotope industries is relatively small;

•competition for, among other things, capital, mineral properties, and skilled personnel;

•the adequacy of our insurance coverage;

•uncertainty as to reclamation and decommissioning liabilities;

•the ability of our bonding companies to require increases in the collateral required to secure reclamation obligations;

•the potential for, and outcome of, litigation and other legal proceedings, including potential injunctions pending the outcome of such litigation and proceedings;

•our ability to meet our obligations to our creditors and to access credit facilities on favorable terms;

•risks associated with our relationships with our business and joint venture partners;

•failure to obtain industry partner, government, and other third-party consents and approvals, when required;

•failure to complete and integrate proposed acquisitions, or incorrect assessment of the value of completed acquisitions, including our newly acquired mineral concessions in the State of Bahia, Brazil;

•risks associated with fluctuations in price levels for heavy mineral sands and their components, including the prices for ilmenite, rutile, titanium and zircon, which could impact planned production levels or the feasibility of production of heavy mineral sands and monazite from our Bahia project in Brazil, and which could impact our planned monazite supply for our RE Carbonate and planned REE oxide production at the Mill;

•risks posed by fluctuations in share price levels, exchange rates and interest rates, and general economic conditions;

•risks inherent in our and industry analysts’ forecasts or predictions of future uranium, vanadium, copper (if and when produced) and REE price levels, including the prices for RE Carbonates, REE oxides, REE metals and REE metal alloys;

•market prices of uranium, vanadium, copper (if and when produced) and REEs, which are cyclical and subject to substantial price fluctuations;

•risks associated with future uranium sales, if any, being required to be made at spot prices, unless we are able to continue entering into new long-term contracts at satisfactory prices in the future;

•risks associated with our vanadium sales, if any, generally being required to be made at spot prices;

•risks associated with our RE Carbonate sales and potential REE oxide sales, if any, being tied in whole or in part to REE spot prices;

•failure to obtain suitable uranium sales terms at satisfactory prices in the future, including spot and term sale contracts;

•failure to obtain suitable vanadium sales terms at satisfactory prices in the future;

•failure to obtain suitable copper (if and when produced) or REE sales terms at satisfactory prices in the future;

5

•risks associated with any expectation that we will be successful in helping the U.S. Environmental Protection Agency (“EPA”) and Navajo Nation address the clean-up of historic abandoned uranium mines;

•risks associated with asset impairment as a result of market conditions;

•risks associated with lack of access to markets and the ability to access capital;

•the market price of our securities;

•public and/or political resistance to nuclear energy or uranium extraction and recovery;

•risks associated with inaccurate or nonobjective media coverage of our activities and the impact such coverage may have on the public, the market for our securities, government relations, commercial relations, permitting activities and legal challenges, as well as the costs to us of responding to such coverage;

•risks associated with potential impacts of public perceptions on our commercial relations;

•uranium industry competition, international trade restrictions and the impacts they have on world commodity prices of foreign state-subsidized production, and wars/conflicts influencing international demand and commercial relations;

•risks associated with foreign governmental actions, policies, laws, rules and regulations, and foreign state-subsidized enterprises, with respect to REE production and sales, which could impact REE prices available to us and impact our access to global and domestic markets for the supply of REE-bearing ores and the sale of RE Carbonate and other REE products and services to world and domestic markets;

•risks associated with our involvement in industry petitions for trade remedies and extension of the Russian Suspension Agreement, including costs of pursuing such remedies and the potential for negative responses/repercussions from various interest groups, consumers of uranium, and participants in other phases of the nuclear fuel cycle domestically and abroad;

•risks associated with governmental actions, policies, laws, rules and regulations with respect to nuclear energy or uranium extraction and recovery;

•risks related to potentially higher than expected costs related to any of our projects or facilities;

•risks related to our ability to potentially recover copper from our Pinyon Plain uranium project mineralized materials;

•risks related to stock price, volume volatility and recent market events;

•risks related to our ability to maintain our listings on the NYSE American and the Toronto Stock Exchange (“TSX”);

•risks related to our ability to maintain our inclusion in various stock indices;

•risks related to dilution of currently outstanding shares from additional share issuances, depletion of assets, etc.;

•risks related to our securities, including securities regulations, and our lack of dividends;

•risks related to our issuance of additional freely tradable common shares of the Company (“Common Shares”) under our At-the-Market (“ATM”) program or otherwise to provide adequate liquidity in depressed commodity market situations;

•risks related to acquisition and integration issues, or related to defects in title to our mineral properties;

•risks related to our method of accounting for equity investments in other companies potentially resulting in material changes to our financial results that are not fully within our control;

•risks related to conducting business operations in foreign countries;

•risks related to any material weaknesses that may be identified in our internal controls over financial reporting. If we are unable to implement/maintain effective internal controls over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports, negatively affecting the market price of our common stock;

•risks of amendment to mining laws, including the imposition of any royalties on minerals extracted from federal lands, the designation of national monuments, mineral withdrawals or similar actions, which could adversely impact our affected properties or our ability to operate our affected properties; and

•risks related to our potential recovery of radioisotopes at the Mill for use in the development and production of emerging targeted alpha therapy (“TAT”) cancer therapeutics, including any expectation that: such potential recovery will be feasible or that the radioisotopes will be able to be sold on a commercial basis; all required licenses, permits and regulatory approvals will be obtained on a timely basis or at all; the cancer treatment therapeutics will receive all approvals and will be commercially successful; and the risk of technological or market changes that could impact the TAT industry or our competitive position.

Such statements are based on a number of assumptions which may prove to be incorrect, including, but not limited to, the following assumptions: that there is no material deterioration in general business and economic conditions; that there is no unanticipated fluctuation of interest rates and foreign exchange rates; that the supply and demand for, deliveries of, and the level and volatility of prices of uranium, vanadium, REEs and our other primary metals, radioisotopes and minerals develop as expected; that uranium, vanadium and REE prices required to reach, sustain or increase expected or forecasted production levels are realized as expected; that our proposed RE Carbonate production or any other REE activities, our proposed radioisotope program, or other potential production activities will be technically or commercially successful; that we receive regulatory and governmental approvals for our development projects and other operations on a timely basis; that we are able to operate our mineral properties and processing facilities as expected; that we are able to implement new process technologies and operations as expected; that existing licenses and permits are renewed as required; that we are able to obtain financing for our development projects on reasonable terms; that we are able to procure mining equipment and operating supplies in sufficient quantities and on a timely basis; that engineering and construction timetables and capital costs for our development

6

and expansion projects and restarting projects on standby are not incorrectly estimated or affected by unforeseen circumstances; that costs of closure of various operations are accurately estimated; that there are no unanticipated changes in collateral requirements for surety bonds; that there are no unanticipated changes to market competition; that our Mineral Reserve and Mineral Resource estimates are within reasonable bounds of accuracy (including with respect to size, grade and recoverability) and that the geological, operational and price assumptions on which these are based are reasonable; that environmental and other administrative and legal proceedings or disputes are satisfactorily resolved; that there are no significant changes to regulatory programs and requirements that would materially increase regulatory compliance costs, bonding costs or licensing/permitting requirements; and that we maintain ongoing relations with our employees and with our business and joint venture partners.

This list is not exhaustive of the factors that may affect our forward-looking statements. Some of the important risks and uncertainties that could affect forward-looking statements are described further under the section heading: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations of this Quarterly Report. Although we have attempted to identify important factors that could cause actual results to differ materially from those described in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated, or expected. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Except as required by applicable law, we disclaim any obligation to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events. Statements relating to “Mineral Reserves” or “Mineral Resources” are deemed to be forward-looking statements, as they involve the implied assessment, based on certain estimates and assumptions that the Mineral Reserves and Mineral Resources described may be profitably extracted in the future.

Market, Industry and Other Data

This Quarterly Report contains estimates, projections and other information concerning our industry, our business, and the markets for our products. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from our own internal estimates and research as well as from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry and general publications, government data, and similar sources.

We qualify all forward-looking statements contained in this Quarterly Report by the foregoing cautionary statements.

7

CAUTIONARY NOTE TO INVESTORS CONCERNING

DISCLOSURE OF MINERAL RESOURCES AND RESERVES

We are a U.S. domestic issuer for United States Securities and Exchange Commission (“SEC”) purposes, a majority of our outstanding voting securities are held by U.S. residents, we are required to report our financial results in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and our primary trading market is the NYSE American. However, because we are incorporated in Ontario, Canada and also listed on the TSX, this Quarterly Report also contains or incorporates by reference certain disclosure that satisfies the additional requirements of Canadian securities laws that differ from the requirements of U.S. securities laws.

All mineral estimates constituting mining operations that are material to our business or financial condition included in this Quarterly Report, and in the documents incorporated by reference herein, have been prepared in accordance with both 17 CFR Subparts 220.1300 and 229.601(b)(96) (collectively, “S-K 1300”), the SEC’s mining disclosure framework effective as of 2021, and Canadian National Instrument 43-101 - Standards of Disclosure for Mineral Projects (“NI 43-101”), a rule developed by the Canadian Securities Administrators (the “CSA”) that establishes standards for all public disclosure an issuer makes of scientific and technical information concerning mineral projects. Furthermore, all mineral estimates constituting mining operations that are material to our business or financial condition included in this Quarterly Report are supported by pre-feasibility studies and/or initial assessments prepared in accordance with both the requirements of S-K 1300 and NI 43-101. S-K 1300 and NI 43-101 both provide for the disclosure of: (i) “Inferred Mineral Resources,” which investors should understand have the lowest level of geological confidence of all mineral resources and thus may not be considered when assessing the economic viability of a mining project and may not be converted to a Mineral Reserve; (ii) “Indicated Mineral Resources,” which investors should understand have a lower level of confidence than that of a “Measured Mineral Resource” and thus may be converted only to a “Probable Mineral Reserve”; and (iii) “Measured Mineral Resources,” which investors should understand have sufficient geological certainty to be converted to a “Proven Mineral Reserve” or to a “Probable Mineral Reserve.” Investors are cautioned not to assume that all or any part of Measured or Indicated Mineral Resources will ever be converted into Mineral Reserves as defined by S-K 1300 or NI 43-101. Investors are cautioned not to assume that all or any part of an Inferred Mineral Resource exists or is economically or legally mineable, or that an Inferred Mineral Resource will ever be upgraded to a higher category.

For purposes of S-K 1300 and NI 43-101, the Company is classified as a development stage issuer because it is engaged in the preparation of Mineral Reserves for extraction on at least one material property.

All mineral disclosure reported in this Quarterly Report has been prepared in accordance with the definitions of both S-K 1300 and NI 43-101.

8

PART I

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.

ENERGY FUELS INC.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(unaudited) (Expressed in thousands of U.S. dollars, except per share amounts)

	Three Months Ended
	March 31,
	2023		2022
Revenues
Uranium concentrates	$	18,470	$	—
Vanadium concentrates	871		2,412
Alternate Feed Materials, processing and other	272		525
Total revenues	19,613		2,937
Costs applicable to revenues
Costs applicable to uranium concentrates	7,715		—
Costs applicable to vanadium concentrates	551		1,229
Underutilized capacity production costs applicable to RE Carbonate	—		1,663
Total costs applicable to revenues	8,266		2,892
Other operating costs and expenses
Exploration, development and processing	3,096		1,173
Standby	2,287		3,475
Accretion of asset retirement obligations	346		394
Selling, general and administration	6,023		5,216
Total operating loss	(405)		(10,213)
Other income (loss)
Gain on sale of assets (Note 5)	116,450		—
Other loss (Note 11)	(1,781)		(4,517)
Total other income (loss)	114,669		(4,517)
Net income (loss)	114,264		(14,730)
Basic and dilutive net income (loss) per common share (Note 8)	$	0.72	$	(0.09)
Items that may be reclassified in the future to income (loss)
Foreign currency translation adjustment	—		1,766
Other comprehensive income (loss)	—		1,766
Comprehensive income (loss)	$	114,264	$	(12,964)
Net income (loss) attributable to:
Owners of the Company	$	114,265	$	(14,729)
Non-controlling interests	(1)		(1)
	$	114,264	$	(14,730)
Comprehensive income (loss) attributable to:
Owners of the Company	$	114,265	$	(12,963)
Non-controlling interests	(1)		(1)
	$	114,264	$	(12,964)

See accompanying notes to the condensed consolidated financial statements.

9

ENERGY FUELS INC.

Condensed Consolidated Balance Sheets

(unaudited) (Expressed in thousands of U.S. dollars, except share amounts)

	March 31, 2023		December 31, 2022
ASSETS
Current assets
Cash and cash equivalents	$	43,831	$	62,820
Marketable securities (Notes 3 and 13)	60,438		12,192
Trade and other receivables, net of allowance for credit losses of $223 and $223, as of March 31, 2023 and December 31, 2022, respectively	2,098		519
Inventories (Note 4)	38,003		38,155
Prepaid expenses and other current assets	4,198		9,529
Property, plant and equipment and other assets held for sale, net (Note 5)	346		12,375
Total current assets	148,914		135,590
Other long-term receivables	1,501		1,537
Inventories (Note 4)	2,078		2,465
Operating lease right of use asset	1,348		1,376
Investments accounted for at fair value (Note 13)	16,374		19,329
Property, plant and equipment, net (Note 5)	14,635		12,662
Mineral properties (Note 5)	113,834		83,539
Convertible note (Notes 3 and 13)	59,259		—
Restricted cash (Note 6)	17,508		17,449
Total assets	$	375,451	$	273,947
LIABILITIES & EQUITY
Current liabilities
Accounts payable and accrued liabilities (Note 11)	$	5,275	$	6,929
Operating lease liability	28		59
Deposits for assets held for sale	—		6,000
Asset retirement obligation and other liabilities held for sale (Note 6)	—		5,636
Total current liabilities	5,303		18,624
Operating lease liability	1,273		1,319
Asset retirement obligations (Note 6)	9,862		9,595
Total liabilities	16,438		29,538
Equity
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 158,029,412 and 157,682,531 as of March 31, 2023 and December 31, 2022, respectively	698,833		698,493
Accumulated deficit	(341,855)		(456,120)
Accumulated other comprehensive loss	(1,946)		(1,946)
Total shareholders' equity	355,032		240,427
Non-controlling interests	3,981		3,982
Total equity	359,013		244,409
Total liabilities and equity	$	375,451	$	273,947
Commitments and contingencies (Note 12)

See accompanying notes to the condensed consolidated financial statements.

10

ENERGY FUELS INC.

Condensed Consolidated Statements of Changes in Equity

(unaudited) (Expressed in thousands of U.S. dollars, except share amounts)

	Common Stock			Deficit		Accumulated Other Comprehensive Income (Loss)		Total Shareholders' Equity		Non-Controlling Interests		Total Equity
	Shares	Amount
Balance as of December 31, 2022	157,682,531	$	698,493	$	(456,120)	$	(1,946)	$	240,427	$	3,982	$	244,409
Net income (loss)	—	—		114,265		—		114,265		(1)		114,264
Share-based compensation	—	1,186		—		—		1,186		—		1,186
Shares issued for exercise of stock options	34,219	72		—		—		72		—		72
Shares issued for the vesting of restricted stock units	312,662	—		—		—		—		—		—
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units	—	(918)		—		—		(918)		—		(918)
Balance as of March 31, 2023	158,029,412	$	698,833	$	(341,855)	$	(1,946)	$	355,032	$	3,981	$	359,013
Balance as of December 31, 2021	156,262,199	$	685,903	$	(396,271)	$	1,943	$	291,575	$	3,951	$	295,526
Net loss	—	—		(14,729)		—		(14,729)		(1)		(14,730)
Other comprehensive loss	—	—		—		1,766		1,766		—		1,766
Shares issued for cash by at-the-market offering	413,751	4,260		—		—		4,260		—		4,260
Share issuance cost	—	(96)		—		—		(96)		—		(96)
Share-based compensation	—	862		—		—		862		—		862
Shares issued for exercise of stock options	135,926	328		—		—		328		—		328
Shares issued for the vesting of restricted stock units	362,350	—		—		—		—		—		—
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units	—	(884)		—		—		(884)		—		(884)
Shares issued for consulting services	6,022	51		—		—		51		—		51
Balance as of March 31, 2022	157,180,248	$	690,424	$	(411,000)	$	3,709	$	283,133	$	3,950	$	287,083

See accompanying notes to the condensed consolidated financial statements.

11

ENERGY FUELS INC.

Condensed Consolidated Statements of Cash Flows

(unaudited) (Expressed in thousands of U.S. dollars)

	Three Months Ended
	March 31,
	2023		2022
OPERATING ACTIVITIES
Net income (loss) for the period	$	114,264	$	(14,730)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depletion, depreciation and amortization	655		813
Share-based compensation	1,186		862
Accretion of asset retirement obligations	346		394
Revision and settlement of asset retirement obligation	—		96
Unrealized foreign exchange (gain) loss	(24)		1,225
Unrealized loss on investments accounted for at fair value	2,959		3,418
Gain on sale of assets	(116,450)		—
Other non-cash income, net	149		42
Changes in current assets and liabilities:
Marketable securities	(325)		(111)
Inventories	538		784
Trade and other receivables	(1,540)		(1,332)
Prepaid expenses and other current assets	(1,233)		(886)
Accounts payable and accrued liabilities	(3,104)		(1,123)
Net cash used in operating activities	(2,579)		(10,548)
INVESTING ACTIVITIES
Additions to property, plant and equipment	(2,042)		(398)
Additions to mineral properties	(1,171)		—
Acquisition of mineral properties	(21,624)		—
Purchases of marketable securities	(47,924)		—
Proceeds from sale of property, plant and equipment, net	53,759		—
Net cash used in investing activities	(19,002)		(398)
FINANCING ACTIVITIES
Issuance of common shares for cash, net of issuance costs	—		4,164
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units	(918)		(892)
Cash received from exercise of stock options	72		318
Net cash provided by (used in) financing activities	(846)		3,590
Effect of exchange rate fluctuations on cash held in foreign currencies	22		19
Plus: release of restricted cash related to sale of assets	3,475		—
Net change in cash, cash equivalents and restricted cash	(18,930)		(7,337)
Cash, cash equivalents and restricted cash, beginning of period	80,269		132,822
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD	$	61,339	$	125,485
Non-cash investing and financing transactions:
Issuance of common shares for consulting services	$	—	$	193
Supplemental disclosure of cash flow information:
Net cash paid during the period for:
Interest	$	11	$	9
Increase (decrease) in accrued capital expenditures and accounts payable for property, plant and equipment and mineral properties	$	1,456	$	(182)

See accompanying notes to the condensed consolidated financial statements.

12

ENERGY FUELS INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2023

(unaudited) (Tabular amounts expressed in thousands of U.S. dollars, except share and per share amounts)

1.    THE COMPANY AND DESCRIPTION OF BUSINESS

Energy Fuels Inc. was incorporated under the laws of the Province of Alberta and was continued under the Business Corporations Act (Ontario).

Energy Fuels Inc. and its subsidiary companies (collectively “the Company” or “Energy Fuels”) are together engaged in conventional and in situ recovery (“ISR”) uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties, along with the exploration, permitting and evaluation of uranium properties in the United States (the “U.S.”). As a part of these activities, the Company also acquires, explores, evaluates and, if warranted, permits uranium properties. The Company’s final uranium product, uranium oxide concentrate (“U3O8” or “uranium concentrate”), known more commonly as “yellowcake,” is sold to customers for further processing into fuel for nuclear reactors. The Company also produces vanadium pentoxide (“V2O5”), along with uranium at the White Mesa Mill (the “White Mesa Mill” or the “Mill”), from certain of its Colorado Plateau properties as market conditions warrant and at times from solutions in its Mill tailings impoundment system. The Mill is also ramping up to commercial production of rare earth element (“REE”) carbonate (“RE Carbonate”) from various uranium- and REE-bearing materials acquired from third parties and is working on modifications and enhancements at the Mill for the potential production of separated REE oxides. Additionally, the Company is evaluating the potential to recover radioisotopes from its existing process streams at the Mill for use in targeted alpha therapy (“TAT”) therapeutics for the treatment of cancer.

With its uranium, vanadium, REE and potentially radioisotope production, the Mill is working to establish itself as a critical minerals hub in the U.S. Uranium is the fuel for carbon-free, emission-free baseload nuclear power – one of the cleanest forms of energy in the world. The REEs produced are used to manufacture permanent magnets for electric vehicles, wind turbines and other clean energy and modern technologies. The Company's uranium and REE production and recycling helps Energy Fuels play a part in addressing global climate change and reducing air pollution. Additionally, the radioisotopes, which the Company is evaluating for recovery from its uranium processing streams, have the potential to provide the isotopes needed for emerging TAT cancer-fighting therapeutics.

The Company is a “development stage issuer” as defined by S-K 1300, as it is engaged in the preparation of Mineral Reserves for extraction of at least one material property.

Mining Activities

Mining activities consist of the Mill, multiple conventional mining projects and an ISR mining project (complete with an ISR recovery facility on standby). The most conventional mining projects are located on the Colorado Plateau, including the Pinyon Plain, Whirlwind, La Sal, Bullfrog, Arizona Strip and Roca Honda Projects, all of which are in the vicinity of the Mill, as well as the Sheep Mountain Project located in Wyoming. The ISR project is the Nichols Ranch Project (which includes Jane Dough and Hank Satellite deposits) located in Wyoming. On February 14, 2023, the Company closed on the sale of the Alta Mesa Project. See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

As of March 31, 2023, other than performing rehabilitation and development work on its La Sal, Whirlwind and Pinyon Plain projects, the conventional mining projects in the vicinity of the Mill and Sheep Mountain are on standby and are being evaluated for continued mining activities and/or are in the process of being permitted. The Mill continues to receive third-party uranium-bearing mineralized materials from mining and recycling activities, such as the Mill’s alternate feed program, for processing, continues to expand its REE initiatives, and continues to develop its cancer therapeutics initiatives.

2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

These unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) applicable to interim financial information and should be read in conjunction with the consolidated financial statements and notes thereto and the summary of significant accounting policies included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC.

These unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information, and, accordingly, do not include all

13

of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements are presented in thousands of U.S. dollars, except for share and per share amounts. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included are adequate to make the information presented not misleading.

In management’s opinion, these unaudited condensed consolidated financial statements reflect all adjustments, consisting solely of normal recurring items, which are necessary for the fair presentation of the Company’s financial position, results of operations and cash flows on a basis consistent with that of the Company’s audited consolidated financial statements for the year ended December 31, 2022. However, the results of operations for the interim periods may not be indicative of results to be expected for the full fiscal year.

Principles of Consolidation

These unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated. Certain prior period amounts have been reclassified in order to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.

3.    MARKETABLE SECURITIES

The Company elected the fair value option for its marketable debt securities and convertible note for which changes in fair value are recorded in Other income (loss) in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The fair value option was elected for these marketable debt securities, as the Company may sell them prior to their stated maturities after consideration of the Company's risk versus reward objectives, as well as its liquidity requirements. The stated contractual maturity dates of marketable debt securities held as of March 31, 2023 and December 31, 2022 are due in one to two years. The convertible note was received as a partial consideration for the Alta Mesa Transaction (defined in Note 5 – Property, Plant and Equipment and Mineral Properties). The Company elected the fair value option for the secured convertible note (the “Convertible Note”), as it has the option of converting into common shares of enCore Energy Corp. (“enCore”). Marketable equity securities are measured at fair value as of each reporting date, and unrealized gains (losses) are recorded in Other income (loss) in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

The following table summarizes our marketable securities by significant investment categories as of March 31, 2023:

	Cost Basis		Gross Unrealized Losses		Gross Unrealized Gains		Fair Value
Marketable debt securities(1)	$	59,359	$	—	$	72	$	59,431
Convertible note(2)	59,457		(198)		—		59,259
Marketable equity securities	2,876		(1,869)		—		1,007
Total marketable securities	$	121,692	$	(2,067)	$	72	$	119,697

(1)     Marketable debt securities are comprised primarily of U.S. government agency bonds.

(2)     The Convertible note was received as consideration in the Alta Mesa Transaction (defined in Note 5 – Property, Plant and Equipment and Mineral Properties) and is valued using a binomial lattice model using Level 3 inputs. See Note 5 – Property, Plant and Equipment and Mineral Properties and Note 13 – Fair Value Accounting for more information.

The following table summarizes our marketable securities by significant investment categories as of December 31, 2022:

	Cost Basis		Gross Unrealized Losses		Gross Unrealized Gains		Fair Value
Marketable debt securities(1)	$	11,435	$	(310)	$	—	$	11,125
Marketable equity securities	2,876		(1,809)		—		1,067
Total marketable securities	$	14,311	$	(2,119)	$	—	$	12,192

(1)     Marketable debt securities are comprised primarily of U.S. government agency bonds.

14

4.    INVENTORIES

Inventories consisted of the following items:

	March 31, 2023		December 31, 2022
Concentrates and work-in-progress	$	35,869	$	35,476
Inventory of ore in stockpiles	256		940
Consumables	3,956		4,204
Total inventories	$	40,081	$	40,620
Inventories – by duration
Current	$	38,003	$	38,155
Long term	2,078		2,465
Total inventories	$	40,081	$	40,620

5.    PROPERTY, PLANT AND EQUIPMENT AND MINERAL PROPERTIES

The following is a summary of property, plant and equipment, net:

	March 31, 2023						December 31, 2022
	Cost		Accumulated Depreciation		Net Book Value		Cost		Accumulated Depreciation		Net Book Value
Property, plant and equipment
Nichols Ranch	$	29,210	$	(20,730)	$	8,480	$	29,210	$	(20,221)	$	8,989
Pinyon Plain	2,058		(746)		1,312		1,617		(714)		903
Equipment and other	17,196		(12,353)		4,843		15,009		(12,239)		2,770
Property, plant and equipment total	$	48,464	$	(33,829)	$	14,635	$	45,836	$	(33,174)	$	12,662

As of December 31, 2022, the net book value of the property, plant and equipment attributable to Alta Mesa was $8.21 million, which was included in Property, plant and equipment and other assets held for sale, net on the Condensed Consolidated Balance Sheets.

The Company recognized depreciation expense of $0.66 million and $0.81 million for the three months ended March 31, 2023, and 2022, respectively, in Exploration, development and process and Standby in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

For the three months ended March 31, 2023 and 2022, the Company capitalized $0.07 million and $0.05 million, respectively, of depreciation expense related to the Mill that was included in the capitalized costs to inventory on the Condensed Consolidated Balance Sheet.

15

The following is a summary of mineral properties:

	March 31, 2023		December 31, 2022
Mineral properties
Sheep Mountain	$	34,183	$	34,183
Bahia Project	29,124		—
Uranerz ISR properties	25,974		25,974
Roca Honda	22,095		22,095
Pinyon Plain	1,171		—
Other	1,287		1,287
Mineral properties total	$	113,834	$	83,539

Bahia Project

On February 10, 2023, the Company closed on two purchase agreements to acquire a total of 17 mineral concessions in the State of Bahia, Brazil totaling approximately 37,300 acres or 58.3 square miles (the “Bahia Project”). Under the terms of the purchase agreements, the Company entered into mineral rights transfer agreements with the sellers to acquire the 17 mineral sand concessions.

The total purchase price under the purchase agreements was $27.50 million, which consisted of $21.60 million due at closing and prior to closing, deposit payments of $5.90 million due upon reaching certain stipulated milestones. Upon final payment on February 10, 2023, the transfer and assignment of the mineral rights was completed (the “Bahia Closing”). Additionally, the Company incurred direct deal costs related to such asset acquisition of $1.63 million. The purchase deposit payments and direct transaction costs were capitalized as Prepaid expenses and other current assets in the Consolidated Balance Sheets as of December 31, 2022 and reclassified to Mineral properties upon closing within the Condensed Consolidated Balance Sheets. The Bahia Closing followed the Brazilian Government’s approval of the transfers to Energy Fuels’ wholly owned Brazilian subsidiary Energy Fuels Brazil Ltda.

Alta Mesa Transaction

On February 14, 2023, the Company closed on its sale of three wholly owned subsidiaries that together hold Energy Fuels’ Alta Mesa ISR Project to enCore for total consideration of $120 million (the “Alta Mesa Transaction”), paid as follows:

a.$60 million cash, which included $6 million prior to closing and $54 million at closing; and

b.$60 million in the Convertible Note, payable in two years from the closing, bearing annual interest of eight percent (8%). The Convertible Note is convertible at Energy Fuels’ election into enCore common shares at a conversion price of $2.9103 per share, being a 20% premium to the 10-day volume-weighted average price of enCore shares ending the day before the Closing (the “Conversion Option”). enCore is currently traded on the TSX-V and NYSE American. The Convertible Note is guaranteed by enCore and fully secured by Alta Mesa. Unless a block trade or similar distribution is executed by Energy Fuels to sell the enCore common shares received on conversion of the Convertible Note, Energy Fuels will be limited to selling a maximum of $10 million of common shares per thirty (30)-day period.

The Company recognized a gain on sale of assets from the Alta Mesa Transaction of $116.45 million, which is calculated as the total fair value of the consideration received of $119.46 million consisting of $60 million in cash and the Convertible Note with a fair value of $59.46 million, less the net book value attributable to the Alta Mesa ISR project assets and liabilities of $3.34 million, net of transaction costs. Receipt of the Convertible Note represents a non-cash investing activity at its initial fair value. See Note 13 – Fair Value Accounting for more information on the fair value of the Note.

In addition, after the closing of the transaction, enCore was required to replace the $3.59 million of reclamation bonds that existed for the Alta Mesa project. As of March 31, 2023, the Company has received $3.48 million cash as a release of collateral from those bonds, which it has reclassified from Property, plant and equipment and other assets held for sale, net to cash and cash equivalents on its Condensed Consolidated Balance Sheets.

In connection with the Alta Mesa Transaction, on May 3, 2023, the Company completed the sale of its Prompt Fission Neutron assets, including the underlying contracts, technology, licenses and intellectual property (collectively, the “PFN Assets”), to enCore in exchange for cash consideration received at closing of $3.10 million. At closing, the PFN Assets, which the Company had purchased in 2020 for cash consideration of $0.5 million, had a net book value of $0.35 million. The PFN Assets were used exclusively at the Alta Mesa ISR Project. Should the Company have the need for the use of a PFN tool in the future, the Company retained a 20-year usage right as a condition of this sale during which, subject to the availability of the PFN Assets, the Company has the right to purchase, lease and/or license at least one fully functional PFN tool and all related and/or

16

required equipment, technology and licenses, as reasonably requested, on commercially reasonable terms and conditions no less favorable than those offered by enCore to third parties. As of May 5, 2023, the Company has not purchased, leased and/or licensed a PFN tool.

6.    ASSET RETIREMENT OBLIGATIONS AND RESTRICTED CASH

Asset Retirement Obligations

The following table summarizes the Company’s asset retirement obligations:

	March 31, 2023		December 31, 2022
Asset retirement obligations, beginning of period	$	9,595	$	13,687
Revision of estimate	—		(238)
Accretion of liabilities	346		1,556
Held for sale(1)	(79)		(5,410)
Asset retirement obligations, end of period	$	9,862	$	9,595

(1)Asset retirement obligations held for sale as of December 31, 2022 are related to Alta Mesa and are included as asset retirement obligation and other liabilities held for sale on the Condensed Consolidated Balance Sheets. Asset retirement obligations held for sale as of March 31, 2023 are related to the accretion expense on Alta Mesa through the closing date and is included within Gain on sale of assets on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

The Company’s asset retirement obligations are subject to legal and regulatory requirements. Estimates of the costs of reclamation are reviewed periodically by the Company and the applicable regulatory authorities.

Restricted Cash

The Company has cash, cash equivalents and fixed income securities as collateral for various bonds posted in favor of the applicable state regulatory agencies in Arizona, Colorado, New Mexico, Texas, Utah and Wyoming, and the U.S. Bureau of Land Management and U.S. Forest Service for estimated reclamation costs associated with the White Mesa Mill, Nichols Ranch, Alta Mesa and other mining properties. The restricted cash will be released when the Company has reclaimed a mineral property, sold a mineral property to a party having assumed the applicable bond requirements, or restructured the surety and collateral arrangements. See Note 12 – Commitments and Contingencies for more information.

The following table summarizes the Company’s restricted cash:

	March 31, 2023		December 31, 2022
Restricted cash, beginning of period	$	17,449	$	20,305
Additional collateral posted	59		734
Held for sale(1)	—		(3,590)
Restricted cash, end of period	$	17,508	$	17,449

(1)Restricted cash held for sale is related to Alta Mesa and is included as Asset retirement obligation and other liabilities held for sale on the Condensed Consolidated Balance Sheets. As of March 31, 2023, $3.48 million has been released and reclassified from Asset retirement obligation and other liabilities held for sale to cash and cash equivalents on the Condensed Consolidated Balance Sheets. The remaining $0.11 million was reclassified Restricted cash on the Condensed Consolidated Balance Sheets. See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

7.    CAPITAL STOCK

Authorized Capital Stock

The Company is authorized to issue an unlimited number of Common Shares without par value, unlimited Preferred Shares issuable in series and unlimited Series A Preferred Shares. The Preferred Shares issuable in series will have the rights, privileges, restrictions and conditions assigned to the particular series upon the Board of Directors approving their issuance. The Series A Preferred Shares issuable are non-redeemable, non-callable, non-voting and have no right to dividends.

Issued Capital Stock

During the three months ended March 31, 2022, the Company issued 0.41 million Common Shares under its At-the-Market (the “ATM”) program offering for net proceeds of $4.16 million after share issuance costs. No Common Shares were issued under the ATM program during the three months ended March 31, 2023.

17

8.    BASIC AND DILUTED NET INCOME (LOSS) PER COMMON SHARE

Basic and diluted income (loss) per Common Share

The calculation of basic and diluted loss per share after adjustment for the effects of all potential dilutive Common Shares, is as follows:

	Three Months Ended March 31,
	2023		2022
Net income (loss) attributable to owners of the Company	$	114,265	$	(14,729)
Basic weighted average common shares outstanding	157,930,097		156,614,344
Dilutive impact of stock options and restricted stock units	1,298,970		—
Diluted weighted average common shares outstanding	159,229,067		156,614,344
Basic net income (loss) per common share	$	0.72	$	(0.09)
Diluted net income (loss) per common share	$	0.72	$	(0.09)

For the three months ended March 31, 2023 and 2022, a weighted average of 0.26 million and 1.53 million, respectively, stock options and restricted stock units (“RSUs”) have been excluded from the calculation of diluted net income per Common Share as their effect would have been anti-dilutive. In addition, the Company excluded stock appreciation rights (“SARs”) of 1.66 million and 2.40 million, respectively, as they are contingently issuable based on specified market prices of the Company’s Common Shares, which were not achieved as of the end of each period.

9.    SHARE-BASED PAYMENTS

The Company maintains an equity incentive plan, known as the 2021 Amended and Restated Omnibus Equity Incentive Compensation Plan (the “Compensation Plan”), for directors, executives, eligible employees and consultants. Existing equity incentive awards include employee non-qualified stock options, RSUs and SARs. The Company issues new Common Shares to satisfy exercises and vesting under its equity incentive awards. As of March 31, 2023, a total of 15,802,941 Common Shares were authorized for future equity incentive plan awards.

The Company’s share-based compensation expense, by type of award, is as follows:

	Three Months Ended March 31,
	2023		2022
RSUs(1)	$	644	$	484
SARs	436		346
Stock options	106		32
Total share-based compensation expense(2)	$	1,186	$	862

(1)The fair value of the RSUs granted under the Compensation Plan for the three months ended March 31, 2023 and 2022 was estimated at the date of grant, using the stated market price on the NYSE American.

(2)Share-based compensation is included in Selling, general and administration in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Restricted Stock Units

The Company grants RSUs to directors, executives and eligible employees. Awards for executives and eligible employees are determined as a target percentage of base salary and generally vest over three years. Holders of unvested RSUs do not have voting rights on those RSUs. The RSUs are subject to forfeiture risk and other restrictions. Upon vesting, the employee is entitled to receive one Common Share of the Company for each RSU at no additional payment.

18

A summary of the Company’s non-vested RSUs activity is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022	747,425	$	4.77
Granted	450,232	7.36
Vested	(448,883)	4.24
Forfeited	—	—
Non-vested, March 31, 2023	748,774	$	6.64

The total intrinsic value and fair value of RSUs that vested and were settled for equity was $3.38 million for the three months ended March 31, 2023.

Stock Appreciation Rights

The Company may grant SARs to directors, executives, and eligible employees.

On January 26, 2023, the Company’s Board of Directors issued SARs under the Compensation Plan, which are intended to provide additional long-term equity incentives for the Company’s senior management.

Each SAR granted entitles the holder to receive, upon a valid exercise, payment from the Company in cash or Common Shares (at the sole discretion of the Company) in an amount representing the difference between the fair market value (“FMV”) of the Company’s Common Shares on the date of exercise and $7.36 (the closing market price or “Grant Price” at the time of grant). Fair Market Value as used herein means the closing price of the Shares on the TSX or the NYSE American on the last trading day immediately prior to the date of exercise. The term of the SARs grant is five years, with SARs vesting only upon the achievement of the following goals: as to one-third of the SARs granted, automatically upon the 90-calendar-day VWAP of the Company’s Common Shares on the NYSE American equaling or exceeding $12.00 for any continuous 90-calendar-day period; as to an additional one-third of the SARs granted, automatically upon the 90-calendar-day VWAP of the Company’s Common Shares on the NYSE American equaling or exceeding $14.00 for any continuous 90-calendar-day period; and as to the final one-third of the SARs granted, automatically upon the 90-calendar-day VWAP of the Company’s Common Shares on the NYSE American equaling or exceeding $16.00 for any continuous 90-calendar-day period. Further, notwithstanding the foregoing vesting schedule, no SARs were able to be exercised by the holder for an initial period of one year from the Date of Grant; the date first exercisable being January 24, 2024.

The fair value of the SARs granted during the three months ended March 31, 2023 was estimated at the date of grant using a Monte Carlo simulation, with the following weighted average assumptions:

Risk-free interest rate	3.58		%
Expected life(1)	5.0 years
Expected volatility(2)	55.00		%
Expected dividend yield	—		%
Weighted average grant date fair value	$	3.45

(1)Monte Carlo analysis of SARs assumes employee suboptimal exercise at first vesting time for each tranche.

(2)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the SARs.

A summary of the Company’s SARs activity is as follows:

19

	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Intrinsic Value
Outstanding, December 31, 2022	2,452,768	$	4.07
Granted	308,333	7.36
Exercised	—	—
Forfeited	(5,554)	6.47
Expired	—	—
Outstanding, March 31, 2023	2,755,547	$	4.43	2.12	$	4,413
Exercisable, March 31, 2023	1,092,143	$	2.92	0.81	$	2,905

A summary of the Company’s non-vested SARs activity is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022	1,360,625	$	2.81
Granted	308,333	3.45
Vested	—	—
Forfeited	(5,554)	5.20
Non-vested, March 31, 2023	1,663,404	$	2.92

Employee Stock Options

The Company, under the Compensation Plan, may grant stock options to directors, executives, employees and consultants to purchase Common Shares of the Company. The exercise price of the stock options is set as the higher of the Company’s closing share price on the NYSE American on the last trading day before the grant date and the five-day volume weighted average price (“VWAP”) on the NYSE American ending on the last trading day before the grant date. Stock options granted under the Compensation Plan generally vest over a period of two years or more and are generally exercisable over a period of five years from the grant date, such period not to exceed 10 years.

The fair value of the stock options granted under the Compensation Plan for the three months ended March 31, 2023 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:

Risk-free interest rate	3.89		%
Expected life	3.25 years
Expected volatility(1)	74.29		%
Expected dividend yield	—		%
Weighted average grant date fair value	$	3.98

(1)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.

A summary of the Company’s stock option activity is as follows:

20

	Range of Exercise Prices	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Intrinsic Value
Outstanding, December 31, 2022	$1.70 - $8.41	767,678	$	3.24
Granted	5.34 - 7.36	120,237	7.28
Exercised	1.70 - 2.92	(34,219)	1.88
Forfeited	3.89 - 7.36	(17,388)	6.51
Expired	—	—	—
Outstanding, March 31, 2023	$1.70 - $8.41	836,308	$	3.83	2.19	$	1,767
Exercisable, March 31, 2023	$1.70 - $7.14	667,523	$	2.99	1.56	$	1,766

A summary of the Company’s non-vested stock option activity is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022	140,586	$	4.12
Granted	120,237	3.98
Vested	(74,651)	3.76
Forfeited	(17,388)	3.87
Non-vested, March 31, 2023	168,784	$	3.97

As of March 31, 2023, there were $0.51 million, $3.32 million, and $1.03 million of unrecognized compensation costs related to the unvested stock options, RSUs and SARs, respectively. This expense is expected to be recognized over a weighted average period of 1.64 years, 2.27 years, and 0.94 years, respectively.

10.    INCOME TAXES

As of March 31, 2023, the Company maintained a full valuation allowance against its net deferred tax assets. The Company continually reviews the adequacy of the valuation allowance and intends to continue maintaining a full valuation allowance on its net deferred tax assets until there is sufficient evidence to support the reversal of all or a portion of the allowance. Should the Company’s assessment change in a future period, it may release all or a portion of the valuation allowance, which would result in a deferred tax benefit in the period of adjustment. The Company will recognize the tax gain on the Alta Mesa Transaction under the installment method of accounting. This method will result in a deferral of a portion of the tax gain until the year in which the remaining proceeds are received.

For the three months ended March 31, 2023, the Company did not record income tax expense on income before taxes of $114.26 million. During the three months ended March 31, 2023, approximately $2.72 million of Net Operating Loss carryforwards will be utilized. For the three months ended March 31, 2022, the Company did not record an income tax benefit on a loss before taxes of $14.73 million. The effective tax rate was 0% for each of the three months ended March 31, 2023 and 2022, which was a result of the full valuation allowance on net deferred tax assets.

21

11.    SUPPLEMENTAL FINANCIAL INFORMATION

The components of total other income (loss) are as follows:

	Three Months Ended March 31,
	2023		2022
Unrealized loss related to investments accounted for at fair value	$	(2,959)	$	(3,418)
Unrealized gain related to marketable securities	325		111
Unrealized loss on convertible note	(198)		—
Foreign exchange gain (loss)	26		(1,213)
Gain on sale of assets	116,450		—
Interest income, net and other	1,025		3
Total other income (loss)	$	114,669	$	(4,517)

The components of trade and other receivables are as follows:

	March 31, 2023		December 31, 2022
Trade receivables	$	874	$	92
Accrued interest receivable	592		—
Notes receivable, net	343		343
Other(1)	1,790		1,621
Total receivables	$	3,599	$	2,056
Receivables – by duration
Current	$	2,098	$	519
Long term	1,501		1,537
Total receivables	$	3,599	$	2,056

(1)As of March 31, 2023 and December 31, 2022, Other receivables includes $1.50 million and $1.58 million, respectively, due from Consolidated Uranium Inc. (“CUR”) pursuant to the terms of (i) the asset purchase agreement related to the sale of certain non-core conventional uranium projects and resulting deferred cash payments, and (ii) the ongoing operating agreement with CUR.

The components of accounts payable and accrued liabilities are as follows:

	March 31, 2023		December 31, 2022
Accounts payable	$	1,275	$	3,224
Payroll liabilities	1,503		2,929
Accrued capital expenditures	1,038		22
Accrued property taxes	410		240
Accrued operating expenses	761		409
Other accrued liabilities	288		105
Accounts payable and accrued liabilities	$	5,275	$	6,929

12.    COMMITMENTS AND CONTINGENCIES

General Legal Matters

Other than routine litigation incidental to our business, or as described below, the Company is not currently a party to any material pending legal proceedings that management believes would be likely to have a material adverse effect on our financial position, results of operations or cash flows.

22

White Mesa Mill

In 2011, the Ute Mountain Ute Tribe filed an administrative appeal of the Utah Division of Air Quality’s (“UDAQ”) decision to approve a Modification to the Air Quality Approval Order at the Mill. Then, in 2013, the Ute Mountain Ute Tribe filed a Petition to Intervene and Request for Agency Action challenging the Corrective Action Plan approved by the State of Utah Department of Environmental Quality (“UDEQ”) relating to nitrate contamination in the shallow aquifer at the Mill. In August 2014, the Ute Mountain Ute Tribe filed an administrative appeal to the Utah Division of Radiation Control’s (“DRC’s”) Radioactive Materials License Amendment 7 approval regarding alternate feed material from Dawn Mining. The challenges remain open at this time and may involve the appointment of an administrative law judge (“ALJ”) to hear the matters. The Company does not consider these actions to have any merit. If the petitions are successful, the likely outcome would be a requirement to modify or replace the existing Air Quality Approval Order, Corrective Action Plan or license amendment, as applicable. At this time, the Company does not believe any such modifications or replacements would materially affect its financial position, results of operations or cash flows. However, the scope and costs of remediation under a revised or replaced Air Quality Approval Order, Corrective Action Plan and/or license amendment have not yet been determined and could be significant.

The UDEQ renewed in January 2018, then reissued with minor corrections in February 2018, the Mill’s radioactive materials license (the “Mill License”) for another ten years and the Groundwater Discharge Permit (the “GWDP”) for another five years, after which further applications for renewal of the Mill License and GWDP are required to be submitted. During the review period for each application for renewal, the Mill can continue to operate under its existing Mill License and GWDP until such time as the renewed Mill License or GWDP is issued. Most recently, on July 15, 2022, the routine GWDP renewal application was submitted to UDEQ for consideration.

In 2018, the Grand Canyon Trust, Ute Mountain Ute Tribe and Uranium Watch (collectively, the “Mill Plaintiffs”) served Petitions for Review challenging UDEQ’s renewal of the Mill License and GWDP and Requests for Appointment of an ALJ, which they later agreed to suspend pursuant to a Stipulation and Agreement with UDEQ, effective June 4, 2018. The Company and the Mill Plaintiffs held multiple discussions over the course of 2018 and 2019 in an effort to settle the dispute outside of any judicial proceeding. In February 2019, the Mill Plaintiffs submitted to the Company their proposal for reaching a settlement agreement. The proposal remains under consideration by the Company. The Company does not consider these challenges to have any merit and, if a settlement cannot be reached, the Company intends to participate with UDEQ in defending against the challenges. If the challenges are successful, the likely outcome would be a requirement to modify the renewed Mill License and/or GWDP. At this time, the Company does not believe that any such modification would materially affect its financial position, results of operations or cash flows.

On August 26, 2021, the Ute Mountain Ute Tribe filed a Petition to Intervene and Petition for Review challenging the UDEQ’s approval of Amendment No. 10 to the Mill License, which expanded the list of Alternate Feed Materials that the Mill is authorized to accept and process for its source material content. Then, on November 18, 2021, the Tribe filed its Request for Appointment of an ALJ, followed shortly thereafter by a stay on the request in accordance with a Stipulation and Agreement between the Tribe, UDEQ and Company. Discussions between the Company and the Tribe are ongoing in an effort to resolve the dispute and other outstanding matters without formal adjudication. However, the Company does not consider this action to have any merit. If the stay is lifted, an ALJ is appointed and the petition is successful, the likely outcome would be a requirement to modify or revoke the Mill License amendment. At this time, the Company does not believe any such modification or revocation would materially affect its financial position, results of operations or cash flows.

Mineral Property Commitments

The Company enters into commitments with federal and state agencies and private individuals to lease mineral rights. These leases are renewable annually, and, as reported in the Company’s Form 10-K for the year ended December 31, 2022, renewal costs for the remainder of 2023 are expected to total $1.60 million.

Surety Bonds

The Company has indemnified third-party companies to provide surety bonds as collateral for the Company’s asset retirement obligations. The Company is obligated to replace this collateral in the event of a default and is obligated to repay any reclamation or closure costs due. As of March 31, 2023, the Company has $17.51 million posted as collateral against an undiscounted asset retirement obligation of $33.00 million. As of December 31, 2022, the Company has $21.04 million posted as collateral against an undiscounted asset retirement obligation of $42.91 million.

Commitments

The Company is contractually obligated under a Sales and Agency Agreement appointing an exclusive sales and marketing agent for all vanadium pentoxide produced by the Company.

23

13.    FAIR VALUE ACCOUNTING

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Fair value accounting utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:

Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2 – Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

The Company’s financial instruments include cash and cash equivalents, restricted cash, accounts receivable, accounts payable and current accrued liabilities. These instruments are carried at cost, which approximates fair value due to the short-term maturities of the instruments. Allowances for doubtful accounts are recorded against the accounts receivable balance to estimate net realizable value.

As of March 31, 2023 and December 31, 2022, the fair values of cash, restricted cash, short-term deposits, receivables, accounts payable and accrued liabilities approximate their carrying values because of the short-term nature of these instruments.

The Company’s investments in marketable equity securities are publicly traded stocks measured at fair value and classified within Level 1 and Level 2 in the fair value hierarchy. Level 1 marketable equity securities use quoted prices for identical assets in active markets, while Level 2 marketable equity securities utilize inputs based upon quoted prices for similar instruments in active markets. The Company’s investments in marketable debt securities are valued using quoted prices of a pricing service and as such, are classified within Level 2 of the fair value hierarchy. The Company’s investments accounted for at fair value consisting of Common Shares are valued using quoted market prices in active markets and as such are classified within Level 1 of the fair value hierarchy. The Company’s investments accounted for at fair value consisting of warrants are valued using the Black-Scholes option model based on observable inputs and as such are classified within Level 2 of the hierarchy.

The Company’s convertible note was received as part of the consideration received for the Alta Mesa Transaction was valued as of February 14, 2023 upon closing of that transaction using a binomial lattice model. The fair value calculation uses significant unobservable inputs including: (i) volatility 60% and (ii) yield of 9.5%. The Company used the same binomial lattice model to value the Convertible Note as of March 31, 2023. As of March 31, 2023, the fair value calculation uses significant unobservable inputs including: (i) volatility of 60% and (ii) yield of 10.6%. Increases or decreases in the volatility and/or the selected risky yield can result in an increase or decrease in the fair value of the Convertible Note.

The following tables set forth the fair value of the Company’s assets and liabilities measured at fair value on a recurring basis (at least annually) by level within the fair value hierarchy as of March 31, 2023 and December 31, 2022. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

March 31, 2023	Level 1		Level 2		Level 3		Total
Cash equivalents(1)	$	—	$	26,200	$	—	$	26,200
Investments accounted for at fair value	16,340		34		—		16,374
Marketable debt securities	—		59,431		—		59,431
Convertible note	—		—		59,259		59,259
Marketable equity securities	976		31		—		1,007
	$	17,316	$	85,696	$	59,259	$	162,271

(1)     Cash equivalents are comprised of United States Treasury Bills and Government Agency Bonds, purchased within three months of their maturity date.

24

December 31, 2022	Level 1		Level 2		Level 3		Total
Cash equivalents(1)	$	—	$	30,336	$	—	$	30,336
Investments accounted for at fair value	19,263		66		—		19,329
Marketable debt securities	—		11,125		—		11,125
Marketable equity securities	1,033		34		—		1,067
	$	20,296	$	41,561	$	—	$	61,857

(1)     Cash equivalents are comprised of United States Treasury Bills and Government Agency Bonds, purchased within three months of their maturity date.

Changes in Level 3 Fair Value Measurements

The following table is a reconciliation of the beginning and ending balance recorded for the Convertible Note classified as Level 3 in the fair value hierarchy.

Beginning balance, February 14, 2023	$	59,457
Unrealized loss included in other income (loss)	(198)
Ending balance, March 31, 2023	$	59,259

As of March 31, 2023, the difference between the fair value of the Convertible Note and the unpaid principal amount is $0.74 million.

Investments Accounted for at Fair Value

The fair value of the investments is calculated as the quoted market price of the marketable equity security multiplied by the quantity of shares held by the Company. As of December 31, 2022, the Company held a 17.4% ownership interest in its investment in CUR and a 13.5% ownership interest in its investment in Virginia Energy Resources Inc. (“Virginia Energy”). These investments provide the Company with the ability to have significant influence, but not control, over their operations. The Company has elected the fair value option for each of these investments. As of December 31, 2022, the fair value of the Company’s investments in CUR and Virginia Energy were $16.50 million and $2.83 million, respectively.

On January 24, 2023, CUR acquired 100% of the issued and outstanding common shares of Virginia Energy for 0.26 common shares of CUR. As a result, the Company’s 9,439,857 common shares of Virginia Energy were converted into 2,454,362 million common shares of CUR (the “Conversion”). Following the Conversion, the Company owned 16,189,548 common shares of CUR, which represented an ownership interest of 16.7% in CUR as of closing. As of March 31, 2023, the fair value of the Company’s investment in CUR was $16.37 million, which represented an ownership interest of 16.3%.

During the three months ended March 31, 2023 and 2022, the Company recognized a loss of $2.96 million and $3.42 million, respectively related to these investments in Other income (loss) in the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss).

14.    REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

All revenue recognized is a result of contracts with customers either through uranium and vanadium sales contracts or Alternate Feed processing and other waste disposal agreements. The Company had satisfied all of its performance obligations as of March 31, 2023.

15.    RELATED PARTY TRANSACTIONS

Robert W. Kirkwood, a member of the Company’s Board of Directors, is a principal of the Kirkwood Companies, including Kirkwood Oil and Gas LLC, Wesco Operating, Inc., and United Nuclear LLC (“United Nuclear”). United Nuclear owns a 19% interest in the Company’s Arkose Mining Venture while the Company owns the remaining 81%. The Company acts as manager of the Arkose Mining Venture and has management and control over operations carried out by the Arkose Mining Venture. The Arkose Mining Venture is a contractual joint venture governed by a venture agreement dated as of January 15, 2008 and entered into by United Nuclear and Uranerz Energy Corporation, a wholly owned, indirectly held subsidiary of the Company.

On October 27, 2021, the Company began providing services to CUR under a mine operating agreement. The Company earned $0.27 million and $0.27 million during the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023 and 2022, $0.27 million and $0.27 million was due from CUR, respectively. Additionally, the Company has accrued $1.50 million and $1.58 million as of March 31, 2023 and December 31, 2022, respectively, in Other long-term receivables

25

related to deferred cash payments for production thresholds pursuant to the terms of the asset purchase agreement with CUR. See Note 11 – Supplemental Financial Information for more information.

26

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements and related notes, which have been prepared in accordance with U.S. GAAP, included elsewhere in this Quarterly Report on Form 10-Q. Additionally, the following discussion and analysis should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the audited consolidated financial statements included in Part II of our Annual Report on Form 10-K for the year ended December 31, 2022. This Discussion and Analysis contains forward-looking statements and forward-looking information that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors. See “Cautionary Statement Regarding Forward-Looking Statements.”

All dollar amounts stated herein are in U.S. dollars, except share and per share amounts and currency exchange rates unless specified otherwise.

Operations Update and Outlook for 2023

Overview

We responsibly produce several of the raw materials needed for clean energy and advanced technologies, including uranium, rare earth elements (“REEs”) and vanadium.

Our primary product is U3O8 (also known as natural uranium concentrate or yellowcake), which, when further processed, becomes the fuel for the generation of clean nuclear energy. According to the Nuclear Energy Institute, nuclear energy provides nearly 20% of the total electricity and more than 50% of the clean, carbon-free electricity generated in the U.S. The Company generates revenues from extracting and processing materials for the recovery of uranium, vanadium and REEs for our own account, as well as from toll processing materials for others.

Our natural uranium concentrate is produced from multiple sources:

•Conventional recovery operations at the White Mesa Mill (the “White Mesa Mill” or “Mill”), including:

◦Processing ore from uranium mines; and

◦Recycling of Alternate Feed Materials, which are uranium-bearing materials that are not derived from conventional ore; and

•In Situ Recovery (“ISR”) operations.

The Company is also currently producing an intermediate REE product called mixed RE Carbonate. In 2020, the Company began evaluating the potential to recover REEs at the Mill. By October 2020, the Company had produced a mixed RE Carbonate, ready for separation, on a pilot scale from natural monazite sands. In December 2020, the Company entered into a contract to acquire natural monazite sands from a heavy mineral sands operation in Georgia, for the recovery of uranium and production of a commercially salable mixed RE Carbonate containing approximately 71% total rare earth oxide (“TREO”). In March 2021, the Company began ramping up commercial-scale production of mixed RE Carbonate from these natural monazite sands. In July 2021, the Company announced the signing of a definitive supply agreement and began commercial shipments of RE Carbonate to a separation facility in Europe, which is the next step in producing usable REE products. On February 10, 2023, the Company closed on its previously announced mineral rights transfer agreements to acquire 17 mineral sand concessions in the State of Bahia, Brazil totaling approximately 37,300 acres or 58.3 square miles (the “Bahia Project”). Based on significant historical drilling performed to date, it is believed that the Bahia Project holds significant quantities of heavy minerals, including monazite, that will feed Energy Fuels’ quickly emerging U.S.-based REE supply chain. See “Rare Earth Element Initiatives,” below for more information.

The Company is also in discussions with other entities around the world to acquire additional supplies of natural monazite sands and has worked with U.S. government agencies and national laboratories on various REE initiatives. The Company is currently modifying and enhancing its existing solvent extraction (“SX”) circuits at the Mill to be able to produce fully separated REE oxides, including NdPr oxide, in addition to uranium, as soon as late-2023 or early-2024. The Company is also evaluating other downstream REE activities, including metal-making and alloying at the Mill or elsewhere in the U.S., and is actively pursuing federal grants to help fund such efforts.

The Company also has a long history of conventional vanadium recovery at the Mill. The Company has several existing mines that contain vanadium resources, and the Mill has produced considerable quantities of vanadium during its operating history. From late 2018 to early 2020, the Company completed a campaign to recover vanadium from solutions in the tailings management system at the Mill (“Pond Return”) from which it recovered over 1.8 million pounds of high-purity V2O5.

27

Finally, pursuant to a strategic alliance with a technology development company, the Company is evaluating the feasibility of recovering radioisotopes from the Mill’s existing process streams for use in the development of medical isotopes for the potential treatment of cancer. This involves evaluating the potential to recover Th-232, and Ra-226 from the Company’s existing RE Carbonate and uranium process streams at the Mill and the feasibility of recovering Ra-228 from the Th-232, Th-228 from the Ra-228 and concentrating Ra-226 at the Mill. Recovered Ra-228, Th-228 and Ra-226 would then be sold to pharmaceutical companies and others to produce Pb-212, Ac-225, Bi-213, Ra-224 and Ra-223, which are the leading medically-attractive targeted alpha therapy (“TAT”) isotopes for the treatment of cancer. Existing supplies of these isotopes for TAT applications are in short supply, and methods of production are costly and currently cannot be scaled to meet the demand created as new drugs are developed and approved. This is a major roadblock in the research and development of new TAT drugs as pharmaceutical companies wait for scalable and affordable production technologies to become available. Under this initiative, the Company has the potential to recover valuable isotopes from its existing process streams for use in treating cancer, thereby recycling back into the market valuable materials that would otherwise not be recoverable.

The Mill, located near Blanding, Utah, processes ore mined from the Four Corners region of the United States, as well as Alternate Feed Materials that can originate worldwide. The Mill is the only operating conventional uranium mill in the U.S. and the only operating facility in the U.S. with the ability to recover vanadium from primary ore sources. The Mill is licensed to process an average of 2,000 tons of ore per day and to produce approximately 8.0 million pounds of U3O8 per year. The Mill has separate circuits to process conventional uranium and vanadium ores, as well as Alternate Feed Materials and REEs.

For the last several years, no mines have operated commercially in the vicinity of the Mill due to low uranium prices. As a result, in recent years, Mill activities have focused on processing Alternate Feed Materials for the recovery of uranium under multiple toll processing arrangements, as well as Alternate Feed Materials for our own account. Additionally, in recent years, the Mill has recovered dissolved vanadium through its Pond Return program from the Mill’s tailings management system that was not fully recovered during the Mill’s prior forty years of operations. During the three months ended March 31, 2023, Mill activities focused primarily on processing monazite sands for the recovery of uranium and production of RE Carbonate. The Company is actively pursuing additional monazite sands and Alternate Feed Materials for processing at the Mill.

The Company continues to pursue additional sources of feed materials for the Mill. For example, a significant opportunity exists for the Company to participate in the clean-up of abandoned uranium mines in the Four Corners Region of the U.S. The U.S. Justice Department and Environmental Protection Agency announced settlements in various forms in excess of $1.5 billion to fund certain cleanup activities on the Navajo Nation. Additional cleanup settlements with other parties are also pending. Our Mill is within economic trucking distance, and is uniquely positioned in this region, to receive uranium-bearing materials from these cleanups and recycle the contained U3O8, while, at the same time, permanently disposing of the cleanup materials outside the boundaries of the Navajo Nation in our licensed tailings management system. There are no other existing facilities in the U.S. capable of providing this service. During 2019 to 2022, the Company received shipments of material generated in the cleanup of a large, historically producing conventional uranium mine located in northwest New Mexico. In addition to generating revenue for the Company, this project demonstrates the ability of the Mill to responsibly cleanup projects similar to those on the Navajo Nation.

The Company’s ISR operations consist of our Nichols Ranch Project, which is on standby at current uranium prices.

While the current spot price of uranium has not supported production for many global uranium producers over the past several years, having resulted in significant production cuts, the spot price of uranium has improved in recent years to levels that we believe could support production if these prices are sustained and result in long-term supply contracts with nuclear utilities. To date, the Company has entered into three long-term contracts with U.S. nuclear utilities with deliveries occurring from 2023 to 2030 at supportive pricing and other terms. In anticipation of potential price recoveries and additional contracts, we continue to maintain and advance our resource portfolio. We stand ready to resume wellfield construction and resume production at our Nichols Ranch Project and mine and process resources from our La Sal Project, Whirlwind Project and/or Pinyon Plain Project. We believe we can bring this new production to market within approximately twelve to eighteen months of a positive production decision. Longer term, we expect to develop our large conventional mines at Roca Honda and/or Sheep Mountain.

Update on Rare Earth Element Initiative

As previously disclosed, in early-2022, the Company began commercial-scale partial separation of lanthanum (“La”) and cerium (“Ce”) on a small scale from our RE Carbonate, resulting in a higher-value carbonate (“Partially Separated RE Carbonate”) using an existing solvent extraction (“SX”) circuit at the Mill, which represents the first commercial level REE separation to occur in the U.S. in many years. The Partially Separated RE Carbonate, which is now our salable product, is an even more advanced RE Carbonate than was produced in 2021, as it contains a higher concentration of valuable neodymium and praseodymium (“NdPr”) (“High Value TREO”).

28

Rare Earth Element Initiatives

The Company is in advanced discussions with several groups holding natural monazite properties to secure additional supplies of monazite sands by offtake or otherwise, which if successful, would be expected to allow the Company to increase production of RE Carbonate, along with separated REE oxides in the future.

The Company continues to make progress toward full REE oxide separation capabilities at the Mill to produce both “light” and “heavy” separated REE oxides. The Company is currently separating La and Ce from its commercial RE Carbonate stream utilizing existing Mill infrastructure to produce an RE Carbonate product with higher concentrations of NdPr and “heavy” (samarium (“Sm”)+) REEs. Energy Fuels is also proceeding with the modification and enhancement of its existing Mill infrastructure (“Phase 1”) to expand its “light” REE separation facilities to be capable of producing commercial quantities of separated NdPr oxide by later this year or early 2024, followed by planned further expansions to further increase NdPr production capacity (“Phase 2”) and to produce separated dysprosium (“Dy”), terbium (“Tb”) and potentially other REE materials in the future (“Phase 3”) from monazite and potentially other REE process streams.

In 2022, the Company began construction on its “Phase 1” REE separation facilities, which includes modifications and enhancements to the SX circuits at the Mill. “Phase 1” is expected to have the capacity to process approximately 8,000 to 10,000 tonnes of monazite per year, producing roughly 4,000 to 5,000 tonnes TREO, containing roughly 800 to 1,000 tonnes of recoverable separated NdPr oxide per year, or sufficient NdPr for 400,000 to 1 million EVs per year. Because Energy Fuels is utilizing existing infrastructure at the Mill, “Phase 1” capital is expected to total approximately $25 million. “Phase 1” is expected to be operational later this year or early 2024, subject to receipt of sufficient monazite supply and successful construction and commissioning.

During “Phase 2,” Energy Fuels expects to expand its NdPr separation capabilities, with an expected capacity to process approximately 15,000 to 30,000 tonnes of monazite per year and expected recovery of approximately 7,500 to 15,000 tonnes of TREO, containing approximately 1,500 to 3,000 tonnes of NdPr oxide per year, or sufficient NdPr for 750,000 to 3.0 million EVs per year. “Phase 2” is also expected to add a dedicated monazite “crack-and-leach” circuit to the Mill’s existing leach circuits. The Company expects to complete “Phase 2” in 2026, subject to licensing, financing, and receipt of sufficient monazite feed.

During “Phase 3,” Energy Fuels expects to add “heavy” REE separation capabilities, including the production of Dy, Tb, and potentially other REE oxides and advanced materials. The Company will also evaluate the potential to produce La and Ce products. The Company expects to have additional “heavy” REE feedstock stockpiled from “Phase 1” and “Phase 2.” as feed for “Phase 3” REE separation. The Company expects to complete “Phase 3” in 2027, subject to licensing, financing, and receipt of sufficient feed.

In addition, the Company completed its purchase of the Bahia Project in Brazil on February 10, 2023. The Bahia Project is a well-known heavy mineral sand (“HMS”) deposit that has the potential to supply 3,000 – 10,000 tonnes of natural monazite sand concentrate per year for decades to the Mill for processing into high-purity REE oxides and other materials. While Energy Fuels’ primary interest in acquiring the Bahia Project is the REE-bearing monazite, the Bahia Project is also expected to produce large quantities of high-quality titanium (ilmenite and rutile) and zirconium (zircon) minerals that are also in high demand.

Natural monazite of 3,000 – 10,000 tonnes contains approximately 1,500 – 5,000 tonnes of TREO, including 300 – 1,000 tonnes of NdPr and significant commercial quantities of Dy and Tb. The Company is focused on monazite at the current time, as it has superior concentrations of these four (4) critical REEs compared to other REE-bearing minerals. These REE’s are used in the powerful neodymium-iron-boron (“NdFeB”) magnets that power the most efficient electric vehicles (“EV”), along with uses in other clean energy and defense technologies. For reference, a typical EV utilizes approximately one (1) to two (2) kilograms of NdPr oxide in its drivetrain. Based on this assumption, monazite from the Bahia Project alone is expected to supply enough NdPr oxide to power 150,000 to 1 million EVs per year. The uranium contained in the monazite, which is expected to be comparable in grade to typical Colorado Plateau uranium deposits, will also be recovered at the Mill.

The acquisition of the Bahia Project is part of the Company’s efforts to build a large and diverse book of monazite supply for its rapidly advancing REE processing business. The Company expects to procure monazite through Company-owned mines like the Bahia Project, joint ventures or other collaborations, and open market purchases, like the Company’s current arrangement with The Chemours Company. The Company is currently in advanced discussions with several additional current and future monazite producers around the world to supply Energy Fuels’ initiative.

Sale of Alta Mesa property to enCore Energy

On February 14, 2023, the Company closed on its previously announced definitive agreement to sell three wholly owned subsidiaries that together hold the Alta Mesa ISR Project to enCore Energy Corp. for total consideration of $120 million. The transaction is expected to help the Company fully finance much of its uranium, REE, vanadium and medical isotope business

29

plans for the next 2 to 3 years without diluting shareholders. See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

Known Trends or Uncertainties

The Company has had negative net cash outflows and net losses in previous years in part due to depressed uranium and vanadium prices, along with smaller quantities of monazite to process into salable RE Carbonate which hasn't allowed the Company to realize economies of scale. We are not aware at this time of any trends or uncertainties that have had or are reasonably likely to have a material impact on revenues or income of the Company other than: (i) recent strengthening of uranium markets, which could result in the Company selling inventories at increased prices and/or signing additional contracts with nuclear utilities for the long-term supply of uranium; (ii) the recently implemented U.S. Uranium Reserve Program, which could result in improved uranium sales prices; and (iii) the Company’s REE and TAT radioisotope initiatives, which, if successful, could result in improved results from operations in future years. We are not aware at this time of any events that are reasonably likely to cause a material change in the relationship between costs and revenue of the Company.

Continued Efforts to Minimize Costs

Although the Company is pursuing two new initiatives - its REE and TAT radioisotope initiatives - in addition to its existing uranium and vanadium products, which will likely require the Company to grow certain of its operations, the Company will continue to seek ways to minimize the costs of all its operations where feasible while maintaining its critical capabilities, manpower, and properties.

Uranium Market Update

According to monthly price data from TradeTech LLC (“TradeTech”), uranium spot prices rose modestly during the Quarter. The uranium spot price began the Quarter at $47.60 per pound on December 31, 2022 and rose 6% to $50.60 per pound by March 31, 2023. During the Quarter, the uranium spot price hit a high of $51.85 per pound during the week of February 24, 2023 and a low of $47.60 per pound at the beginning of the quarter. TradeTech price data indicates that long-term U3O8 prices were flat during the Quarter at $53.00 per pound. On April 28, 2023, TradeTech reported a spot price of $53.75 per pound and a long-term price of $53.00 per pound U3O8.

The following important developments in the uranium and nuclear industries occurred during the Quarter:

–Under South Korea’s 10th Basic Plan for Electricity Supply and Demand, finalized by the Power Policy Council on January 11, 2023, nuclear is expected to provide nearly 34.6% of the nation's electricity generation by 2026, compared to 27.1% in 2021. The Plan also calls for the construction of Units 3 and 4 at the Shin Hanul Nuclear Power Plant to resume (TradeTech, NMR, 1/13/2023).

–Support for nuclear power in Japan continues, where local authorities representing communities surrounding the Ohma Nuclear Power Plant visited the Ministry of Economy, Trade, and Industry to show support for the resumption of construction of the nuclear power plant in Japan's Aomori Prefecture (TradeTech, NMR, 2/10/2023).

–On February 10, 2023, Japan’s Cabinet formally adopted a plan to implement a Green Transformation policy, which will allow for the operation of nuclear power plants beyond their current 60-year limit (TradeTech, NMR, 2/17/2023). During the week of March 3, 2023, the Cabinet approved bills to allow commercial nuclear plants to operate beyond their current 60-year limit (TradeTech, NMR, 3/3/3023).

–U.S. Senators John Barrasso (R-WY), Joe Manchin (D-WV), Jim Risch (R-ID), Martin Heinrich (D-NM), Cynthia Lummis (R-WY), Chris Coons (D-DE), and Roger Marshall (R-KS) introduced bipartisan legislation to ban Russian uranium imports. This is a companion bill to H.R. 1042, which was introduced in February 2023 by U.S. Representatives Cathy McMorris Rodgers (R-WA), and Bob Latta (R-OH) (TradeTech, NMR, 3/10/2023).

–During the week of March 10, 2023, Unit 3 at the Vogtle Nuclear Power Plant in Georgia reached criticality, according to Georgia Power, a subsidiary of Southern Company. Initial criticality is an important step during the startup testing sequence (TradeTech, NMR, 3/10/2023).

–The U.K. government has classified nuclear as “environmentally sustainable” in order to attract investment for the energy sector. This follows the E.U. decision in July 2022 to label nuclear energy as green technologies needed for the energy transition. (TradeTech, NMR, 3/17/2023). The U.K. government announced its “Powering Up Britain” plan, which would increase the share of nuclear generating capacity from 15% to 25% by 2050 (TradeTech, NMR, 3/31/2023).

–The U.S. International Trade Commission has determined in a “sunset review” that termination of the suspended trade investigation on Russian uranium imports “would be likely to lead to continuation or recurrence of material injury within a reasonably foreseeable time.” As a result, on March 23, the ITC said the Russian Suspension Agreement would remain in place (TradeTech, NMR, March 24, 2023).

30

The Company continues to believe that certain uranium supply and demand fundamentals point to higher sustained uranium prices in the future, including significant production cuts in recent years, along with significant increased demand from utilities, financial entities, traders and producers. Globally, the Company believes that nuclear energy is seeing greater acceptance by governments and policymakers as a solution to addressing the issues of climate change and energy security. The Company believes that financial entities purchasing uranium on the spot market for long-term investment continue to represent a fundamental shift in the uranium market due to increasing demand and removing readily available material from the market that would otherwise serve as supply to utilities, traders, and others. Further, the Company believes that Russia’s ongoing invasion of Ukraine has sparked a widespread trend away from Russian-sourced nuclear fuel supply. The Company also continues to believe that a large degree of uncertainty exists in the market, primarily due to transportation issues, trade issues, the life of existing uranium mines, conversion and enrichment bottlenecks, the opaque nature of inventories and secondary supplies, unfilled utility demand, geopolitical risks including Russia’s ongoing invasion of Ukraine, and the market activity of state-owned uranium and nuclear companies.

No additional new uranium agreements were entered into by the Company during the Quarter. However, the Company continues to closely monitor uranium markets and seek additional opportunities to enter into long-term sales contracts with utilities at prices that sustain production, cover overhead costs, and provide a reasonable rate-of-return to investors while also providing the Company and its shareholders with exposure to further upside price movements. The Company is also continuing to evaluate its ramp-up back into production at certain of its conventional mines in anticipation of its fulfillment obligations, as well as the timing and method for the purchase and disposition of its existing uranium inventories, including selling into the spot market, selling to the U.S. Uranium Reserve Program, or as a part of one or more term contracts.

Rare Earth Element Market Update

REEs are a group of 17 chemical elements (the 15 elements in the lanthanum series, plus yttrium and scandium) that are used in a variety of clean energy and advanced technologies, including wind turbines, EVs, cell phones, computers, flat panel displays, advanced optics, catalysts, medicine, and national defense applications. Monazite, the source of REEs currently utilized by the Company, also contains significant recoverable quantities of uranium, which fuels the production of carbon-free electricity using nuclear technology. According to industry analyst Wood-Mackenzie, most demand for REE’s is in the form of separated REEs, “as most end-use applications require only one or two separated rare earth compounds or products.” (Roskill, Rare Earths, Outlook to 2030, 20th Edition). The main uses for REEs include: (i) battery alloys; (ii) catalysts; (iii) ceramics, pigments and glazes; (iv) glass polishing powders and additives; (v) metallurgy and alloys; (vi) permanent magnets; (vii) phosphors; and (viii) others (Adamas Intelligence). By volume, REEs used for permanent magnets (neodymium (Nd), praseodymium (Pr), dysprosium (Dy), and terbium (Tb)) and catalysts (cerium (Ce) and lanthanum (La)) comprised 60% of total consumption, yet over 90% of the value consumed.

Typical natural monazite sands from the southeast U.S. average about 55% TREO and 0.20% uranium, which is the typical grade of uranium found in uranium mines that have historically fed the Mill. Of the 55% TREO typically found in the monazite sands, the NdPr comprise approximately 22% of the TREO. NdPr are among the most valuable of the REEs, as they are the key ingredient in the manufacture of high-strength permanent magnets which are essential to the lightweight and powerful motors required in EVs and permanent magnet wind turbines used for renewable energy generation, as well as in an array of other modern technologies, including mobile devices and defense applications. Monazite also contains higher concentrations of “heavy” rare earths, including dysprosium (Dy) and terbium (Tb) used in permanent magnets, relative to other common REE ores.

The Company is currently primarily focused on NdPr and, to a lesser extent, La, Ce, Sm, Dy and Tb. The REE supply chain starts at a mine. REEs are mined both as a primary target, like the Mountain Pass REE mine in California, and as a byproduct, which is the case for Chemours’ Offerman Mineral Sand Plant, where the natural monazite sands are physically separated from the other mined sands. Mining creates an ore, which in the case of the Chemours material is the natural monazite sands that are physically separated from the other mined mineral sands. The ore then goes through a process of cracking and cleaning at the Mill that may include acids or caustic solutions, elevated temperature, and pressure to recover the uranium and free the REEs from the mineral matrix. After removal of the uranium, which will be sold into the commercial nuclear fuel cycle for the creation of carbon-free nuclear energy, this solution is cleaned of any remaining deleterious elements (including remaining radioactive elements) and made into an RE Carbonate, which is a form acceptable as an SX feedstock for REE separation. SX facilities then use solvents and a series of mixer-settlers for the separation of the REEs in the RE Carbonate from each other and to create the desired purified REE products (often as oxides) for the market or particular end user. Separated REE products are typically sold to various markets, depending on the use. Separated REE products can be made into REE metals and metal-alloys, which are used for magnets and other applications.

To date, the Mill has produced an RE Carbonate, substantially all of which has been sold to Neo Performance Materials (“Neo”). The Mill is currently modifying and enhancing its existing SX facilities to result in an SX REE separation circuit at the Mill, which, based on engineering to date, is expected to be capable of producing up to 1,000 tonnes of separated NdPr oxide

31

per year. The Company is also currently evaluating the potential to produce other downstream REE materials, including REE metals and alloys, in the future at the Mill or elsewhere in the U.S.

REEs are commercially transacted in a number of forms and purities. Therefore, there is no single price for REEs collectively, but numerous prices for various REE compounds and materials. The primary value that the Company expects to generate in the short- to medium-term will come from NdPr, Dy, Tb, Ce, and La, as the price the Company receives from the sale of its RE Carbonate is tied to the prices of those REE oxides. In addition, the Company expects to produce separated REE oxides in the future. According to data from Asian Metal, NdPr Oxide (Pr6O11 25%; Nd2O3 75%) mid-point prices in China dropped approximately 26% during the Quarter from ¥710 RMB/kg (about $103/kg) to ¥525 RMB/kg (about $76kg). The price for NdPr Oxide as April 28, 2023 was ¥443 RMB/kg (about $64/kg). Ce Oxide (99.9%) mid-point prices in China dropped approximately 13% during the Quarter from ¥7.05 RMB/kg (about $1.02/kg) to ¥6.15 RMB/kg (about $0.90/kg). The price for Ce Oxide as of April 28, 2023 was ¥5.60 RMB/kg (about $0.81/kg). La Oxide (99.9%) mid-point prices in China price dropped approximately 16% during the Quarter from ¥6.95 RMB/kg (about $1.00/kg) to ¥5.85 RMB/kg (about $0.85/kg). The price for La Oxide as of April 28, 2023 was ¥5.35 RMB/kg (about $0.77/kg). Dy Oxide (99.5%) mid-point prices in China dropped approximately 19% during the Quarter from ¥2,490 RMB/kg (about $360/kg) to ¥2,025 RMB/kg (about $295/kg). The price for Dy Oxide as of April 28, 2023 was ¥1,900 RMB/kg (about $275/kg). Tb Oxide (99.99%) mid-point prices in China dropped approximately 29% during the Quarter from ¥14,000 RMB/kg (about $2,022/kg) to ¥9,950 RMB/kg (about $1,449/kg). The price for Tb Oxide as of April 28, 2023 was ¥8,450 RMB/kg (about $1,222/kg).

The REE market is dominated by China, which produces approximately 83% of refined REE products with other Asia Pacific operations providing an additional 15%. According to WoodMackenzie, “Prices for rare earths in the years to come will follow different trajectories based on their involvement with the magnet industry.” WoodMacKenzie forecasts that prices for magnet elements, including neodymium (Nd) and praseodymium (Pr), will remain elevated through 2050, supporting new primary and secondary supply. Prices for elements used as additives or fillers in magnets, namely terbium (Tb) and dysprosium (Dy), will see “short-term price support followed by a steady decline as supply availability improves.” Prices for other non-magnet elements, including cerium (Ce) and lanthanum (La), will remain stable at roughly the cost of production.

While China consumes the most REEs in its manufacturing industries, much of it is consumed in the manufacture of end-use goods for export and by non-Chinese companies operating within China. REE separation facilities are additionally located in Vietnam, India, as well as Silmet in Estonia, and use a variety of feedstocks and sources, with small-scale or experimental operational facilities located elsewhere (Russia included).

The Company sees its commercial production of RE Carbonate as the first step in an effort to restore the REE supply chain in the U.S., where one currently does not exist. Multiple potential domestic sources of mined mineral sands, including monazites, exist in North America and are potential feedstocks for the Mill; in addition, there is one producer of REEs from hard rock mining in California, which currently ships its material to Asia. On a global level, there is a potential to acquire natural monazite sands from the following locations: Australia, South Africa, Madagascar, New Zealand, the Philippines, Indonesia, Brazil, Malaysia, Thailand, India, Russia, and others.

As demand for clean energy technologies and other advanced technologies, increases in the coming years, the Company expects demand and prices for REEs to increase. Increases in supply sources for REEs are expected in conjunction with anticipated rising REE prices.

Vanadium Market Update

Vanadium is a metallic element that, when converted into ferrovanadium (“FeV”) (an alloy of vanadium and iron), is used primarily as an additive to strengthen and harden steel and make it anti-corrosive. According to market consultant FastMarkets, over 90% of FeV is used in the steel industry. In addition, vanadium is used in the aerospace and chemical industries, and continues to see interest in energy storage technologies, including vanadium redox flow batteries. China is the largest global producer of vanadium, with additional production coming from Russia, South Africa, and Brazil (Roskill).

During the Quarter, the mid-point price of vanadium in Europe rose 7%, beginning the Quarter at $9.44 per pound V2O5 as of December 31, 2022 and ending the Quarter at $10.13 per pound V2O5 as of March 31, 2023. The price of vanadium was at its high of $10.80 per pound V2O5 between February 3, 2023 and February 16, 2023. The price of vanadium was at its low of $9.44 per pound V2O5 between December 30, 2022 and January 12, 2023. As of April 28, 2023, the price of vanadium is $9.75 per pound V2O5.

Early in the Quarter, FastMarkets reported “vanadium pentoxide and vanadium nitrogen prices increased amid stronger downstream demand and more optimism from market participants due to vanadium batteries gaining more attention in the energy storage industry,” along with “spot tightness due to production cuts at several major vanadium producers for maintenance.” China’s vanadium price increases amid tight spot availability, optimistic outlook, January 13, 2023. However, by the end of the Quarter, sentiment was somewhat muted with Fast Markets reporting “vanadium pentoxide prices fell amid weak demand” with “some traders actively destock[ing] amid bearish market sentiment.” However, one Chinese trader

32

indicated that “we have not seen any signs of recovery in downstream sectors, but some market participants believe this may improve in April when some basic infrastructure projects start.” China’s vanadium price drops on weak demand, March 31, 2023.

Operations Update and Outlook

Overview

The Company continues to believe that uranium supply and demand fundamentals point to higher sustained uranium prices in the future. The Company believes that nuclear energy, fueled by uranium, is experiencing a global resurgence with an increased focus by governments, policymakers, and citizens on decarbonization, electrification, and security of energy supply. In addition, Russia’s invasion of Ukraine and the entry into the uranium market by financial entities purchasing uranium on the spot market to hold for the long-term has the potential to result in higher sustained spot and term prices and, perhaps, induce utilities to enter into more long-term contracts with non-Russian producers like Energy Fuels to foster security of supply, avoid transportation issues, and ensure more certain pricing.

In 2022, we entered into three long-term uranium contracts with major U.S. utilities. To deliver into these contracts, the Company is undergoing the necessary work to recommence production at one or more of its mines and ISR facilities, starting as soon as 2023. Until such time when the Company has ramped back up to commercial uranium production, it can rely on its significant uranium inventories to fulfill its new contract requirements, including its recent purchases of U.S. origin uranium on the spot market.

The Company continually seeks new sources of revenue, including through its emerging REE business, as well as new sources of Alternate Feed Materials and new fee processing opportunities at the Mill that can be processed without reliance on current uranium sales prices.

The Company is seeking additional sources of natural monazite sands to supply feedstock to its emerging REE projects (in addition to the recent acquisition of the Bahia Project discussed in Note 5 – Property, Plant and Equipment and Mineral Properties). The Company is also evaluating the potential to recover radioisotopes from its existing process streams for use in the development of TAT medical isotopes for the treatment of cancer, and continues its support of U.S. governmental activities to assist the U.S. uranium mining industry, including expanding the new U.S. Uranium Reserve Program, supporting efforts to restore domestic nuclear fuel capabilities, and advocating for the responsible sourcing of uranium and nuclear fuel.

We continually evaluate the optimal mix of production, inventory and purchases in order to retain the flexibility to deliver long-term value.

Mill Activities

During the three months ended March 31, 2023, the Mill focused on its mixed RE Carbonate production and produced approximately 250 tonnes of high-purity, partially separated mixed RE Carbonate, containing approximately 115 tonnes of TREO. while working to secure additional monazite ore feedstock to increase production. During the three months ended March 31, 2023 the uranium recovered from processing monazite ore was retained in circuit and was not packaged as final U3O8 product. The Mill did not recover any vanadium during the quarter.

During the first half of 2023, the Company expects to process approximately 600 tonnes of monazite delivered late in 2022 from Chemours and recover approximately 150 to 170 tonnes of TREO at the Mill in the form of approximately 315 to 365 tonnes of high-purity, partially separated mixed RE Carbonate (of which approximately 250 tonnes of high-purity, partially separated mixed RE Carbonate were recovered in the first quarter of 2023 containing approximately 115 tonnes of TREO). The Company expects to receive an additional 400 to 700 tonnes of monazite later in 2023, which the Company expects to process for the recovery of uranium and production of separated NdPr and a heavy REE (Sm+) RE Carbonate upon commissioning of the Mill’s Phase 1 REE separation circuit in late 2023 or early 2024 (see “Rare Earth Element Initiatives” above). The Company is also in active discussion with several parties globally to acquire additional quantities of natural monazite ore, which if secured and delivered to the Mill, could result in significant additional quantities of uranium and separated NdPr and heavy REE (Sm+) Re Carbonate production in 2024 and beyond.

No vanadium production is currently planned during 2023, though the Company continually monitors its inventory and vanadium markets to guide future potential vanadium production.

The Company is also actively pursuing opportunities to process additional sources of natural monazite sands, new and additional Alternate Feed Material sources, and new and additional low-grade mineralized materials from third parties in connection with various uranium clean-up requirements.

Conventional Mine Activities

During the three months ended March 31, 2023, the Company performed rehabilitation and development work on its La Sal Complex, Whirlwind and Pinyon Plain projects for future potential production, including engineering, procurement,

33

construction management, increased development activities, significant workforce expansion and needed rehabilitation of surface and underground infrastructure. The Company expects to continue its rehabilitation and development work on these Projects during 2023, as it prepares them for future production. Although the timing of the Company’s plans to extract and process mineralized materials from these Projects will be based on current contract requirements, inventory levels, sustained improvements in general market conditions, procurement of suitable sales contracts and/or the expansion of the U.S. Uranium Reserve Program, the Company is making the investments required to put one or more of these facilities into production as soon as later in 2023.

The Company is selectively advancing certain permits at its other major conventional uranium projects, such as the Roca Honda Project, which is a large, high-grade conventional project in New Mexico. The Company is also continuing to maintain required permits at its other conventional projects, including the Energy Queen and Pandora mines and Sheep Mountain project. Additionally, the Company is evaluating processing options for future production at its Sheep Mountain project and will continue to evaluate the Bullfrog Project. Expenditures for certain of these projects have been adjusted to coincide with expected dates of price recoveries based on the Company’s forecasts. All of these projects serve as important pipeline assets for the Company’s future conventional production capabilities, as market conditions may warrant.

ISR Extraction and Recovery Activities

The Company expects to produce insignificant quantities of U3O8 in the year ending December 31, 2023 from Nichols Ranch. Until such time when (i) market conditions improve sufficiently, (ii) suitable term sales contracts can be procured, (iii) the U.S. Uranium Reserve Program is expanded or a combination thereof, the Company expects to maintain the Nichols Ranch Project on standby and defer development of further wellfields and header houses. The Company currently holds 34 fully permitted, undeveloped wellfields at Nichols Ranch, including four additional wellfields at the Nichols Ranch wellfields, 22 wellfields at the adjacent Jane Dough wellfields, and eight wellfields at the Hank Project, which is fully permitted to be constructed as a satellite facility to the Nichols Ranch Plant. The Company sold its Alta Mesa ISR Project in February 2023. See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

Inventories

As of March 31, 2023, the Company had approximately 847,000 pounds of finished uranium inventories located at North American conversion facilities. Additionally, the Company has approximately 345,000 pounds of additional U3O8 contained in stockpiled Alternate Feed Materials and other ore inventory at the Mill that can potentially be recovered relatively quickly in the future, as general market conditions may warrant. During the three months ended March 31, 2023, the Company completed the purchase of 120,000 additional pounds of uranium and the sale of 300,000 pounds of uranium to the U.S. Uranium Reserve Program, resulting in the Company holding approximately 847,000 pounds of U3O8 in inventory as of March 31, 2023. The Company expects to deliver 260,000 additional pounds of U3O8 under its existing uranium term contracts in 2023 resulting in expected uranium inventories to total approximately 587,000 pounds of U3O8 at year-end 2023, subject to currently unplanned uranium spot sales and purchases.

The Company sold 79,344 pounds of vanadium during the three months ended March 31, 2023. As of March 31, 2023, the Company holds approximately 906,000 pounds of finished V2O5 in inventory. There remains an estimated 1.0 to 3.0 million pounds of additional solubilized recoverable V2O5 remaining in tailings solutions awaiting future recovery, as market conditions may warrant.

Sales Update and Outlook for 2023

The Company continually evaluates selling a portion of its inventories on the spot market in response to future upside price volatility, for delivery into additional long-term supply contracts if procured, and/or for future additional sales into the newly established U.S. Uranium Reserve Program. The Company also continually evaluates the potential to purchase uranium on the spot market to replace sold inventory, meet sales obligations, and gain exposure to future price increases.

Uranium Sales

The Company entered into four uranium sale and purchase agreements in 2022: three with major U.S. nuclear utilities and one with the U.S. Uranium Reserve Program. Under these contracts, the Company expects to sell 560,000 pounds of U3O8 during 2023 with an expected weighted-average sales price of $58 - $60 per pound, subject to then-prevailing market prices at the time of delivery. In January 2023, the Company completed the sale of 300,000 pounds of its inventories located at the Metropolis Works uranium conversion facility (“ConverDyn”) to the U.S. Uranium Reserve Program, receiving total proceeds of $18.47 million ($61.57 per pound), resulting in a margin of approximately $35.85 per pound of uranium. During the remainder of 2023, the Company expects to sell 260,000 pounds of its U3O8 inventory into its contracts at an expected sales price of approximately $54 to $58 per pound, subject to inflation and spot prices in effect at the time of delivery.

The three utility contracts require deliveries of uranium between 2023 and 2030, with base quantities totaling 3.0 million pounds of uranium over the period, and up to 4.1 million pounds of uranium if all remaining options are exercised. Having

34

observed a marked uptick in interest from nuclear utilities seeking long-term uranium supply, the Company remains actively engaged in pursuing additional selective long-term uranium sales contracts.

To provide the Company with additional flexibility to fulfill its contract obligations and gain direct exposure to potential future uranium price increases, the Company purchased a total of 301,052 pounds of U.S.-origin uranium on the spot market in late 2022 and early 2023 for a weighted-average gross price of approximately $50.08 per pound.

Vanadium Sales

As a result of strengthening vanadium markets, during the three months ended March 31, 2023, the Company sold approximately 79,344 pounds of the Company’s existing inventory of V2O5 at a weighted average price of $10.98 per pound of V2O5. The Company expects to sell its remaining finished vanadium product when justified into the metallurgical industry, as well as other markets that demand a higher purity product, including the aerospace, chemical, and potentially the vanadium battery industries. The Company expects to sell to a diverse group of customers in order to maximize revenues and profits. The vanadium produced in the 2018/19 Pond Return campaign was a high-purity vanadium product of 99.6%-99.7% V2O5. The Company believes there may be opportunities to sell certain quantities of this high-purity material at a premium to reported spot prices. As such, the sales during Q1 2023 were at a $0.60 per pound premium to the average spot price for V2O5 during February and March 2023.

Additionally, the Company intends to continue to selectively sell its V2O5 inventory on the spot market as markets warrant but will otherwise continue to maintain its vanadium in inventory.

Rare Earth Sales

The Company commenced its commercial production of a mixed RE Carbonate in March 2021. All RE Carbonate produced at the Mill in 2022 was sold to Neo for separation at Silmet. Until such time as the Company commissions its own separation circuits at the Mill, which is expected to be in late 2023 or early 2024, all or a portion of RE Carbonate production is expected to be sold to Neo for separation at Silmet and/or, potentially, to other REE separation facilities outside of the U.S. To the extent not sold, the Company expects to stockpile mixed RE Carbonate at the Mill for future separation and other downstream REE processing at the Mill or elsewhere.

While the Company continues to make progress on its mixed RE Carbonate production and additional funds are spent on process enhancements, improving recoveries, product quality and other optimization, profits from this initiative are expected to be minimal until such time when monazite throughput rates are increased and optimized. Throughout this process, the Company is gaining important knowledge, experience and technical information, all of which are valuable for current and future mixed RE Carbonate production and planned future production of separated REE oxides and other advanced REE materials at the Mill or elsewhere.

35

Results of Operations

The following table summarizes the results of operations for the three months ended March 31, 2023 and 2022 (in thousands of U.S. dollars):

	Three Months Ended March 31,				Increase		Percent
	2023		2022		(Decrease)		Change
Revenues
Uranium concentrates	$	18,470	$	—	$	18,470	*
Vanadium concentrates	871		2,412		(1,541)		(64)	%
Alternate Feed Materials, processing and other	272		525		(253)		(48)	%
Total revenues	19,613		2,937		16,676		*
Costs applicable to revenues
Costs applicable to uranium concentrates	7,715		—		7,715		*
Costs applicable to vanadium concentrates	551		1,229		(678)		(55)	%
Underutilized capacity production costs applicable to RE Carbonate	—		1,663		(1,663)		*
Total costs applicable to revenues	8,266		2,892		5,374		186	%
Other operating costs and expenses
Exploration, development and processing	3,096		1,173		1,923		164	%
Standby	2,287		3,475		(1,188)		(34)	%
Accretion of asset retirement obligations	346		394		(48)		(12)	%
Total other operating costs	5,729		5,042		687		14	%
Selling, general and administration
Selling, general and administration (excluding share-based compensation)	4,837		4,354		483		11	%
Share-based compensation	1,186		862		324		38	%
Total selling, general and administration	6,023		5,216		807		15	%
Total operating loss	(405)		(10,213)		9,808		*
Other income (loss)
Gain on sale of assets	116,450		—		116,450		*
Other loss	(1,781)		(4,517)		2,736		(61)	%
Total other income (loss)	114,669		(4,517)		119,186		*
Net income (loss)	$	114,264	$	(14,730)	$	128,994	*
Basic and diluted net income (loss) per common share	$	0.72	$	(0.09)	$	0.81	*

*Not meaningful.

36

The following tables set forth selected operating data and financial metrics for the three months ended March 31, 2023 and 2022.

	Three Months Ended March 31,		Increase	Percent
	2023	2022	(Decrease)	Change
Volumes Sold
Uranium concentrates (lbs.)	300,000	—	300,000	*
Vanadium concentrates (lbs.)	79,344	229,349	(150,005)	(65)	%

*Not meaningful.

	Three Months Ended March 31,				Increase		Percent
	2023		2022		(Decrease)		Change
Realized Sales Price
Uranium concentrates ($/lbs.)	$	61.57	$	—	$	61.57	*
Vanadium concentrates ($/lbs.)	$	10.98	$	10.51	$	0.47	4	%
Costs and expenses applicable to revenues
Uranium concentrates ($/lbs.)	$	25.72	$	—	$	25.72	*
Vanadium concentrates ($/lbs.)	$	6.94	$	5.36	$	1.58	29	%

*Not meaningful.

Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022

For the three months ended March 31, 2023, we recognized net income of $114.26 million or $0.72 per share compared to a net loss of $14.73 million or $0.09 per share for the three months ended March 31, 2022. The change between periods was primarily due to (i) a gain of $116.45 million recognized on the sale of the Company’s Alta Mesa ISR Project in February 2023, (ii) sales of uranium concentrates for $18.47 million, (iii) a $1.66 million decrease in underutilized production costs applicable to RE Carbonate, partially offset by (i) costs applicable to uranium concentrates of $7.72 million, (ii) a decrease in sales of vanadium concentrates of $1.54 million and (iii) increased selling, general and administrative expenses, including non-cash share-based compensation, of $0.81 million due to increased headcount associated with ramping up operating activities.

Operating loss decreased to $0.41 million for the three months ended March 31, 2023 from $10.21 million for the three months ended March 31, 2022, primarily due to sales of uranium concentrates during the three months ended March 31, 2023. There were no such sales during the three months ended March 31, 2022.

Revenues

Uranium concentrates

Revenues from uranium concentrates were $18.47 million for the three months ended March 31, 2023 due to the completed sale of 300,000 pounds of our inventories to the U.S. Uranium Reserve Program at a realized sales price of $61.57 per pound of uranium. There were no revenues from uranium concentrates for the three months ended March 31, 2022.

Vanadium concentrates

Revenues from vanadium concentrates decreased to $0.87 million for the three months ended March 31, 2023 from $2.41 million for the three months ended March 31, 2022, a decrease of 64% primarily due lower volumes sold and realized price between periods. Lower sales volumes (calculated as the change in year-to-year sales volumes times the prior period realized price) accounted for an approximate $1.58 million decrease in vanadium revenue between periods. Lower realized prices (calculated as the change in the year-to-year average realized price times current year sales volumes sold) accounted for an approximate $0.03 million decrease in vanadium revenue between periods.

Alternate Feed Materials, processing and other

Revenues from Alternate Feed Materials, processing and other decreased to $0.27 million for the three months ended March 31, 2023 from $0.53 million for the three months ended March 31, 2022, a decrease of $0.25 million or 48%, primarily due to lower Alternate Feed Materials received and processed between periods.

37

Costs Applicable to Revenues

Costs applicable to uranium concentrates

Costs applicable to uranium concentrates were $7.72 million for the three months ended March 31, 2023 due to the completed sale of 300,000 pounds of our finished uranium concentrate at a weighted average cost of $25.72 per pound to the U.S. Uranium Reserve Program in January 2023. There were no costs applicable to uranium concentrates for the three months ended March 31, 2022.

Costs applicable to vanadium concentrates

Costs and expenses applicable to vanadium concentrates decreased to $0.55 million for the three months ended March 31, 2023 from $1.23 million for the three months ended March 31, 2022, a decrease of $0.68 million or 55%, primarily due to a decrease of approximately 150,005 pounds of V2O5, partially offset by a $1.58 increase in cost per pound sold between periods.

Underutilized capacity production costs applicable to RE Carbonate

Underutilized capacity production costs applicable to RE Carbonate were $1.66 million for the three months ended March 31, 2022. The underutilized capacity production costs were due to low throughput rates as the Mill ramps-up to commercial-scale production of RE Carbonate. To date, the Mill has focused on producing commercially salable RE Carbonate at low throughput rates and has shipped its resulting product to Silmet. The Mill expects to increase its throughput rates as its supplies of monazite sands increase. There were no underutilized production capacity costs applicable to RE Carbonate for the three months ended March 31, 2023.

Other Operating Costs and Expenses

Exploration, development and processing

Exploration, development and processing costs increased to $3.10 million for the three months ended March 31, 2023 from $1.17 million for the three months ended March 31, 2022, an increase of $1.92 million or 164%. Exploration, development and processing costs were primarily related to expenses for our Bahia Project and Whirlwind Project as well as continued progression of the RE Carbonate production program at the Mill.

While we expect the amounts relative to the items listed above have added future value to the Company, the Company expenses these costs in part due to the fact that the Company has not established Proven Mineral Reserves or Probable Mineral Reserves as defined by S-K 1300 or NI 43-101 through the completion of a final or bankable feasibility study for any of the Company’s projects as of the year ended 2022, with the exception of its Sheep Mountain and Pinyon Plain Projects.

Standby

Standby costs related to the care and maintenance of the standby mines are expensed along with standby costs incurred when the Mill in standby status is operating at minimal levels of production or packaging.

Standby costs decreased to $2.29 million for the three months ended March 31, 2023 from $3.48 million for the three months ended March 31, 2022, a decrease of $1.19 million or 34%, primarily due to the Alta Mesa Divestiture on February 14, 2023 as well as lower costs incurred at Colorado Plateau and the Mill between periods.

Selling, general and administrative

Selling, general and administrative expenses include costs associated with marketing uranium, corporate costs and other general and administrative costs. Corporate costs consist primarily of payroll and related expenses for personnel, contract and professional services, share-based compensation expense and other overhead expenditures.

Selling, general and administrative (excluding share-based compensation)

Selling, general and administrative expenses (excluding share-based compensation) increased to $4.84 million for the three months ended March 31, 2023 from $4.35 million for the three months ended March 31, 2022, an increase of $0.48 million or 11%, primarily due to increased salaries and benefits in connection with additional headcount incurred associated with the Company’s efforts to enhance its business processes to prepare for the current and future growth in activity in our Uranium and REE operations. Our headcount increased to 134 full-time employees as of March 31, 2023 from 103 full-time employees as of March 31, 2022.

Share-based compensation

Share-based compensation increased to $1.19 million for the three months ended March 31, 2023 from $0.86 million for the three months ended March 31, 2022, an increase of $0.32 million or 38%, primarily due to Board approved annual 2023 grant of awards coupled with a higher grant date fair value, completion of the requisite service period for 2022 and additional headcount.

38

Other Income (Loss)

Gain on sale of assets

For the three months ended March 31, 2023, we recognized a gain on sale of assets of $116.45 million related to the sale of Energy Fuels’ Alta Mesa ISR Project to enCore for total consideration of $120 million. See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

Other loss

Other loss decreased to $1.78 million, net for the three months ended March 31, 2023 from $4.52 million, net for the three months ended March 31, 2022, a decrease of $2.74 million or 61%, primarily due to an unrealized loss on foreign exchange of $1.24 million during the three months ended March 31, 2022 compared to an unrealized gain on foreign exchange of $0.03 million during the three months ended March 31, 2023, increased interest income of $1.02 million, decreased losses of $0.67 million on mark-to-market investments and marketable securities accounted for at fair value between periods, partially offset by unrealized loss on the convertible note of $0.20 million during the three months ended March 31, 2023.

LIQUIDITY AND CAPITAL RESOURCES

Funding of Major Cash Requirements

Our primary short-term and long-term cash requirements are to fund working capital needs and operating expenses, capital expenditures and potential future growth opportunities through ongoing initiatives such as our REE program, Bahia Project, our S-X project, Pinyon Plain operational readiness and TAT radioisotope initiative as well as business and property acquisitions.

We expect to be able to fund working capital and operating expenses, capital expenditures and currently planned growth initiatives over the next 12 months through available cash balances, and product inventory sales, if needed. We may also increase our working capital through issuances of Common Shares in appropriate circumstances. We intend to continue to pursue the acquisition of monazite mineral rights and other uranium producing assets.

Shares Issued for Cash

The Company has an ATM program in place, which allows the Company to make Common Share distributions to the extent qualified under a U.S. shelf registration statement on Form S-3 and one or more prospectus supplements. The Company’s current U.S. shelf registration statement was declared effective on March 18, 2021 and permits the Company to sell any combination of Securities (as defined therein) in one or more offerings having an aggregate offering price of up to $300.00 million. Most recently, on January 3, 2022, we filed a prospectus supplement with the SEC to our U.S. shelf registration statement, qualifying for distribution up to $50.00 million in additional common shares under the ATM. Sales made pursuant to the above summarized U.S. shelf registration statements and prospectus supplements are made on the NYSE American at then-prevailing market prices, or any other existing trading market of the Common Shares in the U.S. No Common Shares were issued under its ATM offering during the three months ended March 31, 2023. See Note 7 – Capital Stock for more information.

Working Capital and Future Requirements for Funds

As of March 31, 2023, the Company had working capital of $143.61 million, including $43.83 million in cash and cash equivalents, $60.44 million of marketable securities, approximately 847,000 pounds of uranium finished goods inventory and approximately 906,000 pounds of vanadium finished goods inventory. The Company believes it has sufficient cash and resources to carry out its business plan for at least the next twelve months.

The Company manages liquidity risk through the management of its working capital and its capital structure.

39

Cash and Cash Flows

The following table summarizes our cash flows (in thousands):

	Three Months Ended March 31,
	2023		2022
Net cash used in operating activities	$	(2,579)	$	(10,548)
Net cash used in investing activities	(19,002)		(398)
Net cash provided by (used in) financing activities	(846)		3,590
Effect of exchange rate fluctuations on cash held in foreign currencies	22		19
Plus: release of restricted cash related to sale of assets	3,475		—
Net change in cash, cash equivalents and restricted cash	(18,930)		(7,337)
Cash, cash equivalents and restricted cash, beginning of period	80,269		132,822
Cash, cash equivalents and restricted cash, end of period	$	61,339	$	125,485

Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022

Net cash used in operating activities

Net cash used in operating activities decreased by $7.97 million to $2.58 million for the three months ended March 31, 2023 from $10.55 million for the three months ended March 31, 2022 primarily due to sales of uranium concentrates of $18.47 million less costs applicable to uranium concentrates of $7.72 million, partially offset by lower sales and costs of vanadium concentrates and increased selling, general and administrative expenses and exploration, development permitting and land holding expenses between periods.

Net cash used in investing activities

Net cash used in investing activities increased by $18.60 million to $19.00 million for the three months ended March 31, 2023 from $0.40 million for the three months ended March 31, 2022 primarily due to purchases of marketable securities of $47.92 million, the acquisition of the Bahia Project for $21.60 million, partially offset by $53.76 million in proceeds from the sale of the Alta Mesa ISR Project. Additionally, additions to property, plant and equipment and mineral properties increased by $2.82 million between periods. See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

Net cash provided by (used in) financing activities

Net cash used in financing activities was $0.85 million for the three months ended March 31, 2023 compared to net cash provided by financing activities of $3.59 million for the three months ended March 31, 2023. The change in net cash provided by (used in) activities is primarily due to proceeds of $4.16 million for the issuance of common shares for cash, net under our ATM Program during the three months ended March 31, 2023. See Note 7 – Capital Stock for more information.

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of our unaudited condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent liabilities. Certain accounting policies involve judgments and uncertainties to such an extent that there is reasonable likelihood that materially different amounts could have been reported under different conditions, or if different assumptions had been used. We evaluate our estimates and assumptions on a regular basis. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates and assumptions used in preparation of our financial statements. We provide expanded discussion of our more significant accounting policies, estimates and judgments in the Annual Report on Form 10-K for the year ended December 31, 2022. We believe these accounting policies reflect our more significant estimates and assumptions used in preparation of our financial statements.

Off Balance Sheet Arrangements

See Note 12 – Commitments and Contingencies to the unaudited condensed consolidated financial statements for further information on off balance sheet arrangements.

40

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

The Company is exposed to risks associated with commodity prices, interest rates and credit. Commodity price risk is defined as the potential loss that we may incur as a result of changes in the market value of uranium, vanadium and REEs. Interest rate risk results from our debt and equity instruments that we issue to provide financing and liquidity for our business. Credit risk arises from the extension of credit throughout all aspects of our business. Industry-wide risks can also affect our general ability to finance exploration, and development of exploitable resources; such effects are not predictable or quantifiable. Market risk is the risk to the Company of adverse financial impact due to change in the fair value or future cash flows of financial instruments as a result of fluctuations in interest rates and foreign currency exchange rates.

Commodity Price Risk

Our profitability is directly related to the market price of uranium, vanadium and REEs recovered. We may, from time to time, undertake commodity and currency hedging programs, with the intention of maintaining adequate cash flows and profitability to contribute to the long-term viability of the business. We anticipate selling forward in the ordinary course of business if, and when, we have sufficient assets and recovery to support forward sale arrangements, and forward sale arrangements are available on suitable terms. There are, however, risks associated with forward sale programs. If we do not have sufficient recovered product to meet our forward sale commitments, we may have to buy or borrow (for later delivery back from recovered product) sufficient product in the spot market to deliver under the forward sales contracts, possibly at higher prices than provided for in the forward sales contracts, or potentially default on such deliveries. In addition, under forward contracts, we may be forced to sell at prices that are lower than the prices that may be available on the spot market when such deliveries are completed. Although we may employ various pricing mechanisms within our sales contracts to manage our exposure to price fluctuations, there can be no assurance that such mechanisms will be successful. There can also be no assurance that we will be able to enter into term contracts for future sales of uranium, vanadium, RE Carbonate or REE oxides at prices or in quantities that would allow us to successfully manage our exposure to price fluctuations.

The Company currently has three long-term uranium supply contracts. All uranium sales not made under these contracts will be required to be made at spot prices until the Company enters into additional long-term contracts at satisfactory prices in the future. Future revenue will be affected by both spot and long-term U3O8 price fluctuations which are beyond our control, including: the demand for nuclear power; political and economic conditions; governmental legislation in uranium producing and consuming countries; and production levels and costs of production of other producing companies. The Company continuously monitors the market to determine its level of extraction and recovery of uranium in the future.

Interest Rate Risk

The Company is exposed to interest rate risk on its cash equivalents, marketable securities, and restricted cash. The Company does not use derivatives to manage interest rate risk. Our interest income is currently earned in U.S. dollars. See Note 3 – Marketable for more information.

Currency Risk

The foreign exchange risk relates to the risk that the value of financial commitments, recognized assets or liabilities will fluctuate due to changes in foreign currency rates. The Company does not use any derivative instruments to reduce its exposure to fluctuations in foreign currency exchange rates. As the U.S. Dollar is the functional currency of our U.S. operations, the currency risk has been reduced. We maintain a nominal balance in Canadian dollars and Brazilian Real, resulting in a low currency risk relative to our cash balances.

The following table summarizes, in U.S. dollar equivalents, the Company’s foreign currency (Cdn$/R$) exposures as of March 31, 2023 (in thousands):

Cash and cash equivalents	$	679
Trade and other receivables	1,119
Accounts payable and accrued liabilities	(1)
Total	$	1,797

The table below summarizes a sensitivity analysis for significant unsettled currency risk exposure with respect to our financial instruments as of March 31, 2023 with all other variables held constant. It shows how net income would have been affected by changes in the relevant risk variables that were reasonably possible at that date (in thousands).

41

	Change for Sensitivity Analysis	Increase (Decrease) in Other Comprehensive Income (Loss)
Strengthening net earnings	+1% change in U.S. dollar / Cdn$ or R$	$	23
Weakening net earnings	-1% change in U.S. dollar / Cdn$ or R$	$	(23)

Credit Risk

Credit risk relates to cash and cash equivalents, trade, and other receivables that arise from the possibility that any counterparty to an instrument fails to perform. The Company primarily transacts with highly rated counterparties and a limit on contingent exposure has been established for any counterparty based on that counterparty’s credit rating. As of March 31, 2023, the Company’s maximum exposure to credit risk was the carrying value of cash and cash equivalents, trade and note receivables, convertible note and marketable debt securities.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC and to ensure that material information required to be disclosed is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding disclosure. The Chief Executive Officer and the Chief Financial Officer, with assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of March 31, 2023, and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date as was disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the quarter ended March 31, 2023, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

42

PART II

ITEM 1. LEGAL PROCEEDINGS.

We are not aware of any material pending or threatened litigation or of any proceedings known to be contemplated by governmental authorities that are, or would be, likely to have a material adverse effect upon us or our operations, taken as a whole that was not disclosed in the Company’s Form 10-K for the year ended December 31, 2022, or in this Form 10-Q for the three months ended March 31, 2023.

ITEM 1A. RISK FACTORS.

There have been no material changes from the risk factors disclosed in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURE.

The mine safety disclosures required by section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K are included in Exhibit 95.1 of this Quarterly Report, which is incorporated by reference into this Item 4.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS.

Exhibits

The following exhibits are filed as part of this report:

43

Exhibit
Number	Description
3.1	Articles of Continuance dated September 2, 2005 (1)
3.2	Articles of Amendment dated May 26, 2006 (2)
3.3	By-laws (3)
4.1	Uranerz Energy Corporation 2005 Non-Qualified Stock Option Plan, as amended and restated as of June 15, 2011 (4)
4.2	Shareholder Rights Plan Agreement between Energy Fuels Inc. and American Stock Transfer & Trust Company, LLC, dated March 18, 2021 (5)
4.3	2021 Omnibus Equity Incentive Compensation Plan, as amended and restated on March 18, 2021 (6)
10.1	Sales Agreement by and among Energy Fuels Inc., Cantor Fitzgerald & Co., H.C. Wainwright & Co., LLC and Roth Capital Partners, LLC, dated May 6, 2019 (7)
10.2	Amended and Restated Employment Agreement by and between Energy Fuels Inc. and Mark Chalmers dated March 31, 2023 (8)
10.3	Amended and Restated Employment Agreement by and between Energy Fuels Inc. and David C. Frydenlund dated March 31, 2023 (9)
10.4	Amended and Restated Employment Agreement by and between Energy Fuels Inc. and Curtis Moore dated March 31, 2023 (10)
10.5	Employment Agreement by and between Energy Fuels Inc. and Dee Ann Nazarenus dated September 1, 2020 (11)
10.6	Employment Agreement by and between Energy Fuels Inc. and Scott Bakken dated September 1, 2020 (12)
10.7	Amended and Restated Employment Agreement by and between Energy Fuels Inc. and John Uhrie dated March 31, 2023 (13)
10.8	Amended and Restated Employment Agreement by and between Energy Fuels Inc. and Tom Brock dated March 31, 2023 (14)
23.1	Consent of Mark S. Chalmers
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a)) under the Securities Exchange Act of 1934, as amended
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
95.1	Mine Safety Disclosure
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension – Schema
101.CAL	XBRL Taxonomy Extension – Calculations
101.DEF	XBRL Taxonomy Extension – Definitions
101.LAB	XBRL Taxonomy Extension – Labels
101.PRE	XBRL Taxonomy Extension – Presentations

44

(1)	Incorporated by reference to Exhibit 3.1 of Energy Fuels’ Form F-4 filed with the SEC on May 8, 2015.
(2)	Incorporated by reference to Exhibit 3.2 of Energy Fuels’ Form F-4 filed with the SEC on May 8, 2015.
(3)	Incorporated by reference to Exhibit 3.3 of Energy Fuels’ Form F-4 filed with the SEC on May 8, 2015.
(4)	Incorporated by reference to Exhibit 4.2 to Energy Fuels’ Form S-8 filed on June 24, 2015.
(5)	Incorporated by reference to Appendix B of Energy Fuels’ Schedule 14A filed with the SEC on April 2, 2021.
(6)	Incorporated by reference to Appendix A of Energy Fuels’ Schedule 14A filed with the SEC on April 2, 2021.
(7)	Incorporated by reference to Exhibit 10.1 to Energy Fuels’ Form 10-Q filed with the SEC on August 5, 2019.
(8)	Incorporated by reference to Exhibit 10.1 to Energy Fuels’ Form 8-K filed with the SEC on April 4, 2023.
(9)	Incorporated by reference to Exhibit 10.3 to Energy Fuels’ Form 8-K filed with the SEC on April 4, 2023.
(10)	Incorporated by reference to Exhibit 10.5 to Energy Fuels’ Form 8-K filed with the SEC on April 4, 2023.
(11)	Incorporated by reference to Exhibit 10.5 to Energy Fuels’ Form 10-Q filed with the SEC on November 2, 2020.
(12)	Incorporated by reference to Exhibit 10.6 to Energy Fuels’ Form 10-Q filed with the SEC on November 2, 2020.
(13)	Incorporated by reference to Exhibit 10.4 to Energy Fuels’ Form 8-K filed with the SEC on April 4, 2023.
(14)	Incorporated by reference to Exhibit 10.2 to Energy Fuels’ Form 8-K filed with the SEC on April 4, 2023.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ENERGY FUELS INC.

(Registrant)

Dated: May 5, 2023	By:	/s/ Mark S. Chalmers
		Mark S. Chalmers
		President & Chief Executive Officer
Dated: May 5, 2023	By:	/s/ Tom L. Brock
		Tom L. Brock
		Chief Financial Officer

45

EX-23.1

EXHIBIT 23.1

CONSENT OF MARK S. CHALMERS

I consent to the inclusion in the Quarterly Report on Form 10-Q of Energy Fuels Inc. (the “Company”) for the quarter ended March 31, 2023 (the “Quarterly Report”) of technical disclosure regarding the properties of the Company, including sampling, analytical and test data underlying such disclosure (the “Technical Information”) and of references to my name with respect to the Technical Information being filed with the United States Securities and Exchange Commission (the “SEC”) under cover of Form 10-Q.

I also consent to the filing of this consent under cover of Form 10-Q with the SEC and of the incorporation by reference of this consent and the Technical Information into the Company’s Registration Statements on Form S-3 (File Nos. 333-253666 and 333-226878), as amended, and into the Company’s Registration Statements on Form S-8 (Nos. 333-254559, 333-217098, 333-205182, 333-194900 and 333-226654), and any amendments thereto, filed with the SEC.

/s/ Mark S. Chalmers_______________

    Name: Mark S. Chalmers

    Title: President and Chief Executive Officer,

         Energy Fuels Inc.    

Date: May 5, 2023

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934

I, Mark S. Chalmers, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Energy Fuels Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

	/s/ Mark S. Chalmers
Date: May 5, 2023	Mark S. Chalmers
	President and Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934

I, Tom L. Brock, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Energy Fuels Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.	The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

	/s/ Tom L. Brock
Date: May 5, 2023	Tom L. Brock
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Energy Fuels Inc. (the "Company") on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mark S. Chalmers, President and Chief Executive Officer, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Mark S. Chalmers

Mark S. Chalmers

President and Chief Executive Officer

(Principal Executive Officer)

Date: May 5, 2023

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. §1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Energy Fuels Inc. (the "Company") on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Tom L. Brock, Chief Financial Officer, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Tom L. Brock

Tom L. Brock

Chief Financial Officer

(Principal Financial Officer)

Date: May 5, 2023

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-95.1

Exhibit 95.1

Mine Safety Disclosure

Pursuant to Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”), issuers that are operators, or that have a subsidiary that is an operator, of a coal or other mine in the United States, and that is subject to regulation by the Federal Mine Safety and Health Administration under the Mine Safety and Health Act of 1977 (“Mine Safety Act”), are required to disclose in their periodic reports filed with the SEC information regarding specified health and safety violations, orders and citations, related assessments and legal actions, and mining-related fatalities.

The following table sets out the information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd Frank Wall Street Reform and Consumer Protection Act for the period January 1, 2023 through March 31, 2023 covered by this report:

Property	Section 104(a) S&S Citations2 (#)	Section 104(b) Orders3 (#)	Section 104(d)Citations and Orders4 (#)	Section 110(b)(2)Violations5 (#)	Section 107(a)Orders6 (#)	Total Dollar Value of MSHA Assess-ments Proposed7 ($)	Total Number of Mining Related Fatalities (#)	Received Notice of Pattern of Violations or Potential Thereof Under Section 104(e)8 (yes/no)	Legal Actions Pending as of Last Day of Period9 (#)	Legal Actions Initiated During Period (#)	Legal Actions Resolved During Period (#)
Arizona 11	Nil	Nil	Nil	Nil	Nil	$0.00	Nil	No	Nil	Nil	Nil
Beaver1	Nil	Nil	Nil	Nil	Nil	$0.00	Nil	No	Nil	Nil	Nil
Pinyon Plain1	Nil	Nil	Nil	Nil	Nil	$143.00	Nil	No	Nil	Nil	Nil
Energy Queen1	Nil	Nil	Nil	Nil	Nil	$0.00	Nil	No	Nil	Nil	Nil
Pandora1	Nil	Nil	Nil	Nil	Nil	$0.00	Nil	No	Nil	Nil	Nil
Whirlwind1	Nil	Nil	Nil	Nil	Nil	$0.00	Nil	No	Nil	Nil	Nil

1.The Company’s Arizona 1 Project, La Sal Project comprised of the Beaver property, Energy Queen property and Pandora property, and Pinyon Plain Mine were each on standby and were not mined during the period. At the Whirlwind Mine, “Mining Operations,” as defined by the Mineral Rules and Regulations of the Colorado Mined Land Reclamation Board for Hard Rock, Metal, and Designated Mining Operations, are ongoing.

2.Citations and Orders are issued under Section 104 of the Federal Mine Safety and Health Act of 1977 (30 U.S.C. 814) (“MSHA”) for violations of MSHA or any mandatory health or safety standard, rule, order or regulation promulgated under MSHA. A Section 104(a) “Significant and Substantial” or “S&S” citation is considered more severe than a non-S&S citation and generally is issued in a situation where the conditions created by the violation do not cause imminent danger, but the violation is of such a nature as could significantly and substantially contribute to the cause and effect of a mine safety or health hazard. It should be noted that, for purposes of this table, S&S citations that are included in another column, such as Section 104(d) citations, are not also included as Section 104(a) S&S citations in this column.

3.A Section 104(b) withdrawal order is issued if, upon a follow up inspection, an MSHA inspector finds that a violation has not been abated within the period of time as originally fixed in the violation and determines that the period of time for the abatement should not be extended. Under a withdrawal order, all persons, other than those required to abate the violation and certain others, are required to be withdrawn from and prohibited from entering the affected area of the mine until the inspector determines that the violation has been abated.

4.A citation is issued under Section 104(d) where there is an S&S violation and the inspector finds the violation to be caused by an unwarrantable failure of the operator to comply with a mandatory health or safety standard. Unwarrantable failure is a special negligence finding that is made by an MSHA inspector and that focuses on the operator’s conduct. If during the same inspection or any subsequent inspection of the mine within 90 days after issuance of the citation, the MSHA inspector finds another violation caused by an unwarrantable failure of the operator to comply, a withdrawal order is issued, under which all persons, other than those required to abate the violation and certain others, are required to be withdrawn from and prohibited from entering the affected area until the inspector determines that the violation has been abated.

5.A flagrant violation under Section 110(b)(2) is a violation that results from a reckless or repeated failure to make reasonable efforts to eliminate a known violation of a mandatory health or safety standard that substantially and proximately caused, or reasonable could have been expected to cause, death or serious bodily injury.

6.An imminent danger order under Section 107(a) is issued when an MSHA inspector finds that an imminent danger exists in a mine. An imminent danger is the existence of any condition or practice which could reasonably be expected to cause death or serious physical harm before such condition or practice can be abated. Under an imminent danger order, all persons, other than those required to abate the condition or practice and certain others, are required to be withdrawn from and are prohibited from entering the affected area until the inspector determines that such imminent danger and the conditions or practices which caused

the imminent danger no longer exist.

7.These dollar amounts include the total amount of all proposed assessments under MSHA relating to any type of violation during the period, including proposed assessments for non-S&S citations that are not specifically identified in this exhibit, regardless of whether the Company has challenged or appealed the assessment.

8.A Notice is given under Section 104(e) if an operator has a pattern of S&S violations. If upon any inspection of the mine within 90 days after issuance of the notice, or at any time after a withdrawal notice has been given under Section 104(e), an MSHA inspector finds another S&S violation, an order is issued, under which all persons, other than those required to abate the violation and certain others, are required to be withdrawn from and prohibited from entering the affected area until the inspector determines that the violation has been abated.

9.There were no legal actions pending before the Federal Mine Safety and Health Review Commission as of the last day of the period covered by this report. In addition, there were no pending actions that are (a) contests of citations and orders referenced in Subpart B of 29 CFR Part 2700; (b) complaints for compensation referenced in subpart D of 29 CFR Part 2700; (c) complaints of discharge, discrimination or interference referenced in Subpart E of 29 CFR Part 2700; (d) applications for temporary relief referenced in Subpart F of 29 CFR Part 2700; or (e) appeals of judges’ decisions or orders to the Federal Mine Safety and Health Review Commission referenced in Subpart H of 29 CFR Part 2700.

XML

Cover - shares	3 Months Ended
	Mar. 31, 2023	May 02, 2023
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-36204
Entity Registrant Name	ENERGY FUELS INC.
Entity Incorporation, State or Country Code	Z4
Entity Tax Identification Number	98-1067994
Entity Address, Address Line One	225 Union Blvd., Suite 600
Entity Address, City or Town	Lakewood,
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80228
City Area Code	303
Local Phone Number	974-2140
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		158,029,412
Amendment Flag	false
Entity Central Index Key	0001385849
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
NEW YORK STOCK EXCHANGE, INC. [Member]
Entity Information [Line Items]
Title of 12(b) Security	Common Shares, no par value
Trading Symbol	UUUU
Security Exchange Name	NYSEAMER
TORONTO STOCK EXCHANGE [Member]
Entity Information [Line Items]
Title of 12(b) Security	Common shares, no par value

XML

Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues
Uranium concentrates	$ 18,470	$ 0
Vanadium concentrates	871	2,412
Alternate Feed Materials, processing and other	272	525
Total revenues	19,613	2,937
Costs applicable to uranium concentrates	7,715	0
Costs applicable to vanadium concentrates	551	1,229
Underutilized capacity production costs applicable to RE Carbonate	0	(1,663)
Total costs applicable to revenues	8,266	2,892
Other operating costs and expenses
Exploration, development and processing	3,096	1,173
Standby	2,287	3,475
Accretion of asset retirement obligations	346	394
Selling, general and administration	6,023	5,216
Total operating loss	(405)	(10,213)
Gain on sale of assets	116,450	0
Other loss (Note 11)	(1,781)	(4,517)
Total other income (loss)	114,669	(4,517)
Net income (loss)	$ 114,264	$ (14,730)
Basic loss per share (in dollars per share)	$ 0.72	$ (0.09)
Diluted loss per share (in dollars per share)	$ 0.72	$ (0.09)
Items that may be reclassified in the future to income (loss)
Foreign currency translation adjustment	$ 0	$ 1,766
Other comprehensive income (loss)	0	1,766
Comprehensive income (loss)	114,264	(12,964)
Net income (loss) attributable to:
Owners of the Company	114,265	(14,729)
Non-controlling interests	(1)	(1)
Net income (loss)	114,264	(14,730)
Comprehensive income (loss) attributable to:
Owners of the Company	114,265	(12,963)
Non-controlling interests	(1)	(1)
Comprehensive income (loss)	$ 114,264	$ (12,964)

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 43,831	$ 62,820
Marketable securities (Notes 3 and 13)	60,438	12,192
Trade and other receivables, net of allowance for credit losses of $223 and $223, as of March 31, 2023 and December 31, 2022, respectively	2,098	519
Inventories (Note 4)	38,003	38,155
Prepaid expenses and other current assets	4,198	9,529
Property, plant and equipment and other assets held for sale, net (Note 5)	346	12,375
Total current assets	148,914	135,590
Other long-term receivables	1,501	1,537
Inventories (Note 4)	2,078	2,465
Operating lease right of use asset	1,348	1,376
Investments accounted for at fair value (Note 13)	16,374	19,329
Property, plant and equipment, net (Note 5)	14,635	12,662
Mineral properties (Note 5)	113,834	83,539
Convertible note (Notes 3 and 13)	59,259	0
Restricted cash (Note 6)	17,508	17,449
Total assets	375,451	273,947
Current liabilities
Accounts payable and accrued liabilities (Note 11)	5,275	6,929
Operating lease liability	28	59
Deposits for assets held for sale	0	6,000
Asset retirement obligation and other liabilities held for sale (Note 6)	0	5,636
Total current liabilities	5,303	18,624
Operating lease liability	1,273	1,319
Asset retirement obligations (Note 6)	9,862	9,595
Total liabilities	16,438	29,538
Equity
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 158,029,412 and 157,682,531 as of March 31, 2023 and December 31, 2022, respectively	698,833	698,493
Accumulated deficit	(341,855)	(456,120)
Accumulated other comprehensive loss	(1,946)	(1,946)
Total shareholders' equity	355,032	240,427
Non-controlling interests	3,981	3,982
Total equity	359,013	244,409
Total liabilities and equity	375,451	273,947
Commitments and contingencies (Note 12)

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts Receivable, Allowance for Credit Loss, Current	$ 223	$ 223
Common stock, shares, issued (in shares)	158,029,412	157,682,531
Common stock, shares, outstanding (in shares)	158,029,412	157,682,531

XML

Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Total	Common Stock	Deficit	Accumulated Other Comprehensive Income (Loss)	Total Shareholders' Equity	Non-Controlling Interests
Beginning balance ( in shares) at Dec. 31, 2021		156,262,199
Beginning balance at Dec. 31, 2021	$ 295,526	$ 685,903	$ (396,271)	$ 1,943	$ 291,575	$ 3,951
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(14,730)		(14,729)		(14,729)	(1)
Other comprehensive income (loss)	1,766			1,766	1,766
Shares Issued For Cash By At The Market Offering Shares		413,751
Shares issued for cash by at-the-market offering	4,260	$ 4,260			4,260
Share issuance cost	96	96			96
Share-based compensation	862	$ 862			862
shares issued for exrcise of stock options (in shares)		135,926
Shares issued for exercise of stock options	328	$ 328			328
Shares issued for the vesting of restricted stock units (in shares)		362,350
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units	(884)	$ (884)			(884)
Shares issued for consulting services (in shares)		6,022
Shares issued for consulting services	51	$ 51			51
Ending balance (in shares) at Mar. 31, 2022		157,180,248
Ending balance at Mar. 31, 2022	287,083	$ 690,424	(411,000)	3,709	283,133	3,950
Beginning balance ( in shares) at Dec. 31, 2022		157,682,531
Beginning balance at Dec. 31, 2022	244,409	$ 698,493	(456,120)	(1,946)	240,427	3,982
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	114,264		114,265		114,265	(1)
Other comprehensive income (loss)	0
Share-based compensation	1,186	$ 1,186			1,186
shares issued for exrcise of stock options (in shares)		34,219
Shares issued for exercise of stock options	72	$ 72			72
Shares issued for the vesting of restricted stock units (in shares)		312,662
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units	(918)	$ (918)			(918)
Ending balance (in shares) at Mar. 31, 2023		158,029,412
Ending balance at Mar. 31, 2023	$ 359,013	$ 698,833	$ (341,855)	$ (1,946)	$ 355,032	$ 3,981

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Statement of Cash Flows [Abstract]
Net income (loss) for the period	$ 114,264	$ (14,730)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depletion, depreciation and amortization	655	813
Share-based compensation	1,186	862
Accretion of asset retirement obligations	346	394	$ 1,556
Revision and settlement of asset retirement obligation	0	96	(238)
Unrealized foreign exchange (gain) loss	(24)	1,225
Unrealized loss on investments accounted for at fair value	2,959	3,418
Gain on sale of assets	(116,450)	0
Other non-cash income, net	149	42
Changes in current assets and liabilities:
Marketable securities	(325)	(111)
Inventories	538	784
Trade and other receivables	(1,540)	(1,332)
Prepaid expenses and other current assets	(1,233)	(886)
Accounts payable and accrued liabilities	(3,104)	(1,123)
Net cash used in operating activities	(2,579)	(10,548)
INVESTING ACTIVITIES
Additions to property, plant and equipment	(2,042)	(398)
Additions to mineral properties	(1,171)	0
Acquisition of mineral properties	(21,624)	0
Purchases of marketable securities	(47,924)	0
Proceeds from sale of property, plant and equipment, net	53,759	0
Net cash used in investing activities	(19,002)	(398)
FINANCING ACTIVITIES
Issuance of common shares for cash, net of issuance costs	0	4,164
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units	(918)	(892)
Cash received from exercise of stock options	72	318
Net cash provided by (used in) financing activities	(846)	3,590
Effect of exchange rate fluctuations on cash held in foreign currencies	22	19
Plus: release of restricted cash related to sale of assets	3,475	0
Net change in cash, cash equivalents and restricted cash	(18,930)	(7,337)
Cash, cash equivalents and restricted cash, beginning of period	80,269	132,822	132,822
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD	61,339	125,485	$ 80,269
Non-cash investing and financing transactions:
Issuance of common shares for consulting services	0	193
Supplemental disclosure of cash flow information:
Interest	11	9
Increase (decrease) in accrued capital expenditures and accounts payable for property, plant and equipment and mineral properties	$ 1,456	$ (182)

XML

THE COMPANY AND DESCRIPTION OF BUSINESS

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

The Company and Description of Business

THE COMPANY AND DESCRIPTION OF BUSINESS

Energy Fuels Inc. was incorporated under the laws of the Province of Alberta and was continued under the Business Corporations Act (Ontario).

Energy Fuels Inc. and its subsidiary companies (collectively “the Company” or “Energy Fuels”) are together engaged in conventional and in situ recovery (“ISR”) uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties, along with the exploration, permitting and evaluation of uranium properties in the United States (the “U.S.”). As a part of these activities, the Company also acquires, explores, evaluates and, if warranted, permits uranium properties. The Company’s final uranium product, uranium oxide concentrate (“U3O8” or “uranium concentrate”), known more commonly as “yellowcake,” is sold to customers for further processing into fuel for nuclear reactors. The Company also produces vanadium pentoxide (“V2O5”), along with uranium at the White Mesa Mill (the “White Mesa Mill” or the “Mill”), from certain of its Colorado Plateau properties as market conditions warrant and at times from solutions in its Mill tailings impoundment system. The Mill is also ramping up to commercial production of rare earth element (“REE”) carbonate (“RE Carbonate”) from various uranium- and REE-bearing materials acquired from third parties and is working on modifications and enhancements at the Mill for the potential production of separated REE oxides. Additionally, the Company is evaluating the potential to recover radioisotopes from its existing process streams at the Mill for use in targeted alpha therapy (“TAT”) therapeutics for the treatment of cancer.

With its uranium, vanadium, REE and potentially radioisotope production, the Mill is working to establish itself as a critical minerals hub in the U.S. Uranium is the fuel for carbon-free, emission-free baseload nuclear power – one of the cleanest forms of energy in the world. The REEs produced are used to manufacture permanent magnets for electric vehicles, wind turbines and other clean energy and modern technologies. The Company's uranium and REE production and recycling helps Energy Fuels play a part in addressing global climate change and reducing air pollution. Additionally, the radioisotopes, which the Company is evaluating for recovery from its uranium processing streams, have the potential to provide the isotopes needed for emerging TAT cancer-fighting therapeutics.

The Company is a “development stage issuer” as defined by S-K 1300, as it is engaged in the preparation of Mineral Reserves for extraction of at least one material property.

Mining Activities

Mining activities consist of the Mill, multiple conventional mining projects and an ISR mining project (complete with an ISR recovery facility on standby). The most conventional mining projects are located on the Colorado Plateau, including the Pinyon Plain, Whirlwind, La Sal, Bullfrog, Arizona Strip and Roca Honda Projects, all of which are in the vicinity of the Mill, as well as the Sheep Mountain Project located in Wyoming. The ISR project is the Nichols Ranch Project (which includes Jane Dough and Hank Satellite deposits) located in Wyoming. On February 14, 2023, the Company closed on the sale of the Alta Mesa Project. See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

As of March 31, 2023, other than performing rehabilitation and development work on its La Sal, Whirlwind and Pinyon Plain projects, the conventional mining projects in the vicinity of the Mill and Sheep Mountain are on standby and are being evaluated for continued mining activities and/or are in the process of being permitted. The Mill continues to receive third-party uranium-bearing mineralized materials from mining and recycling activities, such as the Mill’s alternate feed program, for processing, continues to expand its REE initiatives, and continues to develop its cancer therapeutics initiatives.

XML

BASIS OF PRESENTATION

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

These unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) applicable to interim financial information and should be read in conjunction with the consolidated financial statements and notes thereto and the summary of significant accounting policies included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC.

These unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information, and, accordingly, do not include all

of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements are presented in thousands of U.S. dollars, except for share and per share amounts. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included are adequate to make the information presented not misleading.

In management’s opinion, these unaudited condensed consolidated financial statements reflect all adjustments, consisting solely of normal recurring items, which are necessary for the fair presentation of the Company’s financial position, results of operations and cash flows on a basis consistent with that of the Company’s audited consolidated financial statements for the year ended December 31, 2022. However, the results of operations for the interim periods may not be indicative of results to be expected for the full fiscal year.

Principles of Consolidation

These unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated. Certain prior period amounts have been reclassified in order to conform to the current period presentation. These reclassifications had no effect on the reported results of operations.

XML

MARKETABLE SECURITIES

3 Months Ended

Mar. 31, 2023

Cash and Cash Equivalents [Abstract]

Marketable Securities

MARKETABLE SECURITIES

The Company elected the fair value option for its marketable debt securities and convertible note for which changes in fair value are recorded in Other income (loss) in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The fair value option was elected for these marketable debt securities, as the Company may sell them prior to their stated maturities after consideration of the Company's risk versus reward objectives, as well as its liquidity requirements. The stated contractual maturity dates of marketable debt securities held as of March 31, 2023 and December 31, 2022 are due in one to two years. The convertible note was received as a partial consideration for the Alta Mesa Transaction (defined in Note 5 – Property, Plant and Equipment and Mineral Properties). The Company elected the fair value option for the secured convertible note (the “Convertible Note”), as it has the option of converting into common shares of enCore Energy Corp. (“enCore”). Marketable equity securities are measured at fair value as of each reporting date, and unrealized gains (losses) are recorded in Other income (loss) in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

The following table summarizes our marketable securities by significant investment categories as of March 31, 2023:

	Cost Basis		Gross Unrealized Losses		Gross Unrealized Gains		Fair Value
Marketable debt securities(1)	$	59,359	$	—	$	72	$	59,431
Convertible note(2)	59,457		(198)		—		59,259
Marketable equity securities	2,876		(1,869)		—		1,007
Total marketable securities	$	121,692	$	(2,067)	$	72	$	119,697

(1)     Marketable debt securities are comprised primarily of U.S. government agency bonds.

(2)     The Convertible note was received as consideration in the Alta Mesa Transaction (defined in Note 5 – Property, Plant and Equipment and Mineral Properties) and is valued using a binomial lattice model using Level 3 inputs. See Note 5 – Property, Plant and Equipment and Mineral Properties and Note 13 – Fair Value Accounting for more information.

The following table summarizes our marketable securities by significant investment categories as of December 31, 2022:

	Cost Basis		Gross Unrealized Losses		Gross Unrealized Gains		Fair Value
Marketable debt securities(1)	$	11,435	$	(310)	$	—	$	11,125
Marketable equity securities	2,876		(1,809)		—		1,067
Total marketable securities	$	14,311	$	(2,119)	$	—	$	12,192

(1)     Marketable debt securities are comprised primarily of U.S. government agency bonds.

XML

INVENTORIES

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Inventories

INVENTORIES

Inventories consisted of the following items:

	March 31, 2023		December 31, 2022
Concentrates and work-in-progress	$	35,869	$	35,476
Inventory of ore in stockpiles	256		940
Consumables	3,956		4,204
Total inventories	$	40,081	$	40,620
Inventories – by duration
Current	$	38,003	$	38,155
Long term	2,078		2,465
Total inventories	$	40,081	$	40,620

XML

PLANT AND EQUIPMENT AND MINERAL PROPERTIES

3 Months Ended

Mar. 31, 2023

Property, Plant and Equipment [Abstract]

Plant and Equipment and Mineral Properties

PROPERTY, PLANT AND EQUIPMENT AND MINERAL PROPERTIES

The following is a summary of property, plant and equipment, net:

	March 31, 2023						December 31, 2022
	Cost		Accumulated Depreciation		Net Book Value		Cost		Accumulated Depreciation		Net Book Value
Property, plant and equipment
Nichols Ranch	$	29,210	$	(20,730)	$	8,480	$	29,210	$	(20,221)	$	8,989
Pinyon Plain	2,058		(746)		1,312		1,617		(714)		903
Equipment and other	17,196		(12,353)		4,843		15,009		(12,239)		2,770
Property, plant and equipment total	$	48,464	$	(33,829)	$	14,635	$	45,836	$	(33,174)	$	12,662

As of December 31, 2022, the net book value of the property, plant and equipment attributable to Alta Mesa was $8.21 million, which was included in Property, plant and equipment and other assets held for sale, net on the Condensed Consolidated Balance Sheets.

The Company recognized depreciation expense of $0.66 million and $0.81 million for the three months ended March 31, 2023, and 2022, respectively, in Exploration, development and process and Standby in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

For the three months ended March 31, 2023 and 2022, the Company capitalized $0.07 million and $0.05 million, respectively, of depreciation expense related to the Mill that was included in the capitalized costs to inventory on the Condensed Consolidated Balance Sheet.

The following is a summary of mineral properties:

	March 31, 2023		December 31, 2022
Mineral properties
Sheep Mountain	$	34,183	$	34,183
Bahia Project	29,124		—
Uranerz ISR properties	25,974		25,974
Roca Honda	22,095		22,095
Pinyon Plain	1,171		—
Other	1,287		1,287
Mineral properties total	$	113,834	$	83,539

Bahia Project

On February 10, 2023, the Company closed on two purchase agreements to acquire a total of 17 mineral concessions in the State of Bahia, Brazil totaling approximately 37,300 acres or 58.3 square miles (the “Bahia Project”). Under the terms of the purchase agreements, the Company entered into mineral rights transfer agreements with the sellers to acquire the 17 mineral sand concessions.

The total purchase price under the purchase agreements was $27.50 million, which consisted of $21.60 million due at closing and prior to closing, deposit payments of $5.90 million due upon reaching certain stipulated milestones. Upon final payment on February 10, 2023, the transfer and assignment of the mineral rights was completed (the “Bahia Closing”). Additionally, the Company incurred direct deal costs related to such asset acquisition of $1.63 million. The purchase deposit payments and direct transaction costs were capitalized as Prepaid expenses and other current assets in the Consolidated Balance Sheets as of December 31, 2022 and reclassified to Mineral properties upon closing within the Condensed Consolidated Balance Sheets. The Bahia Closing followed the Brazilian Government’s approval of the transfers to Energy Fuels’ wholly owned Brazilian subsidiary Energy Fuels Brazil Ltda.

Alta Mesa Transaction

On February 14, 2023, the Company closed on its sale of three wholly owned subsidiaries that together hold Energy Fuels’ Alta Mesa ISR Project to enCore for total consideration of $120 million (the “Alta Mesa Transaction”), paid as follows:

a.$60 million cash, which included $6 million prior to closing and $54 million at closing; and

b.$60 million in the Convertible Note, payable in two years from the closing, bearing annual interest of eight percent (8%). The Convertible Note is convertible at Energy Fuels’ election into enCore common shares at a conversion price of $2.9103 per share, being a 20% premium to the 10-day volume-weighted average price of enCore shares ending the day before the Closing (the “Conversion Option”). enCore is currently traded on the TSX-V and NYSE American. The Convertible Note is guaranteed by enCore and fully secured by Alta Mesa. Unless a block trade or similar distribution is executed by Energy Fuels to sell the enCore common shares received on conversion of the Convertible Note, Energy Fuels will be limited to selling a maximum of $10 million of common shares per thirty (30)-day period.

The Company recognized a gain on sale of assets from the Alta Mesa Transaction of $116.45 million, which is calculated as the total fair value of the consideration received of $119.46 million consisting of $60 million in cash and the Convertible Note with a fair value of $59.46 million, less the net book value attributable to the Alta Mesa ISR project assets and liabilities of $3.34 million, net of transaction costs. Receipt of the Convertible Note represents a non-cash investing activity at its initial fair value. See Note 13 – Fair Value Accounting for more information on the fair value of the Note.

In addition, after the closing of the transaction, enCore was required to replace the $3.59 million of reclamation bonds that existed for the Alta Mesa project. As of March 31, 2023, the Company has received $3.48 million cash as a release of collateral from those bonds, which it has reclassified from Property, plant and equipment and other assets held for sale, net to cash and cash equivalents on its Condensed Consolidated Balance Sheets.

In connection with the Alta Mesa Transaction, on May 3, 2023, the Company completed the sale of its Prompt Fission Neutron assets, including the underlying contracts, technology, licenses and intellectual property (collectively, the “PFN Assets”), to enCore in exchange for cash consideration received at closing of $3.10 million. At closing, the PFN Assets, which the Company had purchased in 2020 for cash consideration of $0.5 million, had a net book value of $0.35 million. The PFN Assets were used exclusively at the Alta Mesa ISR Project. Should the Company have the need for the use of a PFN tool in the future, the Company retained a 20-year usage right as a condition of this sale during which, subject to the availability of the PFN Assets, the Company has the right to purchase, lease and/or license at least one fully functional PFN tool and all related and/or

required equipment, technology and licenses, as reasonably requested, on commercially reasonable terms and conditions no less favorable than those offered by enCore to third parties. As of May 5, 2023, the Company has not purchased, leased and/or licensed a PFN tool.

XML

ASSET RETIREMENT OBLIGATIONS AND RESTRICTED CASH

3 Months Ended

Mar. 31, 2023

Asset Retirement Obligation Disclosure [Abstract]

Asset Retirement Obligations and Restricted Cash

ASSET RETIREMENT OBLIGATIONS AND RESTRICTED CASH

Asset Retirement Obligations

The following table summarizes the Company’s asset retirement obligations:

	March 31, 2023		December 31, 2022
Asset retirement obligations, beginning of period	$	9,595	$	13,687
Revision of estimate	—		(238)
Accretion of liabilities	346		1,556
Held for sale(1)	(79)		(5,410)
Asset retirement obligations, end of period	$	9,862	$	9,595

(1)Asset retirement obligations held for sale as of December 31, 2022 are related to Alta Mesa and are included as asset retirement obligation and other liabilities held for sale on the Condensed Consolidated Balance Sheets. Asset retirement obligations held for sale as of March 31, 2023 are related to the accretion expense on Alta Mesa through the closing date and is included within Gain on sale of assets on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

The Company’s asset retirement obligations are subject to legal and regulatory requirements. Estimates of the costs of reclamation are reviewed periodically by the Company and the applicable regulatory authorities.

Restricted Cash

The Company has cash, cash equivalents and fixed income securities as collateral for various bonds posted in favor of the applicable state regulatory agencies in Arizona, Colorado, New Mexico, Texas, Utah and Wyoming, and the U.S. Bureau of Land Management and U.S. Forest Service for estimated reclamation costs associated with the White Mesa Mill, Nichols Ranch, Alta Mesa and other mining properties. The restricted cash will be released when the Company has reclaimed a mineral property, sold a mineral property to a party having assumed the applicable bond requirements, or restructured the surety and collateral arrangements. See Note 12 – Commitments and Contingencies for more information.

The following table summarizes the Company’s restricted cash:

	March 31, 2023		December 31, 2022
Restricted cash, beginning of period	$	17,449	$	20,305
Additional collateral posted	59		734
Held for sale(1)	—		(3,590)
Restricted cash, end of period	$	17,508	$	17,449

(1)Restricted cash held for sale is related to Alta Mesa and is included as Asset retirement obligation and other liabilities held for sale on the Condensed Consolidated Balance Sheets. As of March 31, 2023, $3.48 million has been released and reclassified from Asset retirement obligation and other liabilities held for sale to cash and cash equivalents on the Condensed Consolidated Balance Sheets. The remaining $0.11 million was reclassified Restricted cash on the Condensed Consolidated Balance Sheets. See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

XML

CAPITAL STOCK

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Capital Stock

CAPITAL STOCK

Authorized Capital Stock

The Company is authorized to issue an unlimited number of Common Shares without par value, unlimited Preferred Shares issuable in series and unlimited Series A Preferred Shares. The Preferred Shares issuable in series will have the rights, privileges, restrictions and conditions assigned to the particular series upon the Board of Directors approving their issuance. The Series A Preferred Shares issuable are non-redeemable, non-callable, non-voting and have no right to dividends.

Issued Capital Stock

During the three months ended March 31, 2022, the Company issued 0.41 million Common Shares under its At-the-Market (the “ATM”) program offering for net proceeds of $4.16 million after share issuance costs. No Common Shares were issued under the ATM program during the three months ended March 31, 2023.

XML

BASIC AND DILUTED INCOME (LOSS) PER COMMON SHARE

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Basic and Diluted Loss Per Common Share

BASIC AND DILUTED NET INCOME (LOSS) PER COMMON SHARE

Basic and diluted income (loss) per Common Share

The calculation of basic and diluted loss per share after adjustment for the effects of all potential dilutive Common Shares, is as follows:

	Three Months Ended March 31,
	2023		2022
Net income (loss) attributable to owners of the Company	$	114,265	$	(14,729)
Basic weighted average common shares outstanding	157,930,097		156,614,344
Dilutive impact of stock options and restricted stock units	1,298,970		—
Diluted weighted average common shares outstanding	159,229,067		156,614,344
Basic net income (loss) per common share	$	0.72	$	(0.09)
Diluted net income (loss) per common share	$	0.72	$	(0.09)

For the three months ended March 31, 2023 and 2022, a weighted average of 0.26 million and 1.53 million, respectively, stock options and restricted stock units (“RSUs”) have been excluded from the calculation of diluted net income per Common Share as their effect would have been anti-dilutive. In addition, the Company excluded stock appreciation rights (“SARs”) of 1.66 million and 2.40 million, respectively, as they are contingently issuable based on specified market prices of the Company’s Common Shares, which were not achieved as of the end of each period.

XML

SHARE-BASED PAYMENTS

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Share-Based Payments

SHARE-BASED PAYMENTS

The Company maintains an equity incentive plan, known as the 2021 Amended and Restated Omnibus Equity Incentive Compensation Plan (the “Compensation Plan”), for directors, executives, eligible employees and consultants. Existing equity incentive awards include employee non-qualified stock options, RSUs and SARs. The Company issues new Common Shares to satisfy exercises and vesting under its equity incentive awards. As of March 31, 2023, a total of 15,802,941 Common Shares were authorized for future equity incentive plan awards.

The Company’s share-based compensation expense, by type of award, is as follows:

	Three Months Ended March 31,
	2023		2022
RSUs(1)	$	644	$	484
SARs	436		346
Stock options	106		32
Total share-based compensation expense(2)	$	1,186	$	862

(1)The fair value of the RSUs granted under the Compensation Plan for the three months ended March 31, 2023 and 2022 was estimated at the date of grant, using the stated market price on the NYSE American.

(2)Share-based compensation is included in Selling, general and administration in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Restricted Stock Units

The Company grants RSUs to directors, executives and eligible employees. Awards for executives and eligible employees are determined as a target percentage of base salary and generally vest over three years. Holders of unvested RSUs do not have voting rights on those RSUs. The RSUs are subject to forfeiture risk and other restrictions. Upon vesting, the employee is entitled to receive one Common Share of the Company for each RSU at no additional payment.

A summary of the Company’s non-vested RSUs activity is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022	747,425	$	4.77
Granted	450,232	7.36
Vested	(448,883)	4.24
Forfeited	—	—
Non-vested, March 31, 2023	748,774	$	6.64

The total intrinsic value and fair value of RSUs that vested and were settled for equity was $3.38 million for the three months ended March 31, 2023.

Stock Appreciation Rights

The Company may grant SARs to directors, executives, and eligible employees.

On January 26, 2023, the Company’s Board of Directors issued SARs under the Compensation Plan, which are intended to provide additional long-term equity incentives for the Company’s senior management.

Each SAR granted entitles the holder to receive, upon a valid exercise, payment from the Company in cash or Common Shares (at the sole discretion of the Company) in an amount representing the difference between the fair market value (“FMV”) of the Company’s Common Shares on the date of exercise and $7.36 (the closing market price or “Grant Price” at the time of grant). Fair Market Value as used herein means the closing price of the Shares on the TSX or the NYSE American on the last trading day immediately prior to the date of exercise. The term of the SARs grant is five years, with SARs vesting only upon the achievement of the following goals: as to one-third of the SARs granted, automatically upon the 90-calendar-day VWAP of the Company’s Common Shares on the NYSE American equaling or exceeding $12.00 for any continuous 90-calendar-day period; as to an additional one-third of the SARs granted, automatically upon the 90-calendar-day VWAP of the Company’s Common Shares on the NYSE American equaling or exceeding $14.00 for any continuous 90-calendar-day period; and as to the final one-third of the SARs granted, automatically upon the 90-calendar-day VWAP of the Company’s Common Shares on the NYSE American equaling or exceeding $16.00 for any continuous 90-calendar-day period. Further, notwithstanding the foregoing vesting schedule, no SARs were able to be exercised by the holder for an initial period of one year from the Date of Grant; the date first exercisable being January 24, 2024.

The fair value of the SARs granted during the three months ended March 31, 2023 was estimated at the date of grant using a Monte Carlo simulation, with the following weighted average assumptions:

Risk-free interest rate	3.58		%
Expected life(1)	5.0 years
Expected volatility(2)	55.00		%
Expected dividend yield	—		%
Weighted average grant date fair value	$	3.45

(1)Monte Carlo analysis of SARs assumes employee suboptimal exercise at first vesting time for each tranche.

(2)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the SARs.

A summary of the Company’s SARs activity is as follows:

	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Intrinsic Value
Outstanding, December 31, 2022	2,452,768	$	4.07
Granted	308,333	7.36
Exercised	—	—
Forfeited	(5,554)	6.47
Expired	—	—
Outstanding, March 31, 2023	2,755,547	$	4.43	2.12	$	4,413
Exercisable, March 31, 2023	1,092,143	$	2.92	0.81	$	2,905

A summary of the Company’s non-vested SARs activity is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022	1,360,625	$	2.81
Granted	308,333	3.45
Vested	—	—
Forfeited	(5,554)	5.20
Non-vested, March 31, 2023	1,663,404	$	2.92

Employee Stock Options

The Company, under the Compensation Plan, may grant stock options to directors, executives, employees and consultants to purchase Common Shares of the Company. The exercise price of the stock options is set as the higher of the Company’s closing share price on the NYSE American on the last trading day before the grant date and the five-day volume weighted average price (“VWAP”) on the NYSE American ending on the last trading day before the grant date. Stock options granted under the Compensation Plan generally vest over a period of two years or more and are generally exercisable over a period of five years from the grant date, such period not to exceed 10 years.

The fair value of the stock options granted under the Compensation Plan for the three months ended March 31, 2023 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:

Risk-free interest rate	3.89		%
Expected life	3.25 years
Expected volatility(1)	74.29		%
Expected dividend yield	—		%
Weighted average grant date fair value	$	3.98

(1)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.

A summary of the Company’s stock option activity is as follows:

	Range of Exercise Prices	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Intrinsic Value
Outstanding, December 31, 2022	$1.70 - $8.41	767,678	$	3.24
Granted	5.34 - 7.36	120,237	7.28
Exercised	1.70 - 2.92	(34,219)	1.88
Forfeited	3.89 - 7.36	(17,388)	6.51
Expired	—	—	—
Outstanding, March 31, 2023	$1.70 - $8.41	836,308	$	3.83	2.19	$	1,767
Exercisable, March 31, 2023	$1.70 - $7.14	667,523	$	2.99	1.56	$	1,766

A summary of the Company’s non-vested stock option activity is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022	140,586	$	4.12
Granted	120,237	3.98
Vested	(74,651)	3.76
Forfeited	(17,388)	3.87
Non-vested, March 31, 2023	168,784	$	3.97

As of March 31, 2023, there were $0.51 million, $3.32 million, and $1.03 million of unrecognized compensation costs related to the unvested stock options, RSUs and SARs, respectively. This expense is expected to be recognized over a weighted average period of 1.64 years, 2.27 years, and 0.94 years, respectively.

XML

INCOME TAXES

3 Months Ended

Mar. 31, 2023

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

As of March 31, 2023, the Company maintained a full valuation allowance against its net deferred tax assets. The Company continually reviews the adequacy of the valuation allowance and intends to continue maintaining a full valuation allowance on its net deferred tax assets until there is sufficient evidence to support the reversal of all or a portion of the allowance. Should the Company’s assessment change in a future period, it may release all or a portion of the valuation allowance, which would result in a deferred tax benefit in the period of adjustment. The Company will recognize the tax gain on the Alta Mesa Transaction under the installment method of accounting. This method will result in a deferral of a portion of the tax gain until the year in which the remaining proceeds are received.

For the three months ended March 31, 2023, the Company did not record income tax expense on income before taxes of $114.26 million. During the three months ended March 31, 2023, approximately $2.72 million of Net Operating Loss carryforwards will be utilized. For the three months ended March 31, 2022, the Company did not record an income tax benefit on a loss before taxes of $14.73 million. The effective tax rate was 0% for each of the three months ended March 31, 2023 and 2022, which was a result of the full valuation allowance on net deferred tax assets.

XML

SUPPLEMENTAL FINANCIAL INFORMATION

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Supplemental Financial Information

SUPPLEMENTAL FINANCIAL INFORMATION

The components of total other income (loss) are as follows:

	Three Months Ended March 31,
	2023		2022
Unrealized loss related to investments accounted for at fair value	$	(2,959)	$	(3,418)
Unrealized gain related to marketable securities	325		111
Unrealized loss on convertible note	(198)		—
Foreign exchange gain (loss)	26		(1,213)
Gain on sale of assets	116,450		—
Interest income, net and other	1,025		3
Total other income (loss)	$	114,669	$	(4,517)

The components of trade and other receivables are as follows:

	March 31, 2023		December 31, 2022
Trade receivables	$	874	$	92
Accrued interest receivable	592		—
Notes receivable, net	343		343
Other(1)	1,790		1,621
Total receivables	$	3,599	$	2,056
Receivables – by duration
Current	$	2,098	$	519
Long term	1,501		1,537
Total receivables	$	3,599	$	2,056

(1)As of March 31, 2023 and December 31, 2022, Other receivables includes $1.50 million and $1.58 million, respectively, due from Consolidated Uranium Inc. (“CUR”) pursuant to the terms of (i) the asset purchase agreement related to the sale of certain non-core conventional uranium projects and resulting deferred cash payments, and (ii) the ongoing operating agreement with CUR.

The components of accounts payable and accrued liabilities are as follows:

	March 31, 2023		December 31, 2022
Accounts payable	$	1,275	$	3,224
Payroll liabilities	1,503		2,929
Accrued capital expenditures	1,038		22
Accrued property taxes	410		240
Accrued operating expenses	761		409
Other accrued liabilities	288		105
Accounts payable and accrued liabilities	$	5,275	$	6,929

XML

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

General Legal Matters

Other than routine litigation incidental to our business, or as described below, the Company is not currently a party to any material pending legal proceedings that management believes would be likely to have a material adverse effect on our financial position, results of operations or cash flows.

White Mesa Mill

In 2011, the Ute Mountain Ute Tribe filed an administrative appeal of the Utah Division of Air Quality’s (“UDAQ”) decision to approve a Modification to the Air Quality Approval Order at the Mill. Then, in 2013, the Ute Mountain Ute Tribe filed a Petition to Intervene and Request for Agency Action challenging the Corrective Action Plan approved by the State of Utah Department of Environmental Quality (“UDEQ”) relating to nitrate contamination in the shallow aquifer at the Mill. In August 2014, the Ute Mountain Ute Tribe filed an administrative appeal to the Utah Division of Radiation Control’s (“DRC’s”) Radioactive Materials License Amendment 7 approval regarding alternate feed material from Dawn Mining. The challenges remain open at this time and may involve the appointment of an administrative law judge (“ALJ”) to hear the matters. The Company does not consider these actions to have any merit. If the petitions are successful, the likely outcome would be a requirement to modify or replace the existing Air Quality Approval Order, Corrective Action Plan or license amendment, as applicable. At this time, the Company does not believe any such modifications or replacements would materially affect its financial position, results of operations or cash flows. However, the scope and costs of remediation under a revised or replaced Air Quality Approval Order, Corrective Action Plan and/or license amendment have not yet been determined and could be significant.

The UDEQ renewed in January 2018, then reissued with minor corrections in February 2018, the Mill’s radioactive materials license (the “Mill License”) for another ten years and the Groundwater Discharge Permit (the “GWDP”) for another five years, after which further applications for renewal of the Mill License and GWDP are required to be submitted. During the review period for each application for renewal, the Mill can continue to operate under its existing Mill License and GWDP until such time as the renewed Mill License or GWDP is issued. Most recently, on July 15, 2022, the routine GWDP renewal application was submitted to UDEQ for consideration.

In 2018, the Grand Canyon Trust, Ute Mountain Ute Tribe and Uranium Watch (collectively, the “Mill Plaintiffs”) served Petitions for Review challenging UDEQ’s renewal of the Mill License and GWDP and Requests for Appointment of an ALJ, which they later agreed to suspend pursuant to a Stipulation and Agreement with UDEQ, effective June 4, 2018. The Company and the Mill Plaintiffs held multiple discussions over the course of 2018 and 2019 in an effort to settle the dispute outside of any judicial proceeding. In February 2019, the Mill Plaintiffs submitted to the Company their proposal for reaching a settlement agreement. The proposal remains under consideration by the Company. The Company does not consider these challenges to have any merit and, if a settlement cannot be reached, the Company intends to participate with UDEQ in defending against the challenges. If the challenges are successful, the likely outcome would be a requirement to modify the renewed Mill License and/or GWDP. At this time, the Company does not believe that any such modification would materially affect its financial position, results of operations or cash flows.

On August 26, 2021, the Ute Mountain Ute Tribe filed a Petition to Intervene and Petition for Review challenging the UDEQ’s approval of Amendment No. 10 to the Mill License, which expanded the list of Alternate Feed Materials that the Mill is authorized to accept and process for its source material content. Then, on November 18, 2021, the Tribe filed its Request for Appointment of an ALJ, followed shortly thereafter by a stay on the request in accordance with a Stipulation and Agreement between the Tribe, UDEQ and Company. Discussions between the Company and the Tribe are ongoing in an effort to resolve the dispute and other outstanding matters without formal adjudication. However, the Company does not consider this action to have any merit. If the stay is lifted, an ALJ is appointed and the petition is successful, the likely outcome would be a requirement to modify or revoke the Mill License amendment. At this time, the Company does not believe any such modification or revocation would materially affect its financial position, results of operations or cash flows.

Mineral Property Commitments

The Company enters into commitments with federal and state agencies and private individuals to lease mineral rights. These leases are renewable annually, and, as reported in the Company’s Form 10-K for the year ended December 31, 2022, renewal costs for the remainder of 2023 are expected to total $1.60 million.

Surety Bonds

The Company has indemnified third-party companies to provide surety bonds as collateral for the Company’s asset retirement obligations. The Company is obligated to replace this collateral in the event of a default and is obligated to repay any reclamation or closure costs due. As of March 31, 2023, the Company has $17.51 million posted as collateral against an undiscounted asset retirement obligation of $33.00 million. As of December 31, 2022, the Company has $21.04 million posted as collateral against an undiscounted asset retirement obligation of $42.91 million.

Commitments

The Company is contractually obligated under a Sales and Agency Agreement appointing an exclusive sales and marketing agent for all vanadium pentoxide produced by the Company.

XML

FAIR VALUE ACCOUNTING

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value Accounting

FAIR VALUE ACCOUNTING

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Fair value accounting utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:

Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2 – Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

The Company’s financial instruments include cash and cash equivalents, restricted cash, accounts receivable, accounts payable and current accrued liabilities. These instruments are carried at cost, which approximates fair value due to the short-term maturities of the instruments. Allowances for doubtful accounts are recorded against the accounts receivable balance to estimate net realizable value.

As of March 31, 2023 and December 31, 2022, the fair values of cash, restricted cash, short-term deposits, receivables, accounts payable and accrued liabilities approximate their carrying values because of the short-term nature of these instruments.

The Company’s investments in marketable equity securities are publicly traded stocks measured at fair value and classified within Level 1 and Level 2 in the fair value hierarchy. Level 1 marketable equity securities use quoted prices for identical assets in active markets, while Level 2 marketable equity securities utilize inputs based upon quoted prices for similar instruments in active markets. The Company’s investments in marketable debt securities are valued using quoted prices of a pricing service and as such, are classified within Level 2 of the fair value hierarchy. The Company’s investments accounted for at fair value consisting of Common Shares are valued using quoted market prices in active markets and as such are classified within Level 1 of the fair value hierarchy. The Company’s investments accounted for at fair value consisting of warrants are valued using the Black-Scholes option model based on observable inputs and as such are classified within Level 2 of the hierarchy.

The Company’s convertible note was received as part of the consideration received for the Alta Mesa Transaction was valued as of February 14, 2023 upon closing of that transaction using a binomial lattice model. The fair value calculation uses significant unobservable inputs including: (i) volatility 60% and (ii) yield of 9.5%. The Company used the same binomial lattice model to value the Convertible Note as of March 31, 2023. As of March 31, 2023, the fair value calculation uses significant unobservable inputs including: (i) volatility of 60% and (ii) yield of 10.6%. Increases or decreases in the volatility and/or the selected risky yield can result in an increase or decrease in the fair value of the Convertible Note.

The following tables set forth the fair value of the Company’s assets and liabilities measured at fair value on a recurring basis (at least annually) by level within the fair value hierarchy as of March 31, 2023 and December 31, 2022. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

March 31, 2023	Level 1		Level 2		Level 3		Total
Cash equivalents(1)	$	—	$	26,200	$	—	$	26,200
Investments accounted for at fair value	16,340		34		—		16,374
Marketable debt securities	—		59,431		—		59,431
Convertible note	—		—		59,259		59,259
Marketable equity securities	976		31		—		1,007
	$	17,316	$	85,696	$	59,259	$	162,271

(1)     Cash equivalents are comprised of United States Treasury Bills and Government Agency Bonds, purchased within three months of their maturity date.

December 31, 2022	Level 1		Level 2		Level 3		Total
Cash equivalents(1)	$	—	$	30,336	$	—	$	30,336
Investments accounted for at fair value	19,263		66		—		19,329
Marketable debt securities	—		11,125		—		11,125
Marketable equity securities	1,033		34		—		1,067
	$	20,296	$	41,561	$	—	$	61,857

(1)     Cash equivalents are comprised of United States Treasury Bills and Government Agency Bonds, purchased within three months of their maturity date.

Changes in Level 3 Fair Value Measurements

The following table is a reconciliation of the beginning and ending balance recorded for the Convertible Note classified as Level 3 in the fair value hierarchy.

Beginning balance, February 14, 2023	$	59,457
Unrealized loss included in other income (loss)	(198)
Ending balance, March 31, 2023	$	59,259

As of March 31, 2023, the difference between the fair value of the Convertible Note and the unpaid principal amount is $0.74 million.

Investments Accounted for at Fair Value

The fair value of the investments is calculated as the quoted market price of the marketable equity security multiplied by the quantity of shares held by the Company. As of December 31, 2022, the Company held a 17.4% ownership interest in its investment in CUR and a 13.5% ownership interest in its investment in Virginia Energy Resources Inc. (“Virginia Energy”). These investments provide the Company with the ability to have significant influence, but not control, over their operations. The Company has elected the fair value option for each of these investments. As of December 31, 2022, the fair value of the Company’s investments in CUR and Virginia Energy were $16.50 million and $2.83 million, respectively.

On January 24, 2023, CUR acquired 100% of the issued and outstanding common shares of Virginia Energy for 0.26 common shares of CUR. As a result, the Company’s 9,439,857 common shares of Virginia Energy were converted into 2,454,362 million common shares of CUR (the “Conversion”). Following the Conversion, the Company owned 16,189,548 common shares of CUR, which represented an ownership interest of 16.7% in CUR as of closing. As of March 31, 2023, the fair value of the Company’s investment in CUR was $16.37 million, which represented an ownership interest of 16.3%.

During the three months ended March 31, 2023 and 2022, the Company recognized a loss of $2.96 million and $3.42 million, respectively related to these investments in Other income (loss) in the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss).

XML

REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer	REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERSAll revenue recognized is a result of contracts with customers either through uranium and vanadium sales contracts or Alternate Feed processing and other waste disposal agreements. The Company had satisfied all of its performance obligations as of March 31, 2023.

XML

RELATED PARTY TRANSACTIONS

3 Months Ended

Mar. 31, 2023

Related Party Transactions [Abstract]

Related Party Transactions

RELATED PARTY TRANSACTIONS

Robert W. Kirkwood, a member of the Company’s Board of Directors, is a principal of the Kirkwood Companies, including Kirkwood Oil and Gas LLC, Wesco Operating, Inc., and United Nuclear LLC (“United Nuclear”). United Nuclear owns a 19% interest in the Company’s Arkose Mining Venture while the Company owns the remaining 81%. The Company acts as manager of the Arkose Mining Venture and has management and control over operations carried out by the Arkose Mining Venture. The Arkose Mining Venture is a contractual joint venture governed by a venture agreement dated as of January 15, 2008 and entered into by United Nuclear and Uranerz Energy Corporation, a wholly owned, indirectly held subsidiary of the Company.

On October 27, 2021, the Company began providing services to CUR under a mine operating agreement. The Company earned $0.27 million and $0.27 million during the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023 and 2022, $0.27 million and $0.27 million was due from CUR, respectively. Additionally, the Company has accrued $1.50 million and $1.58 million as of March 31, 2023 and December 31, 2022, respectively, in Other long-term receivables

related to deferred cash payments for production thresholds pursuant to the terms of the asset purchase agreement with CUR. See Note 11 – Supplemental Financial Information for more information.

XML

MARKETABLE SECURITIES (Tables)

3 Months Ended

Mar. 31, 2023

Cash and Cash Equivalents [Abstract]

Marketable Securities

The following table summarizes our marketable securities by significant investment categories as of March 31, 2023:

	Cost Basis		Gross Unrealized Losses		Gross Unrealized Gains		Fair Value
Marketable debt securities(1)	$	59,359	$	—	$	72	$	59,431
Convertible note(2)	59,457		(198)		—		59,259
Marketable equity securities	2,876		(1,869)		—		1,007
Total marketable securities	$	121,692	$	(2,067)	$	72	$	119,697

(1)     Marketable debt securities are comprised primarily of U.S. government agency bonds.

(2)     The Convertible note was received as consideration in the Alta Mesa Transaction (defined in Note 5 – Property, Plant and Equipment and Mineral Properties) and is valued using a binomial lattice model using Level 3 inputs. See Note 5 – Property, Plant and Equipment and Mineral Properties and Note 13 – Fair Value Accounting for more information.

The following table summarizes our marketable securities by significant investment categories as of December 31, 2022:

	Cost Basis		Gross Unrealized Losses		Gross Unrealized Gains		Fair Value
Marketable debt securities(1)	$	11,435	$	(310)	$	—	$	11,125
Marketable equity securities	2,876		(1,809)		—		1,067
Total marketable securities	$	14,311	$	(2,119)	$	—	$	12,192

(1)     Marketable debt securities are comprised primarily of U.S. government agency bonds.

XML

INVENTORIES (Tables)

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Schedule of Inventory, Current

	March 31, 2023		December 31, 2022
Concentrates and work-in-progress	$	35,869	$	35,476
Inventory of ore in stockpiles	256		940
Consumables	3,956		4,204
Total inventories	$	40,081	$	40,620
Inventories – by duration
Current	$	38,003	$	38,155
Long term	2,078		2,465
Total inventories	$	40,081	$	40,620

XML

PLANT AND EQUIPMENT AND MINERAL PROPERTIES (Tables)

3 Months Ended

Mar. 31, 2023

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment

The following is a summary of property, plant and equipment, net:

	March 31, 2023						December 31, 2022
	Cost		Accumulated Depreciation		Net Book Value		Cost		Accumulated Depreciation		Net Book Value
Property, plant and equipment
Nichols Ranch	$	29,210	$	(20,730)	$	8,480	$	29,210	$	(20,221)	$	8,989
Pinyon Plain	2,058		(746)		1,312		1,617		(714)		903
Equipment and other	17,196		(12,353)		4,843		15,009		(12,239)		2,770
Property, plant and equipment total	$	48,464	$	(33,829)	$	14,635	$	45,836	$	(33,174)	$	12,662

As of December 31, 2022, the net book value of the property, plant and equipment attributable to Alta Mesa was $8.21 million, which was included in Property, plant and equipment and other assets held for sale, net on the Condensed Consolidated Balance Sheets.

Schedule of Summary of Mineral Properties

The following is a summary of mineral properties:

	March 31, 2023		December 31, 2022
Mineral properties
Sheep Mountain	$	34,183	$	34,183
Bahia Project	29,124		—
Uranerz ISR properties	25,974		25,974
Roca Honda	22,095		22,095
Pinyon Plain	1,171		—
Other	1,287		1,287
Mineral properties total	$	113,834	$	83,539

XML

ASSET RETIREMENT OBLIGATIONS AND RESTRICTED CASH (Tables)

3 Months Ended

Mar. 31, 2023

Asset Retirement Obligation Disclosure [Abstract]

Schedule of Change in Asset Retirement Obligation

The following table summarizes the Company’s asset retirement obligations:

	March 31, 2023		December 31, 2022
Asset retirement obligations, beginning of period	$	9,595	$	13,687
Revision of estimate	—		(238)
Accretion of liabilities	346		1,556
Held for sale(1)	(79)		(5,410)
Asset retirement obligations, end of period	$	9,862	$	9,595

(1)Asset retirement obligations held for sale as of December 31, 2022 are related to Alta Mesa and are included as asset retirement obligation and other liabilities held for sale on the Condensed Consolidated Balance Sheets. Asset retirement obligations held for sale as of March 31, 2023 are related to the accretion expense on Alta Mesa through the closing date and is included within Gain on sale of assets on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

Schedule of Restricted Cash and Cash Equivalents

The following table summarizes the Company’s restricted cash:

	March 31, 2023		December 31, 2022
Restricted cash, beginning of period	$	17,449	$	20,305
Additional collateral posted	59		734
Held for sale(1)	—		(3,590)
Restricted cash, end of period	$	17,508	$	17,449

(1)Restricted cash held for sale is related to Alta Mesa and is included as Asset retirement obligation and other liabilities held for sale on the Condensed Consolidated Balance Sheets. As of March 31, 2023, $3.48 million has been released and reclassified from Asset retirement obligation and other liabilities held for sale to cash and cash equivalents on the Condensed Consolidated Balance Sheets. The remaining $0.11 million was reclassified Restricted cash on the Condensed Consolidated Balance Sheets. See Note 5 – Property, Plant and Equipment and Mineral Properties for more information.

XML

BASIC AND DILUTED INCOME (LOSS) PER COMMON SHARE (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The calculation of basic and diluted loss per share after adjustment for the effects of all potential dilutive Common Shares, is as follows:

	Three Months Ended March 31,
	2023		2022
Net income (loss) attributable to owners of the Company	$	114,265	$	(14,729)
Basic weighted average common shares outstanding	157,930,097		156,614,344
Dilutive impact of stock options and restricted stock units	1,298,970		—
Diluted weighted average common shares outstanding	159,229,067		156,614,344
Basic net income (loss) per common share	$	0.72	$	(0.09)
Diluted net income (loss) per common share	$	0.72	$	(0.09)

XML

SHARE-BASED PAYMENTS (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

The Company’s share-based compensation expense, by type of award, is as follows:

	Three Months Ended March 31,
	2023		2022
RSUs(1)	$	644	$	484
SARs	436		346
Stock options	106		32
Total share-based compensation expense(2)	$	1,186	$	862

(1)The fair value of the RSUs granted under the Compensation Plan for the three months ended March 31, 2023 and 2022 was estimated at the date of grant, using the stated market price on the NYSE American.

(2)Share-based compensation is included in Selling, general and administration in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

A summary of the Company’s non-vested RSUs activity is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022	747,425	$	4.77
Granted	450,232	7.36
Vested	(448,883)	4.24
Forfeited	—	—
Non-vested, March 31, 2023	748,774	$	6.64

A summary of the Company’s SARs activity is as follows:

	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Intrinsic Value
Outstanding, December 31, 2022	2,452,768	$	4.07
Granted	308,333	7.36
Exercised	—	—
Forfeited	(5,554)	6.47
Expired	—	—
Outstanding, March 31, 2023	2,755,547	$	4.43	2.12	$	4,413
Exercisable, March 31, 2023	1,092,143	$	2.92	0.81	$	2,905

A summary of the Company’s non-vested SARs activity is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022	1,360,625	$	2.81
Granted	308,333	3.45
Vested	—	—
Forfeited	(5,554)	5.20
Non-vested, March 31, 2023	1,663,404	$	2.92

Share-based Payment Arrangement, Restricted Stock Unit, Activity

The fair value of the SARs granted during the three months ended March 31, 2023 was estimated at the date of grant using a Monte Carlo simulation, with the following weighted average assumptions:

Risk-free interest rate	3.58		%
Expected life(1)	5.0 years
Expected volatility(2)	55.00		%
Expected dividend yield	—		%
Weighted average grant date fair value	$	3.45

(1)Monte Carlo analysis of SARs assumes employee suboptimal exercise at first vesting time for each tranche.

(2)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the SARs.

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of the stock options granted under the Compensation Plan for the three months ended March 31, 2023 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:

Risk-free interest rate	3.89		%
Expected life	3.25 years
Expected volatility(1)	74.29		%
Expected dividend yield	—		%
Weighted average grant date fair value	$	3.98

(1)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.

Schedule of Share-based Compensation, Stock Options, Activity

A summary of the Company’s stock option activity is as follows:

	Range of Exercise Prices	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Intrinsic Value
Outstanding, December 31, 2022	$1.70 - $8.41	767,678	$	3.24
Granted	5.34 - 7.36	120,237	7.28
Exercised	1.70 - 2.92	(34,219)	1.88
Forfeited	3.89 - 7.36	(17,388)	6.51
Expired	—	—	—
Outstanding, March 31, 2023	$1.70 - $8.41	836,308	$	3.83	2.19	$	1,767
Exercisable, March 31, 2023	$1.70 - $7.14	667,523	$	2.99	1.56	$	1,766

A summary of the Company’s non-vested stock option activity is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022	140,586	$	4.12
Granted	120,237	3.98
Vested	(74,651)	3.76
Forfeited	(17,388)	3.87
Non-vested, March 31, 2023	168,784	$	3.97

XML

SUPPLEMENTAL FINANCIAL INFORMATION (Tables)

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Other Nonoperating Income (Expense)

The components of total other income (loss) are as follows:

	Three Months Ended March 31,
	2023		2022
Unrealized loss related to investments accounted for at fair value	$	(2,959)	$	(3,418)
Unrealized gain related to marketable securities	325		111
Unrealized loss on convertible note	(198)		—
Foreign exchange gain (loss)	26		(1,213)
Gain on sale of assets	116,450		—
Interest income, net and other	1,025		3
Total other income (loss)	$	114,669	$	(4,517)

Schedule of Accounts, Notes, Loans and Financing Receivable

The components of trade and other receivables are as follows:

	March 31, 2023		December 31, 2022
Trade receivables	$	874	$	92
Accrued interest receivable	592		—
Notes receivable, net	343		343
Other(1)	1,790		1,621
Total receivables	$	3,599	$	2,056
Receivables – by duration
Current	$	2,098	$	519
Long term	1,501		1,537
Total receivables	$	3,599	$	2,056

(1)As of March 31, 2023 and December 31, 2022, Other receivables includes $1.50 million and $1.58 million, respectively, due from Consolidated Uranium Inc. (“CUR”) pursuant to the terms of (i) the asset purchase agreement related to the sale of certain non-core conventional uranium projects and resulting deferred cash payments, and (ii) the ongoing operating agreement with CUR.

Schedule of Accounts Payable and Accrued Liabilities

The components of accounts payable and accrued liabilities are as follows:

	March 31, 2023		December 31, 2022
Accounts payable	$	1,275	$	3,224
Payroll liabilities	1,503		2,929
Accrued capital expenditures	1,038		22
Accrued property taxes	410		240
Accrued operating expenses	761		409
Other accrued liabilities	288		105
Accounts payable and accrued liabilities	$	5,275	$	6,929

XML

FAIR VALUE ACCOUNTING (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements, Recurring and Nonrecurring

March 31, 2023	Level 1		Level 2		Level 3		Total
Cash equivalents(1)	$	—	$	26,200	$	—	$	26,200
Investments accounted for at fair value	16,340		34		—		16,374
Marketable debt securities	—		59,431		—		59,431
Convertible note	—		—		59,259		59,259
Marketable equity securities	976		31		—		1,007
	$	17,316	$	85,696	$	59,259	$	162,271

(1)     Cash equivalents are comprised of United States Treasury Bills and Government Agency Bonds, purchased within three months of their maturity date.

December 31, 2022	Level 1		Level 2		Level 3		Total
Cash equivalents(1)	$	—	$	30,336	$	—	$	30,336
Investments accounted for at fair value	19,263		66		—		19,329
Marketable debt securities	—		11,125		—		11,125
Marketable equity securities	1,033		34		—		1,067
	$	20,296	$	41,561	$	—	$	61,857

(1)     Cash equivalents are comprised of United States Treasury Bills and Government Agency Bonds, purchased within three months of their maturity date.

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

The following table is a reconciliation of the beginning and ending balance recorded for the Convertible Note classified as Level 3 in the fair value hierarchy.

Beginning balance, February 14, 2023	$	59,457
Unrealized loss included in other income (loss)	(198)
Ending balance, March 31, 2023	$	59,259

As of March 31, 2023, the difference between the fair value of the Convertible Note and the unpaid principal amount is $0.74 million.

XML

MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Marketable Debt Securities and Convertible Note
Cost Basis		$ 11,435
Gross Unrealized Losses		(310)
Gross Unrealized Gains		0
Fair Value		11,125
Marketable equity securities
Cost Basis	$ 2,876	2,876
Gross Unrealized Losses	(1,869)	(1,809)
Gross Unrealized Gains	0	0
Fair Value	1,007	1,067
Cost Basis	121,692	14,311
Gross Unrealized Losses	2,067	2,119
Gross Unrealized Gains	72	0
Fair Value	119,697	$ 12,192
Marketable Debt Securities
Marketable Debt Securities and Convertible Note
Cost Basis	59,359
Gross Unrealized Losses	0
Gross Unrealized Gains	72
Fair Value	59,431
Convertible Note
Marketable Debt Securities and Convertible Note
Cost Basis	59,457
Gross Unrealized Losses	(198)
Gross Unrealized Gains	0
Fair Value	$ 59,259

XML

INVENTORIES - Schedule of Inventory, Current (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Inventory [Line Items]
Concentrates and work-in-progress	$ 35,869	$ 35,476
Inventory of ore in stockpiles	256	940
Consumables	3,956	4,204
Total inventories	40,081	40,620
Current	38,003	38,155
Long term	$ 2,078	$ 2,465

XML

PLANT AND EQUIPMENT AND MINERAL PROPERTIES - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Cost	$ 48,464	$ 45,836
Accumulated Depreciation	(33,829)	(33,174)
Net Book Value	14,635	12,662
Nichols Ranch
Property, Plant and Equipment [Line Items]
Cost	29,210	29,210
Accumulated Depreciation	(20,730)	(20,221)
Net Book Value	8,480	8,989
Alta Mesa(1)
Property, Plant and Equipment [Line Items]
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment		8,210
Pinyon Plain
Property, Plant and Equipment [Line Items]
Cost	2,058	1,617
Accumulated Depreciation	(746)	(714)
Net Book Value	1,312	903
Equipment and other
Property, Plant and Equipment [Line Items]
Cost	17,196	15,009
Accumulated Depreciation	(12,353)	(12,239)
Net Book Value	$ 4,843	$ 2,770

XML

PLANT AND EQUIPMENT AND MINERAL PROPERTIES - Schedule of Summary of Mineral Properties (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Mineral properties	$ 113,834	$ 83,539
Sheep Mountain
Property, Plant and Equipment [Line Items]
Mineral properties	34,183	34,183
Bahia Project
Property, Plant and Equipment [Line Items]
Mineral properties	29,124	0
Uranerz ISR properties
Property, Plant and Equipment [Line Items]
Mineral properties	25,974	25,974
Roca Honda
Property, Plant and Equipment [Line Items]
Mineral properties	22,095	22,095
Pinyon Plain
Property, Plant and Equipment [Line Items]
Mineral properties	1,171	0
Other
Property, Plant and Equipment [Line Items]
Mineral properties	$ 1,287	$ 1,287

XML

PLANT AND EQUIPMENT AND MINERAL PROPERTIES (Narrative) (Details) $ / shares in Units, $ in Thousands				3 Months Ended		12 Months Ended
	May 03, 2023 USD ($)	Feb. 14, 2023 USD ($) subsidiary $ / shares	Feb. 10, 2023 USD ($) mi a purchaseAgreement	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)
Property, Plant and Equipment [Line Items]
Depreciation expense				$ 655	$ 813
Number of purchase agreements | purchaseAgreement			2
Purchase Agreement, acres to purchase | a			37,300
Purchase Agreement, miles to purchase | mi			58.3
Purchase Agreement, purchase price			$ 27,500
Purchase Agreement, payment due at closing			21,600
Purchase Agreement, deposit payment			5,900
Purchase Agreement, direct deal costs			$ 1,630
Gain on sale of assets				116,450	0
Restricted Cash And Cash Equivalents Held For Sale				0		$ 3,590
Plus: release of restricted cash related to sale of assets				3,475	0
Additions to property, plant and equipment				2,042	398
Alta Mesa Divestiture
Property, Plant and Equipment [Line Items]
Number Of Subsidiaries Sold | subsidiary		3
Disposal Group, Including Discontinued Operation, Consideration		$ 120,000
Proceeds from Divestiture of Interest in Consolidated Subsidiaries		60,000
Disposal Group, Cash Due Prior To Closing		6,000
Disposal Group, Cash Due At Closing		54,000
Noncash or Part Noncash Divestiture, Amount of Consideration Received		$ 60,000
Convertible Note Receivable, Term		2 years
Convertible Notes Receivable, Interest Rate		8.00%
Convertible Notes Receivable, Conversion Price Per Share | $ / shares		$ 2.9103
Convertible Notes Receivable, Premium		20.00%
Convertible Notes Receivable, Conversion Limitation Per Transaction		$ 10,000
Convertible Notes Receivable, Conversion Period		30 days
Gain on sale of assets				116,450
Disposal Group, Cash To Be Received				119,460
Notes Receivable, Amortized cost				59,460
Disposal Group, Including Discontinued Operation, Assets		$ 3,340
Restricted Cash And Cash Equivalents Held For Sale				3,590
Plus: release of restricted cash related to sale of assets				3,480
Alta Mesa Divestiture | Subsequent Event
Property, Plant and Equipment [Line Items]
Proceeds from Sale of Productive Assets	$ 3,100
Additions to property, plant and equipment	500
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment	$ 350
Disposal Group, Including Discontinued Operation, Property, Plant And Equipment, Usage Period	20 years
Nichols Ranch
Property, Plant and Equipment [Line Items]
Depreciation				$ 70	$ 50

XML

ASSET RETIREMENT OBLIGATIONS AND RESTRICTED CASH - Schedule of Change in Asset Retirement Obligation (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]
Asset retirement obligations, beginning of period	$ 9,595	$ 13,687	$ 13,687
Revision of estimate	0	(96)	238
Accretion of liabilities	346	$ 394	1,556
Held for sale(1)	(79)		(5,410)
Asset retirement obligations, end of period	$ 9,862		$ 9,595

XML

ASSET RETIREMENT OBLIGATIONS AND RESTRICTED CASH - Schedule of Restricted Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Restricted Cash And Cash Equivalents [Roll Forward]
Restricted cash, beginning of period	$ 17,449	$ 20,305	$ 20,305
Additional collateral posted	59		734
Restricted Cash And Cash Equivalents Held For Sale	0		(3,590)
Restricted cash, end of period	17,508		$ 17,449
Increase (Decrease) In Restricted Cash	(3,475)	$ 0
Restricted Cash	$ 110

XML

CAPITAL STOCK - Narrative (Details) - At The Market Sale Of Stock - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Class of Warrant or Right [Line Items]
Sale of stock, number of shares issued (in shares)	0	410
Sale of stock, consideration received		$ 4,160

XML

BASIC AND DILUTED INCOME (LOSS) PER COMMON SHARE - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Net income (loss) attributable to owners of the Company	$ 114,265	$ (14,729)
Basic weighted average common shares outstanding	157,930,097	156,614,344
Dilutive impact of stock options and restricted stock units	1,298,970	0
Diluted weighted average common shares outstanding	159,229,067	156,614,344
Basic net income (loss) per common share	$ 0.72	$ (0.09)
Diluted net income (loss) per common share	$ 0.72	$ (0.09)

XML

BASIC AND DILUTED INCOME (LOSS) PER COMMON SHARE - Narrative (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	260	1,530
Stock Appreciation Rights (SARs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,660	2,400

XML

SHARE-BASED PAYMENTS - Narrative (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award exercise period	5 years
Grants in period, weighted average exercise price (in dollars per share)	$ 7.28
Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares) | shares	15,802,941
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	2 years
Unrecognized compensation costs related to unvested stock options | $	$ 510
Share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition	1 year 7 months 20 days
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Unrecognized compensation costs related to RSU awards | $	$ 3,320
Share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition	2 years 3 months 7 days
Intrinsic value	$ 3,380,000
Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	5 years
Unrecognized compensation costs related to RSU awards | $	$ 1,030
Share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition	11 months 8 days
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period, weighted average exercise price (in dollars per share)	$ 7.36
Share-based Compensation Award, Tranche One | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period, weighted average exercise price (in dollars per share)	$ 12.00
Period of exercise price	90 days
Share-based Compensation Award, Tranche Two | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period, weighted average exercise price (in dollars per share)	$ 14.00
Period of exercise price	90 days
Share-based Compensation Award, Tranche Three | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period, weighted average exercise price (in dollars per share)	$ 16.00
Period of exercise price	90 days
Common Stock | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in period, weighted average exercise price (in dollars per share)	$ 7.36

XML

SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 1,186	$ 862
Equity Option
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)	$ 4.12
Nonvested, weighted average grant date fair value, end of period (in dollars per share)	$ 3.97
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 106	32
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Unrecognized Compensation Costs Related To Unvested Stock Options	510
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 644	484
Restricted Stock Units (RSUs) | Equity Option
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Number of nonvested shares, beginning of period (in shares)	747,425
Granted, nonvested, number of shares (in shares)	450,232
Vested, number of shares (in shares)	(448,883)
Forfeited, number of shares (in shares)	0
Number of nonvested shares, end of period (in shares)	748,774
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)	$ 4.77
Granted, nonvested, weighted average grant date fair value (in dollars per share)	7.36
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	0
Vested, weighted average grant date fair value (in dollars per share)	4.24
Nonvested, weighted average grant date fair value, end of period (in dollars per share)	$ 6.64
Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 436	$ 346
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Number of nonvested shares, beginning of period (in shares)	2,452,768
Granted, nonvested, number of shares (in shares)	308,333
Exercised, number of shares (in shares)	0
Forfeited, number of shares (in shares)	(5,554)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations	0
Number of nonvested shares, end of period (in shares)	2,755,547
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)	$ 4.07
Granted, nonvested, weighted average grant date fair value (in dollars per share)	7.36
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised, Weighted Average Exercise Price	0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	6.47
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired, Weighted Average Grant Date Fair	0
Nonvested, weighted average grant date fair value, end of period (in dollars per share)	$ 4.43
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number	1,092,143
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price	$ 2.92
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	2 years 1 month 13 days
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term	9 months 21 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding	$ 4,413
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value	$ 2,905
Stock Appreciation Rights (SARs) | Equity Option
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Number of nonvested shares, beginning of period (in shares)	1,360,625
Granted, nonvested, number of shares (in shares)	308,333
Vested, number of shares (in shares)	0
Forfeited, number of shares (in shares)	(5,554)
Number of nonvested shares, end of period (in shares)	1,663,404
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)	$ 2.81
Granted, nonvested, weighted average grant date fair value (in dollars per share)	3.45
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	5.20
Vested, weighted average grant date fair value (in dollars per share)	0
Nonvested, weighted average grant date fair value, end of period (in dollars per share)	$ 2.92

XML

SHARE-BASED PAYMENTS - Schedule of Share-based Payment, SARs, Valuation Assumptions (Details) - Stock Appreciation Rights (SARs)	3 Months Ended
	Mar. 31, 2023 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	3.58%
Expected life	5 years
Expected volatility(1)	55.00%
Expected dividend yield	0.00%
Weighted average grant date fair value	$ 3.45

XML

SHARE-BASED PAYMENTS - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - Employee Stock Option	3 Months Ended
	Mar. 31, 2023 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	3.89%
Expected life	3 years 3 months
Expected volatility(1)	74.29%
Expected dividend yield	0.00%
Weighted average grant date fair value	$ 3.98

XML

SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Stock Options, Activity (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price, beginning of period (in dollars per share)	$ 3.24
Grants in period, weighted average exercise price (in dollars per share)	7.28
Exercises in period, weighted average exercise price (in dollars per share)	1.88
Forfeitures in period, weighted average exercise price (in dollars per share)	6.51
Expirations in period, weighted average exercise price (in dollars per share)	0
Weighted average exercise price, end of period (in dollars per share)	3.83
Exercisable options, weighted average exercise price (in dollars per share)	$ 2.99
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options, beginning of period (in shares) | shares	767,678
Number of grants in period, net of forfeitures (in shares) | shares	120,237
Number of forfeitures in period (in shares) | shares	(17,388)
Number of expirations in period (in shares) | shares	0
Number of options, end of period (in shares) | shares	836,308
Number of exercisable options (in shares) | shares	667,523
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	2 years 2 months 8 days
Exercisable options, weighted average remaining contractual term	1 year 6 months 21 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $	$ 1,767
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $	$ 1,766
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares	34,219
Director
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Expirations in period, weighted average exercise price (in dollars per share)	$ 0
Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price, beginning of period (in dollars per share)	1.70
Grants in period, weighted average exercise price (in dollars per share)	5.34
Exercises in period, weighted average exercise price (in dollars per share)	1.70
Forfeitures in period, weighted average exercise price (in dollars per share)	3.89
Weighted average exercise price, end of period (in dollars per share)	1.70
Exercisable options, weighted average exercise price (in dollars per share)	1.70
Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price, beginning of period (in dollars per share)	8.41
Grants in period, weighted average exercise price (in dollars per share)	7.36
Exercises in period, weighted average exercise price (in dollars per share)	2.92
Forfeitures in period, weighted average exercise price (in dollars per share)	7.36
Weighted average exercise price, end of period (in dollars per share)	8.41
Exercisable options, weighted average exercise price (in dollars per share)	$ 7.14
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Exercisable options, weighted average remaining contractual term	10 years
Equity Option
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Number of nonvested shares, beginning of period (in shares) | shares	140,586
Granted, nonvested, number of shares (in shares) | shares	120,237
Vested, number of shares (in shares) | shares	(74,651)
Nonvested options forfeited, number of shares (in shares) | shares	(17,388)
Number of nonvested shares, end of period (in shares) | shares	168,784
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share)	$ 4.12
Granted, nonvested, weighted average grant date fair value (in dollars per share)	3.98
Vested, weighted average grant date fair value (in dollars per share)	3.76
Nonvested options forfeited, weighted average grant date fair value (in dollars per share)	3.87
Nonvested, weighted average grant date fair value, end of period (in dollars per share)	$ 3.97

XML

INCOME TAXES (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income tax provision	$ 0	$ 0
Net income (loss)	$ 114,264,000	$ (14,730,000)
Effective income tax rate	0.00%	0.00%
Net Operating Loss carryforwards	$ 2,720,000

XML

SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Other Nonoperating Income (Expense) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Unrealized loss related to investments accounted for at fair value	$ (2,959)	$ (3,418)
Unrealized gain related to marketable securities	325	111
Unrealized loss on convertible note	(198)	0
Foreign exchange gain (loss)	26	(1,213)
Gain on sale of assets	116,450	0
Interest income, net and other	1,025	3
Total other income (loss)	$ 114,669	$ (4,517)

XML

SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Receivables (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Trade receivables	$ 874	$ 92
Accrued interest receivable	592	0
Notes receivable, net	343	343
Other(1)	1,790	1,621
Total receivables	3,599	2,056
Current	2,098	519
Long term	$ 1,501	$ 1,537

XML

SUPPLEMENTAL FINANCIAL INFORMATION - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounts payable	$ 1,275	$ 3,224
Payroll liabilities	1,503	2,929
Accrued capital expenditures	1,038	22
Accrued property taxes	410	240
Accrued operating expenses	761	409
Other accrued liabilities	288	105
Accounts payable and accrued liabilities	$ 5,275	$ 6,929

XML

SUPPLEMENTAL FINANCIAL INFORMATION - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Accounts And Other Receivables, Net	$ 1,790	$ 1,621
Consolidated Uranium Inc.
Related Party Transaction [Line Items]
Accounts And Other Receivables, Net	$ 1,500	$ 1,580

XML

COMMITMENTS AND CONTINGENCIES - (Narrative) (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Commitments [Line Items]
Asset retirement obligation	$ 9,862	$ 9,595	$ 13,687
Mining Properties and Mineral Rights
Other Commitments [Line Items]
Renewal costs	1,600
Canyon Project
Other Commitments [Line Items]
Loss contingency, estimate of possible loss	17,510	21,040
Asset retirement obligation	$ 33,000	$ 42,910

XML

FAIR VALUE ACCOUNTING - Fair Value Measurements, Recurring and Nonrecurring (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial instruments fair value	$ 162,271	$ 61,857
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents(1)	26,200	30,336
Investments accounted for at fair value	16,374	19,329
Fair Value, Recurring | Marketable Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	59,431	11,125
Fair Value, Recurring | Convertible Note
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	59,259
Fair Value, Recurring | Marketable Equity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	1,007	1,067
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial instruments fair value	17,316	20,296
Level 1 | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents(1)	0	0
Investments accounted for at fair value	16,340	19,263
Level 1 | Fair Value, Recurring | Marketable Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	0	0
Level 1 | Fair Value, Recurring | Convertible Note
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	0
Level 1 | Fair Value, Recurring | Marketable Equity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	976	1,033
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial instruments fair value	85,696	41,561
Level 2 | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents(1)	26,200	30,336
Investments accounted for at fair value	34	66
Level 2 | Fair Value, Recurring | Marketable Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	59,431	11,125
Level 2 | Fair Value, Recurring | Convertible Note
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	0
Level 2 | Fair Value, Recurring | Marketable Equity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	31	34
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial instruments fair value	59,259	0
Level 3 | Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents(1)	0	0
Investments accounted for at fair value	0	0
Level 3 | Fair Value, Recurring | Marketable Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	0	0
Level 3 | Fair Value, Recurring | Convertible Note
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	59,259
Level 3 | Fair Value, Recurring | Marketable Equity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable Securities, Fair Value	$ 0	$ 0

XML

FAIR VALUE ACCOUNTING - Narrative (Details) $ in Thousands				2 Months Ended	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($) mi	Feb. 14, 2023 mi	Jan. 24, 2023 shares	Mar. 31, 2023 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change In Value Of Investments Accounted At Fair Value					$ (2,959)	$ (3,418)
Convertible Note, decrease in fair value				$ 740
Measurement Input, Price Volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Receivable, Fair Value Measurement Input | mi	0.60	0.60
Measurement Input, Yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Receivable, Fair Value Measurement Input | mi	0.106	0.095
Virginia Energy Resources Inc. | CUR
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired			100.00%
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Entity Shares Issued Per Acquiree Share | shares			0.26
Business Combination, Number of Common Stock Shares Acquired | shares			9,439,857
Business Combination, Acquired Shares Converted To Common Stock | shares			2,454,362
Virginia Energy Resources Inc. | Energy Fuels
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Shares Converted Into Common Stock | shares			16,189,548
CUR | Energy Fuels
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired			16.70%
Virginia Energy Resources Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Percentage Of Fair Value Investment							13.50%
Virginia Energy Resources Inc. | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments accounted for at fair value							$ 2,830
Consolidated Uranium Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Percentage Of Fair Value Investment					16.30%		17.40%
Investments accounted for at fair value	$ 16,370			$ 16,370	$ 16,370
Consolidated Uranium Inc. | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments accounted for at fair value							$ 16,500

XML

FAIR VALUE ACCOUNTING - Schedule of Fair Value Reconciliation Rollforwardd (Details) $ in Thousands	2 Months Ended
	Mar. 31, 2023 USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Unrealized loss included in other income (loss)	$ (198)
Notes Receivable
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance, February 14, 2023	59,457
Ending balance, March 31, 2023	$ 59,259

XML

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Revenue from related parties	$ 270	$ 270
Accounts receivable, related parties	270	$ 270
Accounts And Other Receivables, Net	1,790		$ 1,621
Consolidated Uranium Inc.
Related Party Transaction [Line Items]
Accounts And Other Receivables, Net	$ 1,500		$ 1,580
United Nuclear | Director | Arkose Mining Venture
Related Party Transaction [Line Items]
Equity method, ownership percentage	19.00%
Energy Fuels | Director | Arkose Mining Venture
Related Party Transaction [Line Items]
Equity method, ownership percentage	81.00%